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Thermal spraying of bioglasses offers the opportunity to produce coatings for different
biomedical applications. The resorption of the coatings can be adjusted by tailoring
the chemical composition of the glass and the coating microstructure.
This thesis describes the production of novel bioactive and bioresorbable glass
coatings for biomedical applications via an emerging suspension high velocity-oxy fuel
(SHVOF) thermal spray.
Bioglass® (45S5) was sprayed at the flame power of 90, 75, 50 and 25 kW by
varying fuel (hydrogen) and oxygen flow rates. No coating was obtained at the flame
power of 90 kW, and thin coating (< 10 µm) was obtained at 25 kW. Thick (25 ± 3
µm) and uniform coatings were obtained at the flame powers of 50 and 75 kW. The 50
kW coating was 16 ± 2 % porous, while the 75 kW coating was 10 ± 1 % porous. The
bioactivity tests of the coatings showed that no hydroxyapatite (HA) was deposited
on the surface of 25 kW coating even after seven days of immersion in simulated body
fluid (SBF). Whilst, the coatings produced at 50 and 75 kW revealed HA deposition
after three days. EDX analysis of the cross-section of the coated samples showed that
the 50 kW initial coating thickness reduced from 25 µm to 6 µm after immersion in
SBF for 7 days, which means that this microstructure was highly reactive towards SBF
and hence behaved like a resorbable coating.
Coatings from two bioactive glasses, namely ICIE16 (48.0 % SiO2, 33.0 % CaO,
6.6 % Na2O, 2.4 % P2O5 and 10.0 % K2O, in wt %.) and 13-93 (53.0 % SiO2, 6.0
% Na2O, 20.0 % CaO, 12.0 % K2O, 5.0 % MgO and 4.0 % P2O5, in wt %) were
successfully produced at the flame powers of 50 and 75 kW. For both formulations,
thick, porous and less hard coatings were obtained at 50 kW, whilst harder, dense and
less thick coatings were obtained at 75 kW. ICIE16 coatings showed more dissolution
in SBF than the 13-93 coatings. Moreover, in-vitro cell tests, using MG63 cells, showed
good cell attachment and proliferation on the surfaces of the coating, revealing good
cytocompatibility.
Resorbable phosphate based glass (PBG), P-40 (40.0 % P2O5, 16.0 % CaO, 24.0
% MgO, 20.0 % Na2O in mol %) was sprayed at 50 and 75 kW flame power. The 75
kW coating was thinner and rougher than the 50 kW coating; both coatings presented
globules on the surface. The Raman analysis of the P-40 coatings suggested that the
structure of the glass had changed as the concentration of Q2 (2 bridging oxygen)
species has been decreased. Whilst, Q1 (1 bridging oxygen) concentration has been
increased and Q0 (0 bridging oxygen) species has been formed. Due to these structural
alterations, these coatings showed less ion release and mass degradation than those
reported in the literature for P-40 thin films and bulk glass.
Ga2O3 doped Bioglass
® was manufactured for antimicrobial applications and de-
posited at 50 kW. Moreover, Ga2O3 and Bioglass
® suspensions were co-deposited via
a hybrid nozzle at 50 kW to mix them in the flame. Both coatings showed bioactivity
as HA was deposited on the surfaces of these coatings after immersion in SBF for 3
days.
In summary, SHVOF thermal spraying has been proven to be an effective and versa-
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Biomedical implants intended for load bearing applications such as orthopaedic, and
bone fixation; are made of metals and alloys such as titanium alloys (Ti-6Al-4V),
stainless steel and Co-Cr alloys. This is due to their high yield strength and ability to
perform under cyclic load applications [1]. However, these are susceptible to chemical
and electrochemical degradation in the body as the body fluid is aqueous with dissolved
oxygen and ions such Cl-1 and OH-1 [1]. Moreover, these metallic materials cannot form
any biological or chemical bond at the interface between the implant surface and host
tissue which leads to relative movements resulting in to inflammatory reactions [2].
The surface of an implant plays an important role in the body, since most chemical
and biological reactions occur at the surface. Thanks to surface modification of materials,
it is possible to combine the desired surface properties (bioactivity and ion release) of
the surface with the ideal bulk properties such as tensile strength or stiffness of the
implants [3]. So an effective approach to avoid unwanted reactions and achieve stronger
bonding of the implant with the host tissue is to modify the surface of the implant with
coating of desired properties [2]. Selecting the appropriate coating material and coating
technique is a major challenge in the production of implants for biomedical purposes.
In the United Kingdom alone 708,311 hip procedures were carried out between 2003
and 2013 of which 93% were due to osteoarthrities [4]. Primary revisions were carried
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out for 17,916 patients, while asceptic loosening occurred in 4,376 cases, and this was
the biggest reason of implant failure. Moreover, 2,443 revisions were conducted due to
infections [4].
Figure 1.1: Cumulative incidence revision diagnosis of primary total knee arthroplasty
[5].
Similarly in a study carried out using data from Australian Orthopaedic Association
National Joint Replacement Registry for total knee arthoplast (TKO), data collected
from September 1999 to December 2015, and it was found that the most common
reasons for the revisions were loosening and infections. It can be seen in Figure 1.1) that
the reason for the revisions in simultaneous as well as staged bilateral TKA groups were
infections and loosening of implants [5]. Moreover no significant differences were found
in the revision rates for loosening/lysis or infection when the 3 different staged interval
groups were compared with the simultaneous bilateral TKA. Due to these reasons
the development of innovative implants is necessary for more reliable applications [5].
Thermal sprayed, coatings presented here may be useful for a range of applications
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from hard tissue fixation and soft tissue integration to the therapeutic ions delivery
at the implant site for the promotion of osteogenesis, preventing infection or for the
treatment of degenerative diseases. To anchor the load bearing implant with the host
tissue, hydroxyapatite (HA) coating is usually applied for fixation. Particularly, hip
replacement is fixated to the host tissue via the acetabular cup and the femoral stem
and therefore the coatings are designed to be applied at these locations [6].
Bioactive and fully resorbable coatings have applications for a variety of orthopaedic
implants and could be utilised to fix dental implants, bone fracture plates and cranial
reconstructions. These coatings can stimulate cellular activity that results in enhanced
human osteoblast cells attachment, proliferation and differentiation to regenerate bone
[6].
Bioglass® (45S5) was the first bioactive glass developed by Hench et al. [7] con-
taining 45 % SiO2, 24.5 % Na2O, 24.5 % CaO and 6.0 % P2O5 (wt %). Bioglass
®
makes a bond with the host tissue, undergoes specific surface reactions when incu-
bated in simulated body fluid (SBF) [8] or implanted in human or animal body [9].
After implantation, a hydroxyapatite (HA) layer forms on the surface of the implant,
which makes a strong bond with the host tissue [9]. In addition, bioactive glasses are
osteoconductive (which means bone forms on the surface of the material), and release
osteogenic ions (which stimulates bone formation cells) and therefore attracted much
interest for bone tissue engineering [10]. These glasses can also be used for drugs
delivery applications [11].
The network connectivity (NC) for 45S5 is 2.11 and is suitable for rapid bone
regeneration. The NC is the mean number of bridging oxygen per silicon atom and
is a predictor of the bioactivity and hence reactivity in the physiological fluid of the
composition [12]. Although 45S5 is promising for coating, there are some limitations
such as the higher bioactivity and biodegradability of 45S5, and coating deposited
with this glass may degrade over time resulting in instability of the implant in the
long term [13]. Later other silicate-based glasses were developed, which also had the
ability to bond to bone tissue and enhance bone formation but with low solubility in
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the physiological fluid in comparison to Bioglass®, such as ICIE16 (NC = 2.13) and
13-93 (NC = 2.58). The addition of more network modifiers such as K2O and MgO is
a way to adjust bioactive glasses’ thermal, chemical and biological properties [14, 15].
Another family of biomaterials that is completely resorbable are Phosphate based
glasses (PBGs); these glasses have attracted a lot of interest in the field of tissue
engineering due to their controllable degradation profiles and chemical similarity with
the inorganic component of bone [16, 17]. Fully resorbable coatings could potentially
be advantageous for a variety of orthopaedic implants, such as bone fracture plates
and dental implants. These coatings may promote cellular activity and can result
in enhanced attachment, differentiation and proliferation of human osteoblast cells
[6]. Implants have a potential risk of infection; thus, Bio-engineering researchers are
developing solutions to avoid them. One of the possible strategies to prevent infections
relies on doping of antibacterial agents such as Ag+, Cu2+ and Zn2+ in the implant
coatings [18–20]. The antibacterial effect of these materials could be explained by the
electrical double layer theory [21]. The electrical double layer consists of a positive
charge layer at the surface of the solid and a negative charge layer in the solution next
to it (Figure 1.2).
Figure 1.2: Ti substrate coated with Ag nano particles showing the antibacterial mech-
anism of Ag ions [21].
Due to the chemical similarity of Ga3+ (as bactericidal agent) to the Fe3+ ions
(which is critical for the biological system), it can be used as Trojan horse, as the
biological system cannot distinguish Ga3+ from Fe3+. Ga3+ replaces Fe3+ in protein,
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and that is the reason for its antibacterial properties [22]. Slow release of Ga3+ ions
from a coating could be considered as the desired material for biomedical applications
[20].
The thermal spray is a group of techniques that produce coated surfaces by melting
and accelerating the particles onto a substrate. The thermal spray has existed for
more than a hundred years; however, the research is still ongoing on how to control the
properties of the coatings [23]. Air plasma spray (APS) and High velocity oxygen-fuel
(HVOF) are the two techniques among the thermal spray processes which are widely
used for powder processing [24]. APS utilises hot plasma to melt powder particles and
carried on to a substrate via an inert carrier gas, while, for HVOF, the coatings are
deposited utilising hot hypersonic gas. The jets produced due to the continuous fuel
combustion, which melts and propels the particles to produce coating [25, 26]. Both
these techniques are capable of producing coatings by processing nano sized particles;
however, HVOF coatings appear to be superior to APS due to the defect contents of
APS coatings [27].
The HVOF process is limited to use feedstock in the form of dry powder with a
particle size of 5 µm, as with smaller particle size, the powder flow ability is affected [28,
29]. Nano or micro sized particles can be used as feedstock if these are agglomerated
into granules of size > 5 µm [29–31]. However, coatings obtained from the thermal
spray of large nanostructured granules consist of a non-uniform microstructure in which
the outer layer has lost its nanostructure due to melting and re-solidification, while
the non-molten core has some nano-sized particles remaining [32, 33]. To produce
a homogeneous microstructure, each particle should be individually sprayed [33–35].
Using feedstock in the form of suspension is one of the approaches used to produce
microstructured and nanostructured coatings using thermal spray [31, 32, 35, 36]. The
emerging technology of Suspension high velocity oxy fuel (SHVOF) thermal spraying
is a coating deposition technique with the key advantage of enabling processing of
nano and micrometric particles in a suspension [28, 32, 37]. This process relies upon a
modified HVOF torch to spray a stable suspension instead of powder feedstock [38]. It
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has been shown that using a suspension as feedstock allows producing nano structured
coatings with improved strength and durability [17, 18, 20, 21]. This process produces
layers of flattened particles, resulting in a dense, thick microstructure coating with
good cohesive and adhesive strength. This process has already been experimentally
verified for bioactive coatings such as tri calcium phosphate, HA and Bioglass® [23–
25].
1.2 Aims and Objectives
The primary aim of this study was to develop a comprehensive processing-microstructure-
performance relationship for a range of biomedical coatings using the emerging suspension
high velocity oxy-fuel (SHVOF) thermal spray. Coatings were deposited via SHVOF
using bioactive glasses, Bioglass®, ICIE16 and 13-93 and PBG (P-40). Moreover,
chemically mixed Ga2O3-Bioglass
® was sprayed, and Ga2O3 and Bioglass
® suspensions
were co-sprayed via a hybrid nozzle to produce hybrid coatings with potential antibacterial
properties.
The overall aim of the PhD was achieved using the following four interconnected
objectives:
1. To manufacture Bioglass®, understand the effect of ball milling on powder size
reduction and prepare a stable suspension. Produce Bioactive coatings onto
metallic substrates with varying flame power (25, 50, 75 and 99 kW) and understand
the effect of flame on the microstructure of the coatings. Characterise the coatings
using advanced scanning electron microscopy (SEM), X-ray diffraction (XRD)
and Raman spectroscopy. Study the response of these coatings in simulated
body fluid (SBF) for potential end use applications.
2. Studying two more bioactive glass compositions namely ICIE16 and 13-93. Prepar-
ing their respective suspensions after size reduction and producing ICIE16 and
13-93 coatings at two flame powers of 50 and 75 kW. After basic characterisation
of these coatings, comparing their behaviour in SBF i.e HA precipitation and
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dissolution in SBF of these coatings after immersion in SBF. Moreover, testing
biocompatibility of these coatings using MG63 cells.
3. Third objective was to study the resorbable PBG P-40, ball milling the glass
and then making the suspension and coating at flame powers of 50 and 75 kW.
Determining the microstructure of as-sprayed coatings and then the ion release
study of P-40 coatings in milli-Q water via inductively coupled plasma mass
spectroscopy, whilst, studying the mass degradation conducted in milli-Q water
and phosphate buffered saline (PBS) solution.
4. The last objective was the production of two bioactive coatings (each at 50 kW)
having Ga2O3 as antibacterial agent. Deposition of Ga2O3 doped Bioglass
®
suspension making one coating, while, making the other coating by co-spraying
Ga2O3 and Bioglass
® suspensions. Then determining the microstructure of the
coatings, studying their bioactivity in SBF and determination of cytoxicity using
MG63 cells.
1.3 Thesis Outline
This thesis has been divided into following chapters
• Chapter 2, reviews different generation of biomaterials, explaining bioactive and
bioresorbable glasses, and different antibacterial ions incorporated in bioactive
and bioresorbable glasses. Moreover, coatings for biomedical applications via
SHVOF has been reviewed too. Summary of the literature has been made also
reporting gaps in the literature.
• Chapter 3, presents the materials and methods used throughout this work.
• Chapter 4, discusses the deposition of Bioglass®, the optimisation of the spray
parameters, the characterisation of the coatings, and their bioactivity through
SBF and toxicity tests.
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• Chapter 5, presents the deposition of ICIE16 and 13-93 bioactive glasses, the
coating characterisation, the apatite forming ability and cell proliferation.
• Chapter 6, explains the deposition of P-40 glass, ion release and degradation
profiles of the produced coatings.
• Chapter 7, presents the production of antimicrobial coatings (first coating pro-
duced by depositing Ga2O3 doped Bioglass
® suspension and the second one was
produced by depositing Ga2O3 and Bioglass
® suspension via a hybrid nozzle) its
characterisation, SBF tests, and toxicity tests.
• Chapter 8, concludes the findings of this work.





This chapter focuses on the key concepts which illustrate the underpinning science of
the work presented here, providing information behind the basis for the selection of
the materials and the processes used in this work to produce coatings for biomedical
applications.
Starting with different generations of Biomaterials, explaining bioactive glasses and
PBGs and then their utilisation as coating for biomedical applications, this chapter
also reviewed antibacterial species incorporating in bioactive or PBG, concluding with
the Ga2O3 as antibacterial agent incorporating in bioactive glass for the purpose of an
antibacterial and bioactive coating deposition on metallic implants.
2.2 Biomaterials
Materials which are employed in implants and medical devices are called biomateri-
als. These materials can perform predetermined functions when they interact with a
biological system [2]. In particular, the main feature required for a biomaterial is bio-
compatibility. Biocompatible materials do not release ions in a concentration that is
toxic for the human body, and must not trigger a foreign body response by the immune
system which could lead to reactions such as inflammation and rejection of the implant
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[39, 40]. Also allowing the material to perform the desired function and creating the
appropriate favourable cellular response [40]. Biomaterials can be classified into three
types based on their specific interaction with the human body. These are bioinert,
bioactive and bioresorbable.
2.2.1 Bioinert Materials/Biotolerant
This first generation of biomaterials were designed to be as inert in the physiological
environment as possible. These materials do not release toxic ions and the immune
system does not cause a foreign body response after implantation. The main purpose of
the bioinert materials was to avoid prosthesis rejection [41]. Ceramics such as alumina
and zirconia, Ti and Cr-Co alloys in metals, polymers such as ultrahigh molecular
weight polyethylene, are examples of bioinert materials. In the past, these materials
have been frequently used and are still common in bone repair applications; however,
these materials do not form any chemical or biological bond at the implant- host
tissue interface which could lead to inflammatory reactions due to relative movements
[42]. Due to these reasons, bioinert materials could be implanted successfully only if
loaded under compression and with a close mechanical fitting [43]. The relative micro-
movements can be overcome; some procedures such cementation have been developed
which improves the adhesion between the host tissue and the implant by applying
a polymeric or an inorganic cementing paste [44]. The interfacial adhesion between
prosthesis and implant could be improved when the growing bone attaches to the
surface irregularities of the implant. This can be further enhanced by increasing the
surface area of the implant, this fixation of the implant with the host tissue is called
‘morphological fixation’. When the bone grows in the pores of the implant, it also
improves the adhesion of the implant with host bone and the method is called ‘biological
fixation’ [43]; however, these methods of fixation do not generally improve survivability
over cementation [43]. Also for biological fixation, the implant should be porous which
may be mechanically inadequate.
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2.2.2 Bioactive Materials
The second generation of biomaterials are those which facilitated bond formation at
the interface between the host tissue and the implant by allowing hard tissue formation
at the surface of the implant [45]. The first bioactive material was proposed by Pro-
fessor Larry Hench for resolving the problem associated with implant rejection. The
hypothesis for the development of bioactive materials was;
“The human body rejects metallic and synthetic polymeric materials by forming
scar tissue because living tissues are not composed of such materials. Bone contains a
hydrated calcium phosphate component, hydroxyapatite (HA) and therefore if a material
is able to form a HA layer in vivo it may not be rejected by the body” [46].
When these materials are implanted in the body, they induce the formation of bond
with the host tissue due to the development of dense carbonated hydroxyl apatite
(HCA) layer on the surface and which is similar to the mineral component of the
bone and therefore the implant is not perceived as foreign body [47]. Accordingly,
the implant is not covered with a fibrous tissue as happens with bioinert materials
and also the surface directly bonds to the new host tissue. The direct bonding of
the surface to the host tissue, results in strong adhesion between the implant and host
tissue which reduces the problems associated with the micro-movements [43]. After few
(3-6) months of implantation, the bond between the host tissue and bioactive material
reaches to the strength comparable to the of the host bone; this is called ‘bioactive
fixation’ [43]. Moreover, some bioactive materials can make a bond with the collagen
of soft tissue [46]. Bioactivity of these materials is measured in terms of ‘index of
bioactivity (Ib)’, which relates bioactivity with the time required for 50% of bonded





Bioactive glasses possess the highest bioactivity index (6-12), and glasses with bioac-
tivity index greater than 8 make a bond with the soft tissue as well [49]. This bonding
to bone behaviour was first demonstrated for a range of bioactive glasses that were
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composed of SiO2, NaO2, CaO and P2O5 in specific proportions. The important com-
positional features of these glasses were that it had < 60 mol % SiO2, high content of
CaO and NaO2 and high ratio of CaO to P2O5. These features make the glass highly
reactive when in exposed to an aqoues medium, such as physiological fluid [49].
A compositional diagram SiO2–Na2O–CaO system is shown in Figure 2.1, the effect
of composition on the bioactivity of these glasses can be seen and hence the bonding
ability of different compositions. Composition in region A bonds to bone, region B are
container and window glasses which are bioinert, and their implantation would result
in a fibrous tissue formation around the implant. This behaviour is due to the very
dense silica network of the glass, which makes it resistant to dissolution in the body
fluid. While, region D composition is not feasible due to very low silica content and due
which glass network cannot form or crystals form [42], whereas E is the composition of
Bioglass® (45S5) [50].
Figure 2.1: Bioactive Glasses and Glass ceramics, bioactivity dependency on compo-
sition, where A/W is for apatite-wollastonite. In region A P2O5 is 6 wt % [42].
2.2.2.1 Bioglass® (45S5)
Bioglass which is also known as 45S5, is a soda lime phospho silicate glass. This glass
becomes reactive in a physiological environment and consists of SiO2 network (Figure
2.2 A) with other components such as CaO, Na2O and P2O5 as network modifier (2.2
B) [50]. In the formulation of 45S5 is 45 wt % SiO2, 24.5 wt % Na2O, 24.5 wt % CaO
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and 6 wt % P2O5, and so the name is 45 % SiO2 and Ca/P ratio 5 [49]. Bioglass is the
first known bioactive glass discovered by professor L.L. Hench [42, 43] and that has the
highest bioactivity index (12.5) in the family of bioactive materials [43]. This finding
led to a revolution in the world of prosthetic materials.
Dissolution in the body fluid of different glass composition depends on the connec-
tivity of the silicate network. A glass is more durable if it contains a large proportion
of bridging oxygen bonds. Bridging oxygen bond is silica tetrahedra covalently bonded
to other silica tetrahedra via –O-Si-O bonds. Network connectivity is directly propor-
tional to silica content, due to this reason melt derived glasses with more than 60 mol
% silica are not bioactive [50].
Bioactivity of a material can be assessed by using simulated body fluid (SBF). SBF
is an acellular solution with an ionic concentration similar to blood plasma. Tests are
carried out by immersing sample in SBF in a fixed volume for a specific time period
in a controlled environment [8]. This test is based on Hench’s hypothesis about the
development of HA on the surface of the material while in a physiological environment,
which led to the formation of bioactive glasses. The development of HA on the surface
of biomaterial in SBF is the verification of its bioactivity [8]. The significance of
SBF test is still under debate due to the limitation of their inability to verification of
antibodies reactions; however, SBF tests are the preliminary way for the determination
of potential bioactivity [51].
As supposed by Hench, a material is bioactive if it can form a surface layer of
HA [46]. In total 11 steps are involved in the mechanism of HA layer formation and
consequently bonding with the living tissue [43]. The first 5 steps consist of ionic
reactions between the glass and the physiological fluid, while the subsequent steps are
of the cellular level. This mechanism is described in Table 2.1. Theoretically bioactivity
of these glasses can be predicted from their composition. In these glasses SiO2 acts as
a network former.
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Table 2.1: Reaction of Bioactive Glass with the surrounding tissue and bone formation
with time [43].
LogT (Hrs) Surface Reactions Stages
— 1 and 2
Na+ exchange with H+ leads to the formation of
silanol group (Si-OH),
Network Dissolution: Formation of SiOH groups and
release of Si(OH)4
1
3 Polycondensation of silanol groups
4 Formation of amorphous CaO-P2O5
2 5 HCA Crystallisation
3 6 Biological moties adsorption in HCA layer
4 7 Macrophages Action
5 8 Stem cells attachment
6 9 Osteoblast differentiation and proliferation
7 10 Generation of matrix
8 11 Crystallisation of Matrix
Bioglass and other bioactive glasses can be made by two methods, melt quench and
sol-gel. In the melt-quenched oxide are melted at high temperature (>1300 °C) in a
platinum (95 wt % platinum and 5 wt % gold crucible [12], and platinum-rhodium
crucible [52, 53]) and quenched in a mould of graphite or steel or quenched in water.
The sol-gel is a comparatively low temperature processing method where the precur-
sors in the form of solution (sol) convert to a gel after a polymeric reaction at room
temperature [54]. Gel is three-dimensional skeleton network surrounded by a liquid
phase. Both of the phases are continuing with nanometric dimension. Gelation of the
solution is achieved by hydrolysis and condensation in 48 hrs. Gel is then converted
to glass after drying and heating at high temperature fro 3-6 hrs, such as 600 ◦C [53,
55]. Via sol-gel technique, bioactive glasses can be made that are either mesoporous
or nanoparticles simply applying different catalyst while making the sol [55]. With
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sol-gel, bioactive glasses can be made with wider composition, which is not possible
with the conventional melt-quenched. This is due to their structure which results from
the condensation of Si–OH bonds in solution. This process spontaneously occurs in
the physiological environment and sol-gel glasses assumes an appropriate structure for
the promotion of HCA formation in biological environment [2]. However, the sol-gel
glass may degrade too rapidly in some application where longer regeneration time is
required [56].
Figure 2.2: (A) Silica tetrahedral of silicate glasses, (B) random glass network of
network formers and modifiers [53].
The bioactivity of Bioglass and other bioactive glasses can be predicated theoreti-
cally from the network connectivity, which is given as follows




Where BO represents the total mol % of oxides that can form bridging oxygen per
network forming ions, NBO is the total mol % of oxides that form non-bridging oxygen
and G is the mol % of glass forming units within the network [50]. NC of Bioglass is
1.90 if P is assumed to enter in the silicate network by forming P–O–Si bonds. However,
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in the melt derived glass phosphate forms Q0 [PO4]
3- units instead of becoming a part
of silicate network. This phosphate complex requires three positive charges to balance
its own charge [57]. Due to this reason, the modified NC of 45S5 is 2.11 [15]. Glasses
with NC greater than 2.40 are not likely to be bioactive, as can be seen in Figure 2.3
that with NC greater than 2, the rate of deposition of HCA layer decreases quickly
[50].
Figure 2.3: NC affects HCA formation on SiO2–CaO–Na2O glass discs in simulated
body fluid (SBF) [50, 58].
Other properties such as crystallisation tendency can be predicated from NC of the
glasses. Such as the glasses with NC > 2 generally have high energy barrier to overcome
for crystallisation in comparison to the glasses with NC < 2 [50]. Crystallisation
temperature (Tc) of Bioglass® (45S5) is 677 °C while its glass transition temperature
is (Tg) is 538 °C. The thermal processing window (Tc-Tg) of this glass is 130 °C [50],
which is narrow for sintering purposes [15, 56].
The first Bioglass based implant was used in the USA to replace the small bone
in the middle ear for the treatment of conductive hearing losses [59]. This device was
approved by FDA in 1985 with a commercial name of “Bioglass® Ossicular Recon-
struction Prosthesis”, also known as “Middle Ear Prosthesis” MEP®. This implant
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consisted of a truncated nonporous cone made of 45S5 produced by the melt-quench
method. Sound was conducted through this implant from the ear drum to cochlea.
The implant was firmly bonded at both the ends to the living tissues due to the ability
of Bioglass to bond with hard as well as soft tissue (eardrum) [60]. Better performance
was observed for short term and midterm application of the MEP® than the inert
implants made of alumina; however, long-term clinical study with a follow-up of 10
years showed that Bioglass was liable to progressive dissolution. Also, bioglass was
fragmented in the biological environment of middle ear [45, 61]. Due to these reasons,
MEP® were taken from the US market in the early 2000s. However, in some European
countries, a modified version of MEP® (Douek-MEDTM) which 45S5 Bioglass® cones
of three different sizes, is still commercially available [45]. Similarly, Bioglass®-EPI
(extracochlear percutaneous implant) was commercialised; however, this was taken off
the market in late 1990s due to the risks associated with the dissolution of 45S5 with
time.
In powder form 45S5 has been used to repair bone defects in jaw and orthopaedics,
called ‘NovaBone®’ (NovaBone Products LLC, Alachua, FL) with a particle size range
of 90–710 µm [62]. While using Novabone®, surgeons mix it with the patient’s blood
or balanced salt solution to acquire mouldable consistency. The resultant putty can
then be pressed into defects as its shape and size [45]. In a comparative study carried
out by Brice Ilharreborde et al. while using NovaBone® putty and Iliac crest autograft
revealed less infection (2 %) and mechanical failures (2 %) for NovaBone® in compar-
ison to Iliac crest autograft (5% and 7.5 % respectively) over four years follow up [59].
Biogran® (Biomet 3i, Palm Beach Gardens, FL, USA) is another bioactive glass prod-
uct with a particle size range of 300–360 µm. Biogran is mainly used in maxillofacial
and dental applications to repair of defects in the jaw bone [63]. 45S5 has also been
commercialised as a sintered porous block; however, the working window of Biogalss
is small (130 °C) and devitrification occurs while sintering it which adversely affects
its bioactivity [64]. Novamin® (Technology, FL, USA) is another 45S5 Bioglass based
product in the form of very fine powder (average particle size 18 µm). This new prod-
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uct has been owned by GlaxoSmithKline, Brentford, UK, and added to toothpaste for
treating tooth hypersensitivity [65–67]. Dentinal tubules occlusion and tooth surface
mineralisation are done by Novamin® and so eliminates the origin of disease [68].
2.2.2.2 Alternative Bioactive Glass Formulations
After the discovery of Bioglass (45S5) by Hench, a large number of silicate-based bioac-
tive glasses have been developed which show excellent bone-bonding properties [69].
As glass is a random arrangement of units, so a large number of therapeutic ions can be
incorporated in the chemistry without significantly changing its properties. As men-
tioned earlier, the processing window of 45S5 is low (130 °C), and thus crystallises when
heated at higher temperature than Tg. Crystallisation presents a problem if sintering
of the glass particles is required to make a scaffold or coating a metal implant with
it [50]. Another drawback of the coating metals with Bioglass (45S5) is the mismatch
between thermal expansion coefficients (TEC) of the substrate and 45S5. Ideally, the
TEC of 45S5 should be similar to that of the substrate so that upon cooling after ther-
mal processing, the glass would not pull away from the substrate [70]. Such as TEC of
45S5 is 15 × 10-6 °C-1 and that of Ti alloys about 9 × 10-6 °C-1 which are commonly
used to fabricate orthopaedic and dental implants [13, 45]. So it was needed to develop
new bioactive glass formulations with a TEC more suitable for coating purposes on
metals. Bioactive glasses in the system of SiO2-CaO-MgO-Na2O-K2O-P2O5 have been
extensively explored to match TEC of Ti6Al4V alloy [70–72]. Partially replacing Na2O
and CaO with K2O and MgO was the common strategy to design and adjust the TEC
of the bioactive glass in a controlled way [72] [39]. Addition of B2O3 is also a way to
decrease TEC; however borosilicate silicate glasses shows higher dissolution in aqueous
media and physiological fluid than the silicate glasses [73].
2.2.2.2.1 ICIE16 Bioactive Glass: ICIE16 is a bioactive glass with a modified
composition of 49.46 % SiO2, 36.27 wt % CaO, 6.6 wt % Na2O, 1.07 wt % P2O5 and 6.6
wt % K2O, in mole %. Many of the physical properties such as Tg and solubility are
related to the alkali metal content present in the glass. Incorporation of second alkali
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metal oxide in oxide glass results in a marked deviation in its transport properties such
as viscosity, ionic conductivity, diffusivity of network modifying ions. This phenomenon
is known as ‘mixed alkali effect (MAE)’. Due to the addition of second alkali oxide glass
can be made at lower temperature [14]. Also, the problem associated with the high
solubility of bioactive glasses can be overcome with this addition. MAE in bioactive
glasses could be used to tailor their physical and biological properties [14].
Incorporation of K2O into bioactive glasses has primarily been to manipulate the
processing window. It acts as a network modifier, distorting the glass network reduc-
ing the melting temperature, and improving the durability of the glass with controlled
dissolution characteristics. Salam et al. showed that substituting K2O for Na2O re-
sulted in high Tc [74] by increasing of disorder within the system due to MAE [75].
The increment in the disorder of the glass system is due to the higher ionic radius of
K+ than Na+ and less ionic field strength of K+ than Na+. Thus the addition of K2O
reduces the overall strength of the silicate network through the formation of Si-O-K+
bonds resulting in reduced viscosity of the glass [76]. However, with the addition of
K2O, bioactivity was reduced in terms of delayed apatite layer formation [77]. Due to
MAE the glass processing window of ICIE16 has increased to 180 °C, which was 130
°C for 45S5 composition [77]. Also, the TEC of this glass is 15.3 x 10-6 K-1 while for
45S5 TEC is 15.75 x 10 -6 K -1 [77, 78]. However, ICIE16 composition is closer to 45S5
(as can be seen in Figure 1) and its NC is the same as of 45S5 (2.11) [15, 77], and is
proved to be bioactive [15]. Also, the work done by Nomm et al. showed that this glass
was non− toxic and the scaffold made of ICIE16 supported bone in−growth within a
femoral head defect in a rabbit model [15].
2.2.2.2.2 13-93 Bioactive Glass: 13-93 is a bioactive silicate glass based on 45S5
composition; however, it has comparatively higher silica content and additional network
modifiers such as K2O and MgO (53.0 wt % SiO2, 6.0 wt % Na2O, 20.0 wt % CaO,
12.0 wt % K2O, 5.0 wt % MgO and 4.0 wt % P2O5) [10, 79]. 13-93 has been approved
for in vivo use in Europe [80], also approved for in vivo use by the US Food and Drug
Administration [81]. Due to the better processing window (300 °C [82]) of 13-93, it can
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be pulled in fibres more easily than 45S5 which is due to its better viscous flow [83,
84]. Also, 13-93 is the most common glass used for making dense 3D scaffolds without
crystallisation [10, 15]. Another advantage of 13-93 bioactive glass is that it can be
coated on metallic implants with better (than 45S5 coating) adhesion between coating
the substrate as its TEC is lowest 12.4 x 10-6 K -1 in comparison to other bioactive
glasses such as ICIE16 and 45S5 as investigated by F.Dohler et al. [78]. The reason
for the lower TEC is the low concentration of network modifier, high silica content
and high NC [78]; however, due to high silica content (53.0 wt. %), high network
connectivity (2.6 [77]) and presence of a high amount of MgO glass is less vulnerable
to dissolution and hence reduced bioactivity in terms of HA formation [85, 86]. In
vitro tests showed proliferation and differentiated function of osteoblastic MC3T3- E1
or MLO-A5 cells on 13-93 dense disks similar to 45S5 [87]. Fu. Qaing et al. evaluated
in vivo 13-93 bioactive glass scaffolds with trabecular and columnar microstructures
seeded and unseeded with stem cells (MSCs) in a subcutaneous rat implantation model.
They found that seeded scaffolds showed better integration with the surrounding tissue
as the scaffolds were surrounded by a band of fibrovascular tissue (100–300 µm thick).
Bone like tissue was also noticed in the seeded samples and the authors concluded that
13-93 scaffolds could be used for bone regeneration and integration [9].
Role of magnesium in the glass is under debate in the literature. As investigated
by Watts et al. for particular glass compositions, of the total added Mg2+, 86.0 %
of Mg2+ acts as network modifier, while 16.0 % as a network former [86]. However,
in the literature, mixed reports are present for the role of magnesium in glass that it
can act as network former or modifier and this also depends on its content present in
the glass composition [88]. Addition of MgO is also beneficial as its presence causes a
decrease in the glass Tg and an increase in Tc, thus widening the processing window
of the glass [10, 86]. On the other hand, the presence of Mg has detrimental effects on
the bioactivity of bioactive glasses as it retards apatite formation during bioactivity
tests (SBF) [88–90]. However, Vallet. Regi et al, demonstrated that the rate of apatite
formation would be slow if the MgO content in a bioactive glass was more than 7 mole
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% [90]. It suggests that magnesium can slow down apatite crystal growth; however, it
is a cofactor in a number of enzymes necessary for the bone health [89], as indicated
by Ferreira et al. that bioactive glasses incorporating MgO are suitable for osteoblast
like cell proliferation [91]
2.2.3 Bioresorbable Materials
The third generation of bio-materials is the ‘Bioresorbable materials’, which gradually
dissolve in the body whilst being replaced by the new living tissue that replace the
implant material completely [92]. Resorbable materials could be the optimal solution
for the bone implants as living tissues can repair and replace throughout life. Also the
problem associated with the long term stability could be overcome as the implant itself
is gradually replaced by the living tissue [92, 93]. Disadvantage of these materials is
their mechanical performance required for the substitution time, when the living tissues
are regenerating while the implant materials is already being dissolved. Moreover rate
of tissue regeneration must match with the degradation rate of these materials. The
resorption rate of the implant material can be tailored using several methods such as
doping, or the adjustment of the geometry (interconnected pores) of the bioreorbable
device [92]. Also, the dissolution product of these materials must be tolerable by the
human metabolism. Due to this reason resorbable materials are doped with ions which
can induce genetic stimulation and tissue can heal naturally [94, 95].
Resorbable polymers such as poly (lactic-acid) and poly (glycolic-acid) are used in
clinical practice (are employed for the sutures). These materials metabolise to CO2
and H2O after withstanding an appropriate time [93]. Ceramics such as tricalcium
phosphate could be used as resorbable material in particulate form or porous devices.
However, these materials are not able to withstand mechanical stresses while resorbing
[96].
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2.2.3.1 Phosphate Based Glasses:
Phosphate based glasses (PBG) consists of phosphate as the glass network former.
For example, calcium phosphate glasses can have a composition similar to the mineral
part of the bone (HCA), that is biological calcium phosphate [97]. These glasses are
fully resorbable in aqueous media whilst realising a custom array of ionic constituents
which activate the cellular response in a controlled manner and thus could be desirable
for potential biomedical applications [17, 98–100]. Backbone of PBG is the PO4
3-
tetrahedra [101], while CaO and Na2O act as network modifier [99]. These glasses can
be doped with other metal oxides such as Mg [99, 102], Ca [103, 104], Sr [101, 105] , F
[106] which have been investigated for tissue regeneration, Ti [107, 108], Fe [109], for
durability, Ag [110, 111], Cu [112] and Ga for their antibacterial properties [113].
PBGs are made by the conventional melt-quench method, e.g. mixing the glass
precursors (phosphates, oxides and carbonates in powder form; also phosphoric acid
could be used as a phosphate source) and then melting this mixture at high temperature
in Pt crucible. Melting temperatures of PBG are comparatively lower than bioactive
silicate glasses and usually are in the range of 800-1300 °C [97]. In order to reduce
stresses in the glass, the melt is poured into preheated graphite or metal moulds and
placed into a furnace preheated to Tg of the glass and annealed (slow cooling to room
temperature) [97] . PBG can also be made by a sol-gel process too, however, the sol-gel
phosphate glasses are more fragile than bioactive silicate glasses and are very soluble
[97, 114].
Similar to silicate glasses, PBGs show short-range order and do not have significant
symmetry of atomic arrangement [97]. The basic network former in PBG is the or-
thophosphate tetrahedron (PO4
3-) (Figure 2.4) [101]. In the glass structure, phosphate
tetrahedra bond the bridging oxygen to the phosphorus atom and the tetrahedron
forms P-O-P bonds with the adjacent tetrahedron [115] . Hoppe et al. investigated
by Neutron diffraction experiments that within the PO4 unit two bonds of different
lengths existed, i.e., one bond is of the phosphorus with the terminal oxygen atom
and other with the bridging oxygen atom [116]. The presence of terminal oxygen in
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phosphate anions reduces the NC of PBG in comparison to silicate glasses [117]. The
structure of PBGs are usually defined by the number of BO, which is represented by
Qn (where ‘n’ represents the number of bridging oxygen per tetrahedron as can be
seen in Figure 2.5 ). So, the structure of PBG can be produced in 3D cross-linked
Q3 tetrahedra (ultra-phosphate), chain-like Q2 structure (meta-phosphate), invert Q1
(pyro-phosphate) and Q0 ortho-phosphate structure [118]. The 3D network of P2O5 is
very unstable due to its hygroscopic nature. P-OH bonds can form due to the pres-
ence of moisture in glass composition (or moisture from the atmosphere) and which
can cause de-polymerisation. Moisture can also affect chain lengths in meta-phosphate
glasses which results in shorter phosphate chains. With the decrease of chain lengths
these glasses are resistant to water attack and the subsequent scission, and that’s why
the glass becomes more stable when exposed to the humid environment [97].
Figure 2.4: Phosphate tetrahedron in PBG structure [97].
Figure 2.5: In figure (a) shows phosphate tetrahedra with O:P ratios (b) shows the
Qn species [113].
PBG network can also be depolymerised by the addition of alkali and alkaline
metal ions (M), which breaks the bridging oxygen P-O-P bonds and creates more
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terminal oxygen (P-O-M) and making the glass stable [115]. Chemical durability and
other properties of PBG such as crystallisation tendency and mechanical characteristics
depend on the P2O5 content as well as the charge to size ratio of the network modifiers
[97]. Incorporation of metallic ions with small ionic radii with high electrical charges
is known to form strong P-O-M bonds. The consequence of these bonds can be high
resistance to hydration. Such as the addition of Fe2O3 and TiO2 have been shown to
significantly decrease the dissolution rate of PBG [109, 119]. These positive ions make
the glass network strong via cross-linking between two NBOs. An increase in charge-
to- size ratio results in stronger cross-linking. Due to this fact, the cross-linking would
be expected to increase in the order of Na+ → Ca2+ → Fe3+ → Ti4+ [97]. Similarly,
for cations of the same charge but with decreasing ionic radii the cross-linking would
be increased in the order of Ba2+ → Sr2+ → Ca2+ → Mg2+ [97].
2.2.3.2 Dissolution of PBG:
Deionised water (deiH2O) and distilled water have been used to conduct the degrada-
tion studies of PBG [97, 107, 118, 120, 121]. To mimic conditions within the body, in
vitro media such as SBF, Simulated Urine (SU), and Phosphate Buffered Saline (PBS)
have also been used for dissolution [8, 111]. As said earlier, SBF mimics ionic con-
centration and chemical composition of human blood plasma [8]. Ionic concentration
and chemical composition of SU is similar to human urine [111], whilst PBS buffers
the solution to recreate the pH conditions within the body [122, 123]. Degradation of
PBG is also highly dependent on the pH of the media, with increased degradation at
lower pH as investigated by Bunker et al [122]. Similar to the physiological pH within
the body, PBS buffers to a pH of 7.40 at 37 °C. That is why PBS has been the media
of choice to observe the in vitro dissolution kinetics of degradable polymers and PBG
[121, 124]. Melt quenched PBG degradation mechanism is well understood. The disso-
lution rates of PBG have been shown to vary by orders of magnitude as a consequence
of changes in glass compositions. In aqueous solution, PBG degrades by reacting with
H2O molecules which de-polymerise the network by breaking P-O-P bonds [120, 122].
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For the glasses containing monovalent ions such Na+, the degradation process consists
of three stages. Acid/base reaction is the first stage during which the glass surface
becomes saturated with acid H+ ions or base OH- ions. This reaction increases linearly
with time until no more uptake is possible (Figure 2.6) [120, 122]. H2O molecules then
diffuse in the network hydrating it, which results in the degradation profile of t
1
2 [122].
The third phase is the linear dissolution and is the hydrolysis reaction upon which the
polymeric chains disentangle and separate completely as described by Bunker et al.
[122].
Figure 2.6: Acid/base reaction leading to hydration and chain hydrolysis [120].
In both dissolution phases (t
1
2 and linear) were uniform for the alkali ions present
rather than the pre-selective leaching of certain elements and therefore throughout the
degradation, the stoichiometry remained constant. Degradation is pH dependent, such
that in various solutions degradation may be increased up to 100 times [122].
Post-degradation, the solution was saturated with Ca and P ions and no glass
structure remained [122]. Haque et al. investigated the dissolution of 40-P2O5 24-MgO
16-CaO 16-Na2O 4-Fe2O3 mol % fibres in dH2O. Following 8 hrs degradation in water,
they found that the glass fibres were peeling off and described this as a form of pitting
corrosion [125]. Similar flaking around the boron-containing PBG fibres was found
while degrading in PBS by Sharmin et al. [124]. Similar peeling effect of Fe containing
PBG fibres was reported by Abou Neel et al. [109]. It was suggested that this peeling
effect in fibres was due to the differential hydration at the surface and bulk layers,
which led to the tensile forces and resulted in cracking [125, 126].
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The effects of structural changes in controlling degradation rates have been explored
by comparing various PBG compositions [127, 128]. Parsons et al. concluded that there
was no significant correlation between the phosphate content and the glass degradation
and thermal properties; however, the effects of di- and trivalent metals content on these
properties were significant. Authors attributed the overriding cause of changes in glass
properties to the cross-linking of the glass structure by di- and tri-valent metals than
the state of the phosphate chain backbone. In addition, results presented suggested
that with the increase of these metals content, density and Tg of glass increased while
degradation rates decreased [127, 128]. Islam et al. reported that with varying MgO
content in the glass composition 40P2O5-(40-x)CaO-xMgO-(20-y)Na2O-yTiO2 (where
0 ≤ x ≤ 24 and y = 0 or 1) the degradation rate also varied such that degradation
rate decreased with an increase of MgO content [99]. Stuart et al. investigated the
degradation of PBG, namely P40 (40P2O5-24MgO-16CaO-16Na2O-4Fe2O3) in dH2O
and PBS and found that the glass exhibited a linear degradation profile over 83-days
test period in both media. However, in dH2O degradation occurred 1.38 times faster
than in PBS which could be due to the pH of the two media, as during tests pH of
dH2O was in the range of 6.77 - 7.02 and for PBS was 7.27 - 7.40 [129].
2.2.4 Biomaterials Containing Antimicrobial Ions
Infections are the most serious and common cause of postoperative complications in
patients surgically treated with implants. Implants related infections are generally diffi-
cult to cure and have a larger adverse impact on the quality of life [130–132]. Implants
can become colonised by bacteria at the time of surgery or through haematogenous
route from a distant source [133]. These infections are due to the highly adaptive abil-
ity of bacteria to colonise the surface of the implant or of adjacent damaged tissue cells
[134]. Mostly implant surfaces are physiochemically active and control cellular adhe-
sion, integration and inflammatory responses [135]. Moreover, the host extracellular
matrix proteins such as fibronectin, fibrinogen, elastin and collagen adsorb by implant
surfaces and hence provide receptor locations for bacterial adhesion [134–136]. Sev-
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eral bacterial species have adhesins that facilitate cell anchorage and binding to host
extracellular proteins [137]. Such as Staphylococcus aureus has distinct binding sites
for extracellular matrix proteins (collagen and fibronectin). This family of adhesins
facilitate adhesion to implants as well as bone matrix [136].
Mostly the isolates from the infected implant surfaces are Gram positive S. aureus
and Staphylococcus epidermidis. Additional isolated microbes include Escherichia coli,
Pseudomonas aeruginosa, Proteus mirabilis and beta haemolytic Streptococcus [134,
138]. However, a large proportion of these infections are due to S. aureus and S.
epidermidis as infections occur due to other microbes represent small percentage of ap-
proximately 22.0 % [137]. The alarming level of antibiotic resistance of S. aureus is the
reason of the most infections produced by this specie. As four out of five strains resist
penicillin drugs, while four out of ten strains do not respond to methicillin/oxacillin
[137]. Also S. aureus can form biofilms on implant surfaces where bacteria can con-
tinue in a low metabolic and stationary growth phase. In these biofilm, they resist
the action of host immune system and antibiotics [139]. Antibiotics general toxicity
(with associated liver and renal complications) and resistance, demonstrated antibiotics
ineffectiveness in the prevention of implant-related infections [110].
Due to the onset of antibiotic resistance in many bacterial strains, innovative ther-
apeutic strategies are being sought out [110]. Bioactive glasses could be the ideal
material for implants as they not only promote regeneration of living tissue but they
also have been shown to exhibit antibacterial activity. Furthermore, these glasses could
be used for sustained delivery of antibacterial ions to the local microenvironment [140,
141]. The antibacterial effect of these glasses is due to the increase of the local pH
because of the leaching of ions when these are implanted in the body. The elevated
pH alters the pH gradient of the cytoplasmic membrane of bacterial cells (and the
function of which is the movement nutrients in to the cells). As a result of this high pH
cytoplasmic membrane is compromised, and eventually, cells die [142]. Second theory
about the bactericidal effects of bioactive glasses is that the OH− ions can react with
the fatty acid present in the membrane and form free lipid radicals that weaken the
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membrane and causing it to collapse [142]; however, these effects were found to kill
certain oral bacteria [143] and skin pathogen [144]. Hu et al. investigated the effect
of pH on killing bacteria. The media used by the author had a pH of 7.0 with a bac-
tericidal percentage lower than 10. With the addition of 50 mg/ml of 45S5 particles,
pH was increased to 9.8, and the bactericidal percentages for S. aureus, S. epidermidis
and E. coli increased up to 98.0 % [144]. On the contrary, Bellantone et al. demon-
strated that the bioactive glasses are not antibacterial as the authors did not find any
significant difference between the mean cell viabilities of the control cultures and for
the 45S5 containing cultures when tested against S. aureus, S. epidermidis and E. coli
[145]. Stoor et al. reported that bioactive glasses are not antibacterial and could only
be subject to bacterial adhesion [146]. Although, bioactive glasses have been found to
have bactericidal effects on a range of pathogenic bacteria in vitro, adding antibacterial
ions in the glass system have also demonstrated bactericidal effects. Research has been
done by developing bioactive glass doped with Ag+ ions and have shown promising
results [18, 145]. Cu2+ ions doped PBG have also been proved to be antibacterial [19,
112]. Similarly, Zn2+ has been shown to inhibit biofilm formation from several Gram-
positive and negative bacteria when used in micromolar concentration [20]. However,
recently bioactive glasses containing Ga3+ attracted more attention due its bactericidal
and chemotherapeutic properties [20, 147].
Ga3+ ion chemical properties are similar to those of Fe3+ ion, such as ionic ra-
dius [20], and can be used as Trojan horse as many of the biological systems cannot
distinguish Ga3+ from Fe3+. The oxidation and reduction of Fe3+ is critical for of
biological systems so supplementation of Ga3+ can disrupt these Fe3+ processes by
incorporated into enzymes and as Ga3+ cannot be reduced under physiological condi-
tions, this disrupts enzymatic action and leads to cell death [22]. The ability of Ga3+
to replace Fe3+ in proteins makes it antimicrobial. Chemically durable materials which
can release gallium slowly would be considered the desired materials for medical ap-
plications. Ga3+ has been previously incorporated in phosphate-based glasses (PBG)
for controlled antibacterial effect [148]. Wren et al. and Towler et al. doped bioactive
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glasses with gallium for bone cementation and antibacterial functionality [124], and
the results presented suggest that the glasses were bioactive [149, 150].
The toxic limit of Ga3+ in the blood is 14 ppm [151], and the amount of gallium
incorporated in materials should be balanced to avoid cytotoxicity and have antimi-
crobial effects. Frachini et al. incorporated Ga2O3 in 45S5 in the range of 1.0 - 3.5
mol % and observed that the glass having Ga2O3 1.0 mol % and 1.6 mol % behaved
in the same way as the 45S5 glass composition in SBF; however, the glass having 3.5
mol % was very stable in SBF and did not form HA even after 30 days of immersion
in SBF [152]. Wren et al. added Ga2O3 in bioactive glass 42.0 mol % SiO2-, 8.0 mol
% CaO-, 10.0 mol % Na2O3-, (40-x) mol % ZnO-, x mol % Ga2O3, where x = 8 and
16. They observed that by adding 8 mol % of Ga2O3 increased network connectivity
from 1.23 (glass with no Ga2O3) to 2.32 and for 16.0 mol % of Ga2O3 it increased to
3.0 [153]; however, glasses with network connectivity more than 2.4 are not bioactive
[50]. Keenan et al. continued by performing cell viability tests with the same glasses
as reported by Wren et al, and found that after 90 days larger amounts of Ga was
released induced toxic effects on the L-929 fibroblast. However, these glasses did not
negatively affect MC-3T3-E1 osteoblasts [150]. Valappil et al. studied the antibacterial
effect of Ga doped phosphate-based glass (PBG) with different Ca content and having
3.0 mol % of Ga, and found that the PBG which had 14.0 mol % Ca with 3.0 mol % of
Ga2O3 had an antibacterial effect on planktonic P. aeruginosa species [148]. Valappil
et al. in another study tested Ga doped PBG which had 1.0, 3.0 and 5.0 mol % of
Ga2O3 against S. aureus, E. coli, P. aeruginosa, MRSA and C. difficile, and found that
the PBG containing 1 mol % of Ga2O3 had more bactericidal effect than the glasses
containing 3.0 and 5.0 mol % of Ga2O3. Also, the ion leaching data showed that the
1.0 mol % Ga2O3 released the highest level of Ga3+ ions than the glasses with 3.0 and
5.0 mol % of Ga2O3, which is due to the network stability of glass by adding more
Ga2O3 [22].
29
Chapter 2 Section 2.3
2.3 Coatings for Biomedical Applications
Bioactive coatings are important for metallic implants such as hip prosthesis and peri-
odontal implants as due to the inert nature of metals these encapsulated with fibrous
tissue after implantation. Bioactive coatings have the potential to bond with the host
tissue and thus improve the stability of the implant [60].
Inorganic phase in bone tissue is mainly composed of carbonated- HA. Moreover, it
is the reason that HA ceramics have always been a choice for deposition a coating on
to bone implants. The calcium phosphate (CaP) coatings were shown to be bioactive
and in numerous pre-clinical and clinical studies have shown to stimulate the formation
of new bone tissue [154–158]. To optimise the performance of these ceramic coatings,
chemical parameters such as Ca/P ratio, crystalline structure and phase composition
have been evaluated and tested extensively. CaP coatings significantly improved the
osteoconductivity of the metallic implants [159–161].
Recently and during the past two decades, research trends on CaP coatings focused
on modification of its chemical structure and doping with other ions. Several CaP based
coatings have been explored, such as HA [162–166]. HA incorporating Si [165], as it
has been investigated that Si substituted HA can improve the rate of bone apposition
significantly compared with the pure HA [167]. Sr− doped HA [168], as the presence of
Sr in coating enhanced osteoblast activity and differentiation, whilst inhibit osteoclast
production and proliferation [168–170]. Fluorinated-HA is made by substituting the
OH- with the F- ions to increase the thermal stability and chemical solubility of coatings
[171]. Also, Ag+ ions substituted HA films have been shown to exhibit excellent anti-
microbial properties as well as bioactive at the same time [172–174].
HA coated implants have been examined in clinical trials with contrasting results.
Some studies show improvements in the oseointigration, while other show failure of the
HA coating. Studies revealed that one mechanism of the failure involves the delamina-
tion and resorption of the HA coating due to worst attachment between coating and
implant. Due to loosing HA coating debris particles form leading to micromotions of
the implant [175]. Moreover, HA coating induces a layer of HCA in the body soon
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after implantation as a result of ion exchange with the environment. The deposited
HCA layer acts as a scaffold for osteoblast cells and further resorb by ostecoclast and
replaced by new bone tissue. The amount of HCA that forms on HA coating is deter-
mined by the amount of soluble calcium phosphate in the coating [176]. Since HA is
relatively less soluble due to the resemblance with the body environment, hence new
bioactive materials were needed to be explored for coating purposes and are required
for fast fixation applications [27, 177, 178].
Several researchers proposed bioactive glasses as a promising alternative to HA to
produce coatings on metallic implants [179] due to their excellent bioactivity [180], and
could be used to enhance the adhesion of the implant to the bone. Moreover, PBG
could be potentially exploited as coatings for enhanced bonding to bone tissue due to
the fact that these glasses mainly composed of calcium phosphate ions [129].
Commonly used coating techniques for the production of glass coated- implants are
sol-gel, electropherotic deposition, enamelling, laser cladding and thermal spray [181].
Enamelling is relatively cheaper and simple, moreover thick (several tens of micron)
and few microns thin coatings can be obtained with this technique [182]. In this
process, a thin piece of glass or a suspension containing glass particles are deposited
on to a metallic substrate and then glazing the glass by a proper heat treatment.
Temperature of the process should be carefully select to avoid the crystallisation of the
glass, degradation of the substrate and also to avoid the substrate- glass reaction, which
could lead the formation of by products and subsequently may reduce coating- substrate
adhesion [94]. The main disadvantage of the enamelling is possible the inter-facial
stresses and poor adhesion which may be caused by the thermal expansion mismatch
between glass and substrate [183].
Electrophoretic deposition (EPD) is an inexpensive technique and has a high de-
position rate. Moreover this technique allows coating complex shaped objects. In this
process a suspension of colloidal particles in a liquid medium is used. The substrate
acts as an electrode and the glass particles are deposited on to it after an electrical
field is applied to the suspension. After coating, a sintering step is done to fuse the
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glass particles present in the deposited coating. With EPD suspensions which are sta-
ble and can be electrically charged can be processed. Currently, via EPD suspension
of glasses, ceramics, polymers and metals are processed. The coating microstructure
can be easily optimised by controlling deposition parameters [184]. Manrique et al.
deposited bioactive glass on to Ti6Al4V substrate which were used as anode. Sintering
of the coating was done in a hybrid microwave furnace, where SiC absorbers were used
for the conventional heating. The benefit of the hybrid microwave was the very fast
heating and cooling. The combination of EPD and microwave optimised the interface
strength between the coating and substrate and also limited the reactions between
these. Further improvement can be done in the process as some cracks propagated
on the coating surface [185]. Similar EPD was employed by Balamurugan et al. for
depositing composite HA-Bioglass coating on to Ti6Al4V substrate. This coating had
controlled solubility due to the presence of 45S5 and the stability of HA. However, due
to sintering of the coating β-Tricalcium phosphate was present with pure HA. Also,
due to sintering small amounts of (Ca Mg)3(PO4)2 and calcium silicate (CaSiO3) were
present in the coating [186]. Moreover, the main disadvantage of the EPD process is
the requirement of the conductive substrate or it should be coated with a conductive
material [184].
An alternative coating technique for the production of biomedical coated implants
could be Laser cladding too. In this powder feedstock is melted for coating the sub-
strate. The powder is normally injected on to the substrate through a nozzle. To melt
the powder, the laser beam hits the powder flow. Currently HA coatings are produced
via conventional laser cladding process [187]. This technique can also be used as a re-
active deposition process for HA coating. The feed stock is a precursors paste for HA,
and synthesis of HA occurs during the coating deposition [188]. Recently bioactive
glass (S520) coatings produced has reported good results with dense microstructure
and good interface with the substrate. This technique is promising as the deposition
rate is good and also the substrate is not exposed to high temperature. However,
despite of the good results obtained with this technique, crystallisation of the glass
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coating was observed [189].
Thin film technology such as physical vapour deposition (PVD) which is currently
used to produce thin film coatings on to implants via radio frequency magnetron sput-
tering [129]. In this process, ions or neutral particles are bombarded on to solid target,
consequently material is removed from the target by its atomisation [115]. Stuart et al.
deposited 2.5 µm thick coating of PBG on to Ti6Al4V substrates via radio-frequency
magnetron sputtering. The author found that the coatings composition was similar
to the bulk glass, however, the structure of these coatings was different from the bulk
glass [129]. Stuart et al. investigated the structure of the PBG coatings and melt-
quenched glass and found that the dissimilarity in the structure of the coatings and
bulk glass is due to the polymerisation of the glass in coatings as suggested by NMR
and XPS results [16]. Stuart et al. also studied the mechanical properties of 2.7 µm
thick coatings of PBG and found that both, the as deposited and heat treated coatings
displayed interfacial strength more than 73.6 MPa [190]. However, the disadvantage
of magnetron sputtered PBG coatings is their variations compared to melt quenched
glass. The coatings consisted of reduced phosphate content and hence lower sputtering
rates; whilst the network modifying ions such as Ca, Na, and Mg were deposited more.
It was shown that the order of sputtering was P <Fe <Ca <Mg <Na [191]. Moreover,
due to higher sputtering powers ( > 100 W) the target could crack [114].
Among all above mentioned technique for coating of biomedical implants, the most
popular is thermal spray [192], due to the high productivity, its ability to coat complex
shapes and its flexibility concerning the choice of both coating material and substrate.
Moreover, uncontrolled microstructural changes and distortion of substrate is prevented
due to the low temperature of substrate [192]. With this family of processes, success-
fully controlled chemically and structurally coatings can be obtained [193].
2.3.1 Thermal Spray
In the field of surface engineering, the term thermal spray (TS) is generally used for a
family of processes in which a feedstock metallic or non-metallic (but do not decompose
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at high temperature at melting point) is melted and accelerated towards a substrate as
distinct particles or liquid droplets. These materials are heated by using combustion
or thermal energy. The molten or semi-molten feed particles are propelled to a surface
by a compressed carrier gas, striking the surface, impingement and flattening forming
splats, adhering to the surface . As these particles are sprayed, they cool and form
splats in a lamellar arrangement, forming a coating. Thermal sprayed coatings are not
uniform and contain porosity, and if the feedstock is metallic, the deposited coating
material will contain oxide [194, 195]. Feedstock can be in the form of powder, wire
and rod. Coating and substrate may be bonded through chemical, mechanical, and
metallurgical or any combination of these. Properties and microstructure of these
coating depends on the nature of feedstock, thermal spray process, process parameters
and any treatment after application of coating [40, 196, 197]. Also thermal spray can
yield coating thickness with few micrometres to millimetres (Figure 2.7) [24]. The
history of TS dates back to late 19th century when M.U Schoop yielded the first patent
by spraying tin and lead on a metallic substrate using a technique which is almost the
same as flame spray [24]. Staring from these early studies and passing through many
evolutionary stages, resulting in innovative techniques such as Plasma Spraying (PS),
Arc Spraying, Detonation-Gun Spraying, High-Velocity Oxy-Fuel (HVOF) Spraying
and Cold-Gas Spraying [24].
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Figure 2.7: Schematic representation of thermal spray process [24].
2.3.2 Thermal Spray Techniques
Based on the energy source (which is used for melting of the material) there are two
major classes of thermal spray, and these are further divided into sub-types. These
are i) electric energy spraying ii) combustion spraying [23, 24]. In the first class of
the spraying process, the energy for melting is produced by the electric arc of the
direct or pulsating current [24]. In the second, class heat energy is produced by com-
bustion of fuel such as hydrogen, methane, propane etc. The third class developed
since 1980’s, which is called “Cold Spray” and use no electric energy nor flame or uses
low-temperature combustion. It sought to deposit materials with their original fea-
tures intact. It does so at a low degree of oxidation (warm spray and air-fuel system)
or without melting (solid-state spraying) [196]. Different spray techniques are shown
diagrammatically in Figure 2.8.
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Figure 2.8: Classification of thermal spray process based on energy source. Where the
abbreviations meanings are HVOF (high-velocity oxygen fuel), D-gun (detonation gun),
APS (atmospheric plasma spray), VPS (vacuum plasma spray), LPPS (low-pressure
plasma spray), CGSM (cold gas spraying method), HVAF (high-velocity air fuel) and
WS (warm spray) [24].
Spray material, spray process and its parameters affect coating microstructure and
its properties. To get desired microstructure with a pre-determined set of properties is
a challenge which is existed since early 1900’s and passed from several evolution stages
[198]. Flame temperature and particle velocity are the two important variables for any
thermal spray technique, which are known as “T-V relationship”. T-V relationship
illustrates the interaction of particles, the high energy temperature field, gas velocity
field, and splat formation. T-V value is influenced by factors such as spray parameters
[197]. Thermal energy of the particle is the function of flame temperature while kinetic
energy is dependent on the carrier gas velocity. For material having high melting
point such as ceramics plasma spray(PS) is suitable while for materials like tungsten
carbide high velocity oxy-fuel (HVOF) is suitable because of its high kinetic energy
[29]. Temperature and velocity of the particles play an important role for a coating
microstructure and its properties (Table 2.2) [24].
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Figure 2.9: Flame temperature and particle velocity relationship for different thermal
spray techniques [199].
2.3.3 High Velocity Oxy Fuel Spray (HVOF)
In the HVOF process, the fuel and oxygen mixture is introduced in the combustion
chamber and ignition starts the combustion. The exhaust gas is formed, pass through
nozzle to a barrel and emerges out in the atmosphere. The coating material can be
introduced in radial position as well as in axial into the gas jet [199]. In this process,
the particle velocity can be 450 m/s [200], with this much velocity particle when it
strikes with the substrate surface it flattens resulting in a dense microstructure with
good bond strength. Advanced HVOF guns with convergent-divergent nozzle design
can increase particle velocity up to 1200 m/s [201]. In HVOF thermal spray, liquid
fuel (kerosene) or gaseous fuel (hydrogen, methane, acetylene, propylene, propane and
ethylene) can be used. Fuelling spray gun with kerosene requires extra controls, like
liquid fuel pumps and a high volume of air to support combustion. Flame temperature
can be tailored by adjusting fuel to oxygen ratio [194]. Challenging materials like
WC–Co and ceramic-metallic coatings (cermet) can be sprayed with high bonding
strength with HVOF thermal spray. With this process particles in the range 5-45 µm
can be sprayed with a stand-off distance 150-300 mm [202].
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2.3.4 Suspension High Velocity Oxy Fuel Spray (SHVOF)
SHVOF is the novel form of HVOF which uses feedstock in the form of suspension
rather than powder as shown in Figure 2.10 [203]. Material is deposited by melting
submicron or nanoscale particles by carrying in a liquid media and can be injected
radially or axially [202]. Spray with sub micrometric and nanoscale particles give a
coating with significantly improved wear resistance, fracture toughness and enhanced
hardness [29]. All these benefits are since the nanoscale ceramic particles are more
ductile than the bulky material which is brittle. Similarly, nanoscale metallic particles
are stronger than the bulk as these are free from dislocation [204].
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Nanostructured thick coating can be obtained by thermal spray; however, this faces
two problems, i.e. poor flowability of the powder, which is due to the agglomeration
and discontinuation in the powder feeding system and the injection of fine light parti-
cles in a flame. The low mass of these sub micrometric particles give them low thermal
and kinetic inertia, as these particles tend to be outside of the main core of the flame,
they deposit as lumps without flattening as compare to individual particle flattening
on its impact [205, 206]. Powder flowability is extremely important to have a homo-
geneous microstructure, because if flow-ability is poor so there will be fluctuations in
the powder feed rates resulting in a non-uniform coating microstructure [207].
Powder flowability can be increased by increasing the carrier gas flowrate but it will
lower the flame temperature [32]. To overcome these problems the best approach is
the use of feedstock in the form of suspension. The attraction in suspension spraying
is the freedom in the particle size choice, chemical composition and solute and solvent
percentages. The spray process and coating structure depend on the suspension char-
acteristics as particle size, solid loading, solvent used and suspension viscosity. Various
interaction occurs between the liquid suspension and the hot gas stream of a flame
or plasma. The solvent and solute show different effects when those come in contact
with the hot gas stream [208]. The enhanced properties of the coating are achieved
via direct injection of the suspension into the combustion chamber. This favours sig-
nificant heat transfer between particles and the flame. After the solvent evaporates,
particles are heated by the gas in the combustion chamber and expansion nozzle. The
combustion gas attains supersonic velocity upon expansion to ambient pressure outside
of the torch, and the particles are ejected at high velocity towards the substrate. This
results in layers of flattened particles, which results in a dense thick microstructure
coating with high cohesive and adhesive strength [27].
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Figure 2.10: Suspension High Velocity Oxy Fuel (SHVOF) set up for suspension
feeding: (a) Piston-pump (b) Pressurised vessel [32].
In SHVOF heat is generated in a pressurised chamber by the continuous combustion
of the fuel-oxygen mixture. The combustion chamber geometry depends upon the
melting point of the material to be deposited different combustion geometries given
in Figure 2.11. For example, high melting point materials such as ceramics need a
long chamber for enhancing heat transfer by encountering turbulence and giving high
residence time to the particles in the chamber. For low melting point materials such
as glass and hydroxyapatite (HA) small shorter length chamber is appropriate [208].
Figure 2.11: GTV Top Gun SHVOF spraying system with exchangeable suspension
injectors (a, b, c, and d of different injector geometries) [208].
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As the stand-off distance effect the substrate temperature and deposition pattern,
SHVOF has a wide range of stand-off distance which is 90-300 mm, but it can be
specified by feedstock, desired coating properties [209]. SHVOF is being used for a
dense coating of high bond strength and better mechanical properties [32, 36, 208]. So,
it can be said that SHVOF has the potential to be a standard for coating submicron
and nanoscale materials.
This process has already been explained so starting with the process parameters.
2.3.5 Suspension Thermal Spray Feed Stock Preparation
Two sets of variables govern the process and affect the resulting microstructure. These
are 1) Suspension parameters 2) Spray parameters. These are given below in Table
2.3:
Table 2.3: Suspension and Spray parameters for SHVOF process.
Suspension Parameters Spray Parameters
Particle size Feed flow rate
Type of solvent Fuel and Oxygen flow rate, their ratios
Suspension stability
Spray distance
Substrate Temperature + scanning speed,
2.3.5.1 Particle Size (Ball milling)
A uniform coating highly depends upon the particle size and their stable dispersion
in the suspension throughout the whole process as stationary and aggregated particles
would lead compositional gradient in coatings. At the same time, this cause sedimen-
tation and may clog the gun. Reducing the particle size would result in small flattened
splats instead of flowery ones, and nano-sized splats attract cells, enhancing bioactivity.
However, if the particle size is small, which results in larger surface area, higher elec-
trostatic attraction and ultimately flocs will form. For larger particles, gravitational
forces are more, which will result in sedimentation of particles. So for a stable suspen-
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sion, the particle size needs a compromise to avoid flocculation and sedimentation [36,
207, 208, 210].
Mechanical ball milling is a way to reduce the particle size, as the ball mill is the
most energy-intensive, less expensive and also less time consuming [211, 212]. Planetary
ball mill (PM) is the ball mill in which two forces act on balls and the materials to be
ground, one gravitational and centrifugal force. Mills move on the disk like a planet
that is why it is called a planetary ball mill [108]. Important parameters for ball milling
are milling speed, milling time, process control agent (PCA), and ball diameter, the
number of balls and weight ratio of balls to materials. In these parameters, the rotation
speed offers the largest (84 %) contribution in materials milling, while, milling time
and PCA offer second largest contribution (i.e., 16 %) [213]. By increasing mill speed
and milling time, machine efficiency will increase, but after a specific time, there would
be no change on particle size. There is a specific speed which is called critical speed,
speeding the machine beyond this point would have no effect on grinding because the
ball and material will be stuck with the shell of the mill. Similarly, after a specific
particle size, there would be an equilibrium between grinding and agglomeration. So
further grinding will increase the surface area, which will result in more attractive
forces and ultimately, agglomerates will form [213, 214].
2.3.5.2 Type of the Suspending Media
The suspending media used for making bioactive glass suspension must not react with
the glass. Water solely is not a suitable media for making bioactive glass suspension,
as the water leach out alkaline earth and alkali metal oxide and then these react with
atmospheric CO2 resulting as layers of carbonates on the top surfaces [210, 215]. At
the same time dielectric constant (78.5) for water is enough for making a stable sus-
pension but its surface tension is high (72.75 erg/cm) which would be a hindrance for
uniform dispersion. If organic solvent (mostly alcohols for safety and health) is used,
because of its low dielectric constant (18.8 for Isopropyl alcohol), the suspension would
be unstable, but its low surface tension (21.4 ergs/cm) is a good sign for particles
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dispersion [216]. In the case of bioactive glass suspension, a mixture of solvents is sug-
gested to have a good compromise in surface tension and dielectric constant for stable
homogeneously dispersed suspension,[217–222].
2.3.5.3 Suspension Stability
Suspension stability is mainly related to the particle size, solvent used, and solid load-
ing. Particle size is a factor for determination of the tendency of sedimentation and
flocculation as discussed earlier. Similarly, solvent type has a major contribution in
suspension stability. By increasing the amount of solids in suspension will increase the
deposition efficiency, whilst, it would decrease the distance between particles, which
would cause more electrostatic attractive forces resulting in flocculation. The best ap-
proach for suspension stability is to manipulate zeta potential [223]. Zeta potential
is the difference between the double layer and diffused layer if its value is high so the
particles would be covered by counter ions resulting in more electrostatic repulsion and
higher suspension stability (Figure 2.12) [224].
Figure 2.12: Negatively charged particle surface and double layer model [225].
Zeta potential can be increased by electrostatic stabilisation or steric stabilisation.
Electrostatic stabilisation is achieved by adding a surfactant which may be 1) non-ionic
2) anionic 3) cationic 4) zwitterionic having both positive negative charges. Type of
surfactant depends on the net charge of the particle. Since the net charge on bio-glass
particle is positive, so anionic is used for stabilisation [216]. Dolapix -65 and Dolapix-
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64 (C3H4O2.XH3N) is mostly used for bio-glass suspension and ceramic suspension
[27, 218]. Sometime with higher zeta potential sedimentation occurs because of larger
particle size [225]. Steric stabilisation is done by the addition of stabilizer, which must
be copolymer. These copolymers may be random, graft, or block. One part of these
polymer absorbed on the surface of the particle and the other keep away the other
particle at a distance usually 10-20 nm as can be seen in Figure 2.13 [226].
Figure 2.13: Stearic stabilisation achieve by adding polymer [226].
2.4 Novel Thermal Spray Techniques for Deposi-
tion of Biomedical Coatings
Several investigations have been conducted by using innovative techniques to produce
glass coating and are summarised in Table 2.4. Reactive plasma spray (React PS) is
one of the innovative techniques, in which the glass is made in the plasma to skip the
conventional melt, and quenching or sol-gel method so have a uniform glass composition
without any gradient in it. In the reactive plasma method the raw material required
for glass production is used in aqueous suspension form, then homogenised and milled
to have a particle size of 20 µm, then spray dried. Now this is the feedstock for PS
instead of making glass and then milling, so it will save time and also energy [227, 228].
The innovative technique of suspension plasma spray was utilised to spray bioactive
glass (4.7 Na2O, 42.3 CaO, 6.1 P2O5, 46.9 SiO2 in oxide wt %). The Coating was all
amorphous with some development of crystalline wollastonite as can be seen in Figure
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2.14, while the circled areas show splat and crystallised zone. However, the coatings
were bioactive as the HA precipitated on the surface of the coatings after immersion
in SBF [217].
Figure 2.14: (a) SE SEM image of the as sprayed SP sprayed wollastonite coating
with outline molten splats and crystallised zone, (b) the high magnification image of
the crystallised area with the acicular morphology of CaSiO3 [217].
The non-conventional thermal spray technique for bioactive glass coating SHVOF
are given in Table 2.4 [192, 229, 230]. section 2.5 is on the studies reported about the
SHVOF bioactive coating.
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Chapter 2 Section 2.5
2.5 SHVOF Sprayed Glass Coatings for Biomedical
Implants
SHVOF thermal spray has been shown to be a promising technique for the deposition of
bioactive glass coatings. For instance, L. Altomare et al. produced 45S5 coatings using
SHVOF thermal spray. The microstructure of these coatings exhibited a gradient, and
that’s why the process parameters need to be optimised to reduce the overall porosity.
Moreover, the produced coatings were very reactive towards SBF, as the original glass
coatings had been replaced by the interaction product with the SBF in one week as can
be seen in Figure 2.15 a, that only a small layer of the glass was there whose chemical
composition was lightly altered when compared with the original bulk glass (Figure
2.16 b EDX analysis, spectrum 1 is for layer 1(HA), spectrum 2 for SiO2 gel layer
(layer 2), spectrum 3 is for the residual glasses and spectrum 4 is for the bulk glasses
. So, these coatings might be useful in those applications where short osseointegra-
tion and progressive dissolution of the bioactive layer is required. these coatings were
cytocompatible towards MG63. As can be seen in Figure 2.16a that after 1 day of incu-
bation cells spread on the 45S5 coating surface homogeneously. Figure 2.16 b, c shows
the coating surface was uniformly covered with cell sheets [241]. Similarly, Bolelli et
al. used SHVOF technique and deposited 45S5 and a newly developed bioactive glass
labelled as Bio-K. The coatings’ thickness and porosity were significantly affected by
the process parameters. Both glass coatings were glassy; however, the structure of the
Bio-K glass coatings was different from that of the bulk as revealed by Raman analysis
as can be seen in Figure 2.17 b, the peaks at 862 cm−1, 933 cm−1, 965 cm−1 and 1052
cm−1 in the spectrum of bulk were assigned to the symmetric stretching of SiO4
−4
monomers, symmetric stretching of Si2O6
−4 chain and ring structures, P-O-P network
stretching and three dimensional network of SiO2 asymmetric stretching [242]; however,
the peaks in the spectrum of the Bio-K coating have appeared at 869 cm−1, 948 cm−1,
1000 cm−1 and 1081 cm−1 (Figure 17 b). The first two peaks although shifted, still
can be assigned to the symmetric stretching of SiO4
-4 monomers and Si2O6
−4 rings and
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chain structures; however, the peak at 1000 cm−1 was due to the 0O-P-O stretching in
P2O5
-4 sheet.
Figure 2.15: (a) cross-section of the 45S5 coating after 7days of SBF test, (b) is the
EDX analysis of the same cross-section, where spectrum 1 and 2 are for layer 1,2 3 is
for the residual glass coating while spectrum 4 is for the original glass [237].
Figure 2.16: SEM images of MG63 cells on SHVOF sprayed 45S5 coatings, (a) after
1 day, (b) 3 days and (c) 7 days, in SBF [241].
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Moreover, the peak at 1081 cm−1 belonged to the Si22O5
-2 planer structure [242].
It means that due to SHVOF spraying of Bio-K glass, the peaks belonging to the
three-dimensional SiO2 and P-O-P network, became so weak that these could not be
recognised any more. These peaks were replaced by the planer structures of Si2O5
−2
and P2O5 sheets. This indicated that the three-dimensional network of the glass was
degraded in the SHVOF deposited Bio-K coating [218]
Figure 2.17: (a) Raman spectra of 45S5 coating and (b) Bio-K glass coating and the
corresponding bulk glasses [218].
The Bio-K glass was also deposited utilising the same deposition technique (SHVOF
thermal spray) by Bellucci et al. onto titanium substrates with and without a bond
coat of TiO2, and it was found that the microstructure of the coatings was independent
of the bond coat but dependent on the process parameters, as can be seen in Figure
2.18, the difference in the coating thickness and porosity was due to the different feed,
oxygen and fuel flow-rates. However, the bond coat contributed significantly to the
adhesion strength of the coating with the substrate reaching a maximum value of 17
MPa. Also, all of the coatings were bioactive in terms of HA precipitation on the
surface of the coatings in SBF [192].
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Figure 2.18: BSE, SEM images of the cross-section of Bio-K glass deposited at dif-
ferent spray parameters (feed, oxygen and fuel flow rates), all coatings have TiO2 bond
coat [192].
Figure 2.19: BSE, SEM image of Bio-Ka glass coating after two weeks of immersion
in SBF, where layer1 is the precipitated HA and layer 2 is the depleted glass coating.
Bolelli et al. investigated Bio-K coatings that showed high reactivity towards SBF,
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as the entire coating thickness (∼ 50 µm) was affected by the interaction with the
SBF in two weeks as can be seen in Figure 2.19, whereas layer1 is the precipitated
HA and layer 2 is the depleted glass coating [229]. However, the Raman analysis of
the coatings showed that alterations occurred in the glass structure during SHVOF
thermal spraying which is also reported in the previous studies [218, 229, 234].
In another study by Bolelli et al. SHVOF thermal spray was used to deposit ap-
atite–wollastonite bioactive glass–ceramic and good quality coatings consisted of lamel-
lae and partially molten particles with spherical morphology that had central pores as
shown in Figure 2.20. These coatings showed reactivity in SBF with the formation of
HA crystals; however, unlike common bioactive glasses, HA did not precipitate as a
layer on top of the coatings, but rather as regions dispersed inside each layer as shown
in Figure 2.21. Moreover, at the top of the coating, 10 µm thick SiO2 was observed
which increased to 30 µm after two weeks and 70 µm after 5 weeks of immersion in
SBF [243].
Figure 2.20: Fractured sections of SHVOF deposited A-W coatings. (A) General view;
(B) details (circle: flattened lamella; arrows: rounded particles with central pore[243].
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Figure 2.21: SEM cross-sections of AW coating after soaking in SBF for 1 week (A),
2 weeks (B) and 5 weeks (C), while the bright inclusions are HA [243].
According to the literature about the deposition of biomedical coatings, SHVOF
thermal spray deposition has been proved to produce high quality dense bioactive glass
coatings of approximately 50 µm thick [27, 244], these coatings proved to be very reac-
tive towards SBF solution. ICIE16 and 13-93 are bioactive glasses and comparatively
stable in SBF than 45S5. Therefore, coating production using these two compositions
could result in less coating dissolution towards SBF. Moreover, bioactive coating with
Ga2O3 as an antibacterial agent would be a worth try to address the post operative
infections. Moreover, the structure of the melt-quenched and PVD thin film of PBG
(P-40) is well documented in literature. However, the properties of thermal sprayed
P-40 coatings will depend upon process parameters leading to structural and compo-
sitional changes. Whilst, the functionality of these coatings will depend upon their
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dissolution and ion release properties to facilitate cellular activity.
2.6 Summary
Following summary can be made from this chapter:
• This review highlighted different generations of biomaterials and their utilisation
for orthopaedic applications.
• Ga2O3 incorporated bioactive glasses and PBG have been explored for tissue
generation and antimicrobial effects. In the literature it is reported that incorpo-
rating more than 1 mol % Ga2O3 in PBG, make the glass resistant to dissolution.
Moreover, adding high mol % (3.5) of Ga2O3 made 45S5 resistant to SBF.
• HA was and still is the first choice for producing a bioactive coating for biomedical
applications, however, HA is comparatively stable in body environment and thus
more bioactive materials such as Bioglass® or other bioactive glasses needed to
be explored for the said purpose.
• Similarly PBG mainly contain calcium phosphate and could be another choice
for coating on metallic implants for enhanced osseointegration due to the high
resorption rate in physiological fluid.
• Several competing deposition technologies such as plasma spray, sol-gel, enam-
elling, PVD for production of biomedical coatings have been assessed.
• Due to the high productivity, ability to coat complex shapes, flexibility about the
choice of both coating material and substrate and no microstructural changes and
distortion of substrate (due to the low temperature of substrate) of thermal spray
technique, it could be a choice of deposition technique for biomedical applications.
• SHVOF thermal spraying is a coating deposition technique with the key advan-
tage of enabling processing of nano and micrometric particles in a suspension.
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This process allows the production of nano-structured coatings and has been
shown be to be a potent technique for the deposition of bioactive glass coatings.
• However, these coatings microstructure needs to be optimised to meet the end
applications. As these glasses are highly reactive in the physiological environ-
ment, so coatings made of these glasses may be resorbed before the integration
of the implant with the host tissue.
2.7 Gaps in the Literature Review
• Currently no literature is available on thermal sprayed coatings of ICIE16 bioac-
tive glass which is closer to 45S5 composition, and 13-93 bioactive glass which
is not very reactive in SBF as 45S5. Meaning this will be the first work to pro-
duce ICIE16 coating with more dissolution in SBF and 13-93 coating which can
survive longer in the media.
• For resorbable PBG, literature is reported only about the PVD coating technique
and which changes the structure and composition of the glass coating than the
bulk due to the preferential sputtering of the ions based on atomic weight of the
elements. So thermal spraying of PBG (P-40) will be a novel work too.
• Addition of Ga3+ ion as antibacterial agent is an emerging research area. This
work will add to the current knowledge by coating Bioglass® and Ga2O3 via
SHVOF spraying by assuming that Ga2O3 will improve the base coating antibac-
terial and osteogenic properties whilst maintaining the desirable characteristics




In this chapter, an overview of the suspension high velocity oxy fuel (SHVOF) thermal
spraying with the summary of the manufacturing process of the glasses used in the
deposition of coatings is provided. Besides, bioactivity tests of the bioactive coatings
using simulated body fluid (SBF), and cytotoxicity tests using MG63 cells (osteoblast
like cells) has been explained here. Moreover, ion release and mass degradation study
of P-40 coating is reported too. The characterisation techniques of the as-deposited
coatings and after SBF and cell tests are also included in this chapter.
3.1 Glass Manufacturing
The glasses used in this project were made through the melt and quench method. High
purity silica (SiO2) (high purity, prince minerals, Stoke on Trent), phosphate (P2O5)
and carbonates for the modifying oxides were purchased from Sigma Aldrich UK of
99.5% purity (Table 3.1). Except of Ga2O3, which was used in the fourth formulation
(chemically mixed Ga2O3-Bioglass
®) given in Table 3.1, was purchased from Changsha
Rich Nonferrous Metals Co., Ltd China of 99 % purity.
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SiO2 46.1 49.46 54.60 - 45.1
CaO 26.9 36.60 22.40 16 26.9
Na2O 24.4 6.6 6.0 20 24.4
P2O5 2.6 1.0 1.7 40 2.6
K2O — 6.6 7.9 — —
MgO — — 7.7 24 —
Ga2O3 — — — — 1
The quantity of different precursors, used to make glass are given in Table 3.2.
Table 3.2: Amounts of precursor used for glass.
Precursor
(g)
45S5 ICIE16 13-93 P-40
Ga2O3
Incorporated 45S5
SiO2 27.7 72.0 32.0 — 27.0
Na2CO3 25.8 16.9 6.3 — 25.8
CaHPO4 7.0 — — 32.6 7.0
CaCO3 21.7 87.9 22.1 — 21.7
K2CO3 — 22.1 10.9 — —
P2O5 — — — — —
NaHPO4 — — — 47.9 —
MgHPO4.3H2O — — 5.9 27.8 —
MgCO3 — — 3.6 — —
Ga2O3 — — — — 1.0
Total 82.3 202.7 81.1 108.5 82.7
When the precursors are heated, the following reactions occurs in a batch of the
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molten glass.
CaCO3 −−→ CaO + CO2 (3.1)
Na2CO3 −−→ Na2O + CO2 (3.2)
K2CO3 −−→ K2O + CO2 (3.3)
2 CaHPO4 −−→ 2 CaO + P2O5 + H2O (3.4)
K2CO3 −−→ K2O + CO2 (3.5)
2 NaHPO4 −−→ Na2O + P2O5 + H2O (3.6)
2 MgHPO4 · 3 H2O −−→ 2 MgO + P2O5 + 4 H2O (3.7)
MgCO3 −−→ MgO + CO2 (3.8)
All the precursors were mixed in Wheaton mini roller (UK) and homogenised for
2 hours. This mixture was then transferred to a 95 wt % platinum and 5 wt %
gold crucible and heated for 2 hours at 1400 ◦C. Glass melt was then quenched in
deionised water and coarse frit was obtained. This frit was then dried at 100 ◦C.
Melting temperatures of 45S5, 13-93 and chemically mixed Ga2O3-45S5 were also 1400
◦C. However, the melting temperature for P-40 glass was 1150 ◦C, while the preparation
time was 1.5 hours. Platinum-rhodium crucible was used to make this glass (Birming-
ham Metal Company, Birmingham, UK).
3.2 Grinding of Glass
PM-100 ball mill (Retsch1-5, Germany) was used for milling of all glasses. PM is
the abbreviation for the planetary mill and it owes its name due to the planet- like
movement of its jars. Jars are arranged on a rotating disk while these rotate around
their own axis due to a special mechanism. The centrifugal forces produce by rotating
vials and the rotating support disk act on the content present in the vials. This content
consists of the material to be ground and the grinding balls. Since the disk and vials
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rotate in opposite directions, hence the centrifugal forces act in the same and opposite
directions. This causes the grinding balls to run down along the walls of the vials
producing a friction effect, followed by the material being ground. Also, the lifting off
and then travelling freely inside the chamber and colliding against the opposing inside
walls produce an impact effect (Figure 3.1). In a single mill, there can be one, two or
four vials. The grinding jars and balls are available in different types of materials, such
as silicon nitride, agate, zirconia, tungsten carbide, chrome steel, Cr-Ni steel, sintered
corundum and plastic polyamide.
Figure 3.1: A schematic diagram showing the movement of balls inside the mill [212].
The 45S5, ICIE16, 13-93 and Ga2O3 incorporated 45S5 was milled in 150 ml zirconia
jar with 5 mm diameter zirconia balls for 30 minutes at 550 rpm. A second ball milling
step was performed with 2 mm diameter zirconia beads for 30 minutes at 500 rpm. For
P-40 glass, the first step of ball milling was performed for 30 minutes at 450 rpm with
5 mm diameter balls, and the second step of milling was done again for 30 minutes
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at 350 rpm with 2 mm diameter zirconia beads. In all case balls to materials weight
ratio was kept at approximately 5. Results for the first step of ball milling for all of
the materials are given in Table 3.3.
Table 3.3: Particle size after 1st step of ball milling.
Materials D10(µm) D50 (µm) D90 (µm)
45S5 2 21 55
ICIE16 1.8 8.3 24





P-40 1.5 12 48
3.3 Particle Size Measurement
Particle size was analysed by using laser diffraction (Beckman Coulter, USA) having a
750 nm laser. Particles are dispersed in water and in a micro volume cell. The added
particles should be 8- 10 % of the volume of the liquid in the chamber. The laser is
scattered by particles when they move in the medium. The particles are continuously
stirred during measurement. Small particles scatter light at a large angle and vice versa
(Figure 3.2). The particle size distribution is measured by measuring the scattered laser
pattern. The critical component of this instrument is the Fourier lens, which focuses
the incident beam and prevents its interference with the scattered light. Also, this lens
transforms the scattered light into a function of location in the detection plane. The
scattered light’s intensity and pattern are analysed to determine the particle size by
using Mei theory [245]. This theory depends on the characteristics of suspending media
and the particles. The analysis gives the particle size as the diameter of the equivalent
sphere volume.
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Figure 3.2: Working principle of Coulter diffractometer, light scattering through dif-
ferent size of particles ( µm) [245].
3.4 Suspension Preparation
45S5, ICIE16, 13-93 and Ga2O3 doped 45S5 suspensions were made in mixed suspend-
ing media of water and isopropanol alcohol (IPA) with 85 wt % water and 15 wt %
IPA [246]. water alone was not used as a suspending media for suspension preparation
as water leaches out alkali and alkaline oxides from the glass [210, 219]. For 45S5 sus-
pension, the solid loading was 8 wt %, while for ICIE16, 13-93 and Ga2O3 doped 45S5
the solid loading in the suspension was 10 wt %. For P-40 glass, water was used as
suspending media with 10 wt % solid loading.With this solid loading, the suspension
was for the time duration which was enough for spray. The suspensions were made
by using electric stirrer (IKA® RW 20 digital dual-range mixer system, Cole-Parmer
UK). The suspensions were stirred at 1000 rpm for 1 hour at room temperature.
3.5 Substrate Preparation
A good substrate is a pre-requisite for good quality coatings, as the adhesion of the
coating is critical. 304 stainless substrates with a nominal composition of 9.25 Ni, 19.0
Cr, 1.0 Si, 2.0 Mn, 0.08 C, 0.04 P, 0.03 S and 68.6 Fe—all in wt % were used for
coating deposition as it is less expensive in comparison to Ti and its alloys which are
commonly used for the implant production. The thickness of the substrates was 2 mm,
while these were 25 mm wide and 60 mm long. Substrates were first grit blasted using
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Guyson blast cleaner, UK, with F100 brown alumina (0.125–0.149 mm) particles at 3
bar pressure. After this, substrates were cleaned with the industrial methylated spirit
(IMS) in an ultrasonic bath for 10 minutes to remove any embedded alumina particles.
These substrates were then mounted on twelve substrate holder carousel rotating at 73
rpm.
3.6 SHVOF Thermal Spraying
The SHVOF spray (Figure 3.4) consists of the following units:
3.6.1 Gas Supply and Flowmeter
The gas supply unit controls the pressure and flow of oxidant and fuel gas. Oxygen
was used as an oxidant, while hydrogen was used as fuel. The pressure of these both
gases may be adjusted using regulators attached to each of the gas cylinders. These
cylinders are kept outside of the spray room for safety reasons. Gases are sent to the
flowmeters given in Figure 3.3. The flowmeters here are actually rota metres, which
consists of graduated tubes with a float in. These floats travel freely inside the tubes
depending on the gas’s flowrates. The gas flowing in the tube causes the float to the
point of dynamic balance. With the increase of flow area, the float rises, while with the
decrease, it goes down. Flowrates of these gases are adjusted according to the spray
conditions and depending on the material to be sprayed.
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Figure 3.3: Gas flow meter control unit.
3.6.2 Suspension Feeding Unit
The suspension feeding unit is a self-contained unit, which is designed to deliver sus-
pension to the gun at specific flow rate. This unit consists of two vessels, one is for
the cleaning liquid, and the second is for the suspension, which has of the capacity of
2l (Figure 3.5). There is a regulator with the assembly (Figure 3.5) with which sus-
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pension flow rate may be adjusted by using an ultrasonic flow meter (ES – FLOWTM
Bronkhorst, Nether Land) (Figure 3.5). This flowmeter can measure volume flow in
the range of 4 - 1500 ml/min at operating pressures up to 10 bar. It has an ultrasonic
flow sensor with a measuring probe which is protected with IP66/IP67 and equipped
with LCD display. The touchscreen is there for adjustment of flow indication, alarm
and control (if applicable). The feeding unit has a stirrer to continuously stir the
suspension throughout the process to prevent sedimentation of the dispersed material
while spraying.
3.6.3 UTP Top Gun
UTP top gun (UTP/Miller Appleton, WI, USA) is the main component of the SHVOF
thermal spray (Figure 3.6). The gun consists of four parts; combustion chamber,
mixing block, water circulation system and suspension injector. Fuel gas, oxygen and
suspension enter the back end of the gun and pass through the combustion chamber
and mixing block. In the water circulation system, cooling water circulates, which
also enters at the back of the gun. The suspension injector has a diameter of 0.3 mm
which injects suspension at the centre of the combustion chamber. The length of the
combustion chamber is 22 mm with a 110 mm long barrel nozzle [247].
3.6.4 Substrate Holder
The substrate holder has a capacity of holding 12 samples for coating. This holder
rotates at a speed of 75 mm/s.
3.6.5 Traverse Unit
A semi-automated system is used to control the spraying distance and number of passes
of coating, which is called traverse unit (Trav 1200). This system can move up and
down with a speed of 5 mm/s.
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Figure 3.4: Schematic diagram showing of SHVOF spraying set up [248].
Figure 3.5: Suspension feed unit.
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Figure 3.6: Different parts of UTP top gun for SHVOF spraying.
3.7 Coating Deposition
In this work, 5 different compositions were sprayed: 45S5, ICIE16, 13-93, P-40 and
chemically mixed Ga2O3-Bioglass
® (45S5). 45S5 was sprayed first as this is the com-
mon bio silicate glass. Different runs were made by changing oxygen and hydrogen
flowrates, while spraying distance (85 mm), feed flow rate (50 ml/min) and the num-
ber of torch passes (20) were kept constant.
3.7.1 Bioglass® (45S5) Deposition
Four depositions of 45S5 were sprayed using the flow rates of hydrogen and oxygen
given in Table 3.4. Theoretical flame power (kW) was calculated by using standard
combustion formulae and each coating is labelled according to their theoretical flame
energy.
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1 182 77.9 25
2 355 152 50
3 527 226 75
4 695 249 90
3.7.2 ICIE16, 13-93, P-40 and Chemically mixed Ga2O3-Bioglass
®
coatings
After spraying 45S5 at four different parameters (flame power), 2 spray parameters
were optimised:flame powers of 50 kW and 75 kW. ICIE16, 13-93, P-40 and Ga2O3
doped 45S5 were sprayed at the optimised 50 and 75 kW flame powers.
3.7.3 Coating Deposition via Hybrid Nozzle
1 wt % Ga2O3 suspension in water and 10 wt % Bioglass
® suspension (85 wt % water
and 15 wt % IPA as a suspending media) were co-sprayed via hybrid nozzle (Figure
3.7). Bioglass® suspension was axially injected at a flow rate of 50 ml/min,whilst, the
Ga2O3 suspension was radially injected at 25 ml/min flow rate. The depositing flame
power was 50 kW.
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Figure 3.7: The hybrid nozzle, a thermal spray attachment.
3.8 Coatings and Powders Characterisation
3.8.1 Scanning Electron Microscopy SEM
A scanning electron microscope (SEM) focuses a beam of electrons on the area to
be examined. After the interaction of the electrons with materials, different types
of signals are produced, including secondary electrons, back-scattered electrons and
characteristic x-rays. These signals are produced from specific emission volumes in the
sample and may use to examine the surface topography and/or elemental composition
of the material [249]. Typically in SEM the electron beam is produced by thermionic
from the cathode, which is usually tungsten. Electron are accelerated by applying a
voltage that usually ranges 0.2 keV to 40 keV, with the value depending on the sample
being scanned. High-resolution images can be obtained by applying high voltage;
however, if the samples are unstable or biological might be damaged if high voltage is
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applied.
Figure 3.8: Right image is the schematic of the electron microscope, the left image
shows the interaction volume of and depth of penetration of electrons [250].
Apertures, condenser and objective lenses are used to focus electron beam on to
the sample to a spot of about 0.4 to 5 nm. For the scanning of the sample, the beam
is deflected by the scan coils to interact with the sample. The size of the interaction
volume depends on the applied voltage e.g. high voltage will result high volume of
interaction. When the elements are of high atomic number, the large atoms will stop
the electron from penetration. Secondary electrons are generated from the first few
manometers of the sample (Figure 3.8) and thus make an image showing the sample’s
surface architecture. Whereas the backscattered electrons give information about the
chemical composition of the sample as these are coming from much deeper within the
sample, and also the signals depend on the atomic number. X-rays are detected using
in-situ energy-dispersive X-ray spectroscopy (EDX). This gives information about the
chemical composition of the sample where the beam is focused.
In this study, Quanta-600 and JEOL 6490 SEM were used to examine the coating
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microstructure under secondary electron (SE) mode. EDX line scan along with the
cross-section of coatings, area scan on the surface of the coatings, and point analysis
for powder was done using SEM (JEOL 6490, Tokyo Japan, EDX: INCA 350, Oxford
Instruments, Abingdon, UK). The accelerating voltage was 20 kV, spot size was 4 and
the working distance was 10 mm.
3.8.2 Sample preparation for SEM
Sample preparation is required for the SEM characterisation of coatings as glasses
are non-conductive. To observe the powder morphology a representative sample was
placed on to carbon sticky tabs on steel mounts stub and carbon coated (using Edwards
Coating System E306A) for 2 minutes. Also, the as-sprayed coatings were carbon-
coated to observe the surface morphology. For the observation of the cross-sectional
view of the coatings, these were cut transversely with SiC cutting disc using a precision
cutting machine (Brilliant 220, ATM GmbH, Mammelzen, Germany). Then the cross-
sectional samples were mounted in conductive resin of Bakelite . Then the cross-section
samples were ground and polished to 1 µm using diamond paste. The cross-sectional
samples were then carbon coated too for SEM observation.
3.8.3 X-ray Diffraction (XRD)
XRD is used to determine the crystalline phases within a material by using monochro-
matic X-rays. These X-rays are generated by the bombardment of electrons of the
copper source to emit electrons from the inner shell and resulting in X-rays are directed
towards the samples. After interacting with the material, these X-rays are diffracted
depending on the long-range structure of the material (Figure 3.9). A detector de-
termines the angle and scattering of diffracting X-rays for constructive interference,
which satisfies Bragg’s law (Equation 3.9). These diffractions are specific to the lattice
parameters of material and results in a characteristic diffraction pattern. In Equation
3.9 ‘d’ is the space between lattices, ‘θ’ is the incident angle of X-rays, whilst ‘λ’ is
the X-rays wavelength and ‘n’ is any integer. From these information, crystal size and
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structure may be determined.
Figure 3.9: Bragg diffraction from a cubic crystal lattice.
2dSinθ = nλ (3.9)
In this study all the XRD analysis was carried out using Bruker D8 Advance, (Cu
Kα source, λ = 1.5418 Å, 40 kV, 35 mA). Powder of the melt quenched glasses was
flatly pressed into a sample holder, while the coated samples after thermal spray and
the samples following SBF tests were centred and placed horizontally into the sample
holder. For 45S5 glass and coatings after spray and SBF tests, the samples were
scanned for 2θ range of 20◦ to 70◦ with a step size of 0.1◦ and dwell time of 3 s. for
other glasses, the samples were scanned with a step size of 0.05◦ and dwell time of 7 s.
Phase identification and peak matches were made using Eva software.
3.8.4 Raman Spectroscopy
Raman spectroscopy is a light scattering technique, a high-intensity laser light gets
scattered when incident on a molecule. This technique provides information about
chemical structure, phase and molecular interactions. The scattering of light depends
on the interaction of light with the bonds in a molecule (Figure 3.10). After interaction
with the molecule, most of the scattered light is of the same wavelength as the inci-
dent light and which is called Rayleigh Scatter- this does not provide any information
about the sample. However, 0.0000001 % of the incident light scatters with a different
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wave length than the original,which depends on the molecule under investigation - this
scattering is called Raman Scattering [251].
Figure 3.10: Raman principle [252].
Raman usually consists of the following four components
• Excitation source which is laser
• Illumination arrangement for the sample and optics for light collection
• Selector for the wavelength, which is a filter or a spectrophotometer
• Detector
A laser beam in the ultraviolet (UV), visible (Vis), or near-infrared (NIR) range is
used to illuminate the sample. A sample is illuminated with a laser, and the scattered
light is collected with a lens. Then this light is sent to an interference filter or spec-
trometer to get a spectrum. In this study, HORIBA Jobin Yvon LabRAM (Japan)
HR spectrometer was used. 532 nm laser was used as the excitation source, while a
100× objective, 300 µm confocal pinhole and 600 diffracting gratings were used for the
collection of spectra. Spectra were recorded for 15 s and 20 accumulations. Raman
spectra were acquired for the powder, coatings and after SBF tests of the coatings.
Also, commercial HA was analysed using Raman for a direct comparison with the HA
deposited on the surface of the coatings [251].
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3.8.5 Micro Hardness Measurements
Hardness of the coatings was measured using Vickers tester (BUEHLER, UK). All
the tests were carried out on the polished cross-sectional surfaces of the coatings by
applying a load of 25 gf for 30 sec in 5 different regions of the coatings.
3.8.6 Surface Profilometry
The surface roughness (Ra) following coating deposition was measured by using two
techniques. For 45S5 coatings, Ra was measured by using Zygo NewView 8300. This
coherent scanning interferometer (SCI) is 3D optical surface profiler and provides ver-
satility in non-contact optical surface profiling. This technique is non-destructive and
requires no sample preparation. The interferometer was used in a white light mode
with 5.5× objective at 0.5× zoom (NA 0.15, a field of view (3.02 × 3.02) mm. Also, the
LR- pixel was 2.95 µm, and LR-optical was 1.82 µm where LR is the lateral resolution.
For each sample five fields of view were measured at various position across the sample
by using Zygo proprietary software.
For coatings other than 45S5, the contact technique of form Talysurf Intra was
used, which is a stylus profilometer. This instrument measures vertical displacement
by using an inductive (LVDT) gauge over profile lengths of up to 50 mm. In this
research, Talysurf Profilometer (Taylor Hobson Ltd, UK) was used which has a stylus
radius of 2 µm. Also, the sampling distance was 0.5 µm in the scan direction, while
the speed of the stylus was 0.25 mm/s.
3.8.7 Porosity and Thickness Measurement
The porosity of each coating was analysed from five SEM (SE) images (270 x 232 µm)
using thresholding technique in image-J software (NIH, USA). Coating thickness was
measured with the same software at five different locations by using SEM images (134
x 117 µm) of the polished cross-sectioned coatings.
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3.9 Simulated Body Fluid SBF
A simulated body fluid (SBF) test is used to assess the acellular bioactivity of the
bioactive materials (chapter 2). , The deposition of HA on the surface of the material
is an indication of its bioactivity. SBF was prepared by using the standard method
outlined in ISO 23317:2014 [253]. The reagents used in the preparation of SBF are
shown in Table 3.5, these were added in the order as given in table. During preparation,
the temperature was maintained at 37 ± 1 ◦C by using a heated water bath, while pH
was adjusted at 7.40 ± 0.01 by adding 1 molar HCl through a drip- feeder. During
preparation, the solution was magnetically stirred in a scratch-free polymer beaker.
The SBF was filtered at room temperature using a 20 µm particle filter. The samples
were placed in a specific volume (Vs in mm3) of SBF in polyethylene vials, while
Vs= Sa/10 such that Sa (mm) is the surface area of the sample. These samples were
incubated at 37 ◦C and 5 % CO2 for 1, 3 and 7 days. After soaking for one-time
point, the samples were not soaked again. After removing the SBF samples, these were
washed with distilled water and dried at room temperature. These samples were then
analysed using SEM, XRD, and Raman for the assessment of HA.
Table 3.5: Chemicals used for the preparation of 1 litre SBF [253].
Number Reagent Amount
1 NaCl 8.035 g
2 NaHCO3 0.355 g
3 KCl 0.225 g
4 K2HPO4.3H2O 0.225 g
5 MgCl2H2O 0.311 g
6 1.0 Molar. HCl 39 ml
7 CaCl2.2H2O 0.292 g
8 Na2SO4 0.072 g
9 Tris ((HOCH2)3CNH2) 6.118 g
10 1.0 Molar HCl 0 ml to 5 ml
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3.10 Biological Characterisation of ICIE16 and 13-
93 Bioactive Glass Coatings using MG63 Cells
Human osteoblast-like cells, MG63 were used for the cytotoxicity and cytocompatibility
tests of the coatings. These cells are derived from osteosarcoma. Two time points of 3
and 7 days were used for cell tests.
3.10.1 Sample Cutting, Cleaning and Sterilisation
10 mm discs were cut from the coatings using an Ormond 5 axis waterjet cutting
machine (Ormond LLC, Washington) with a 1 mm diameter nozzle. The pressure of
the water was 3000 bar, while abrasive feed was 125 g/min, and cutting speed was 600
mm/min.
Before cell seeding, all the samples were cleaned and sterilised. Successive washes
were done for the samples by using acetone, isopropanol and distilled water in an
ultrasonic bath for 5 minutes each. Two more washes to remove any of the debris
which might come from the sample cutting procedure. After this cleaning, the samples
were washed with 70 % IMS for 5 to 10 minutes and then were placed in a hood for
ultraviolet (UV) sterilisation. The sterilisation time was 30 minutes for each side.
3.10.2 Cell Seeding
MG63 cells (passage 6) in a confluent flask were washed with PBS. Then 1 ml of the
enzyme solution (containing 100 ml sterile PBS, 1.5 ml of Trypsin (0.2 % Trypsin with
Ethylene diamine tetra-acetic acid (EDTA)) was used to detach cells from the flask
surface. Samples were placed in a 48 well plate. The cell suspension (µl) with density
(40,000 cells/cm2) (calculated from a cell count formula) was added to each of the
sample. Also, cells were seeded to four empty wells for the tissue culture plastic control.
500 µl of the media (which consists of 500 ml of DMEM (Dulbecco’s Modified Eagle
Medium); Foetal Bovine Serum (50 ml); L-Glutamine (5 ml); antibiotics-antimycotics
AA/AM (10 ml); HEPES buffer (10 ml); non-essential amino acids (5 ml) and ascorbic
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acid (75 mg)) was added to each of the well. The well plates were then incubated at 37
◦C in 5 % CO2 atmosphere. After 1 day of seeding, the media was changed and then
after every 2 days media was changed.
3.10.3 Alamar Blue Assay
Alamar blue assay which is a non-destructive technique to the cells and is used as
cytotoxicity test. This test can quantify cell metabolic activity and thus evaluates cell
growth and proliferation. Alamar blue is a dye and cells metabolic activity results in
the reduction of the active component resazurin of the alamar blue to resorufin (Figure
3.11). Alamar blue spread into the cells reduced to a fluorescent dye. The concentration
of the fluorescent dye is proportional to the number of viable cells. The rate of cell
proliferation is analysed by the difference of cell relative fluorescence intensity at each
time point.
Figure 3.11: Reduction of resazurin to resorufin.
Before adding the alamar blue assay,, the samples were washed three times with
PBS to remove any of the culture media. This was done for both time points. 1:10
ratio of the alamar blue with HBSS (Hanks Balanced Salt Solution) was used for the
tests and of which 1 ml was added to every sample to submerge the samples. For the
blank control, three empty well plates were filled with the solution. Samples were then
placed in an incubator for 90 minutes. Then the samples were placed on the shaker
to shake at 150 rpm for 10 minutes. Three aquilots of 0.1 ml of alamar blue were
taken from each sample and placed in 96 well plates. The fluorescence of the sample
was measured using FLx 800 microplate reader (BioTek Instruments Inc). 560 nm
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excitation wavelength and 590 nm emission wavelength was used.
3.10.4 Sample Preparation for SEM after Cell Tests
For SEM examination, after each time point cells were fixed and dehydrated. For the
removal of the media, samples were washed three times with PBS for 5 minutes for
each of the wash. For fixation 3 % Glutaraldehyde in 0.1M Sodium cacodylate buffer
(fixative) was added to the samples and kept in fume hood for 30 minutes. Then 0.3
ml of (7 %) sucrose was added to each of the sample and refrigerated overnight at
4◦C. Samples were then washed three times with 0.1M cacodylate buffer for 5 minutes
per wash. After washing, enough amount of (1 %) Osmium tetroxide was added to
submerge samples. For fixation and staining, samples were left for 45 minutes. Then
Osmium tetroxide was removed, and samples were dehydrated at steps with 20 %, 40
%, 60 %, 70 %, 80 %, 90 % and 100 % of ethanol. Hexa-methyldisilazane HMDS) was
used for 5 minutes to dry samples. After all these steps, the samples were air-dried
overnight by replacing the well plate lid with loose aluminium foil. Then samples were
then gold-coated by sputtering and examined using JEOL JSM-6490LV SEM.
3.10.5 Statistical Analysis
Prism graph pad (2365 Northside Dr.Suite 560 San Diego, USA) was used for statistical
analysis. To analyse data from cell experiments with Tukey post-test, one –way analysis
of variance was used to determine the significant effect of the results. A smaller P-
value than 0.05 would show significant differences, while a higher value would show no
significant differences.
3.11 Degradation of P- 40 Phosphate Based Glass
Coatings
9 mm diameter discs were cut from P-40 coatings using water jet cutting machine.
These discs were then placed in polyethene vials with 15 ml of ultra-pure Milli Q water
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or PBS and were incubated at 37 ◦C. The samples were kept for 1, 3, 7 and 14 days.
At each time point the samples were removed from the solution and dried in an oven
at 50 ◦C for the removal of surface water. The mass of the samples was measured
using a Mettler Toledo precision scale accurate to 0.01 mg. The samples were then
again immersed until the next measurement time point. The pH was measured before
and after degradation when using PBS, while it was measured only after degradation
in the case of ultra-pure milli Q water as degradation media. For PBS solution pre-
prepared tablets of PBS (Sigma Aldrich) were dissolved in 200 ml of water. The mass








Where Mo is the initial mass, Mt is the mass and Areat is the area of the sample at
test time point t.
3.12 Ion Release of P- 40 Phosphate Based Glass
Coating
Ion release profiles of the P-40 coatings were determined by immersing 9 mm diameter
discs in 15 ml of ultra-pure milli Q water. These tests were carried out for 1, 3, 7 and 14
days at 37 ◦C. The dissolution medium at each time point was analysed for phosphorus,
calcium, magnesium and sodium ions. The dissolution medium was analysed for Ca,
Mg, Na and P using Inductively coupled plasma mass spectroscopy (ICPMS).
ICPMS is a mass spectroscopy technique that detects very low metal ions concen-
tration in a liquid sample. The sample is ionised via a high-temperature plasma, and
then a mass spectrometer is used for the separation and quantification of those ions.
A number of elements can be detected simultaneously with this technique or it can
be set to detect the user required elements. The dissolution media was introduced
to ICPMS (Thermo-Fisher ICAP-Q, Bermen, Germany) to determine the ion release
profiles. This instrument runs employing three operational modes, which are,
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• CCTED (collision cell technology with energy discrimination) is typically charged
with helium gas and is upstream of the analytical quadrupole to reduce poly-
atomic interference.
• Standard mode (STD), where the collision cell is evacuated.
• The hydrogen mode cell (H2-cell), which utilises H2 gas as the cell gas.
An autosampler (Cetac ASX-520) was used to introduced the samples. The sampler
was incorporated with an ASXpress™ rapid uptake module through a perfluoroalkoxy
(PFA) Microflow PFA-ST nebuliser (Thermo Fisher Scientific, Bremen, Germany).
Internal standards, which are Sc(50 µg l-1), Ge (20 µg l-1) Rh(10 µg l-1) and Ir(5 µg
l-1) in the preferred matrix of 2 % HNO3 were introduced to the sample stream on a
separate line via the ASXpress. Instead of HNO3, HCl can also be used with a similar
concentration of 2 %. Calibration standards (external) are usually in the range of 0 –
100 µg l-1 (ppb). Sample analysis was done by using ‘Qtegra software’ (Thermo-Fisher
Scientific). While the results were reported as mass weight concentrations (µg l-1 or




Relationship of SHVOF Thermal
Spraying of Bioglass®
4.1 Introduction
This chapter presents the processing, microstructure, and Bioglass® coating proper-
ties relationship by SHVOF thermal spraying. Process parameters were changed by
changing the fuel (H2) and oxygen flow rates, which ultimately change the flame power.
Four spray runs were conducted by applying four different flame powers of 25 (low),
50 (medium), 75 (high) and 99 kW (very high). The as-sprayed coatings were charac-
terised using different techniques such as SEM, XRD, Raman, and surface profilometry.
The final section of this chapter reports the bioactivity tests results of the 45S5 coatings
using SBF.
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4.2 Feedstock Characterisation
4.2.1 Particle Size Distribution and Powder Morphology of
the Bioglass® Powder for Suspension Preparation
The first step of ball milling resulted in D10 = 2 µm, D50 = 21 µm and D90 = 55
µm (where Ds is the particle diameter of S % particles). After second step of ball
milling size distribution of the Bioglass® powder is given in Figure 4.1 a, and which
characterises Bioglass® powder with D10 = 1.7 µm, D50 = 2 µm and D90 = 10 µm,
which was used for suspension preparation.
Figure 4.1: (a) Bioglass® 45S5 particle size distribution and (b) SEM image of ball-
milled Bioglass® powder before suspension preparation.
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The particles were distributed with a range of 0.8 µm -27 µm which suggests that
the Bioglass® particles were agglomerated. The SEM image (Figure 4.1 b) shows that
the Bioglass® powder was a mixture of fine and coarse particles before suspension
preparation. Among the coarse particles the largest particle size was ∼ 5 µm, while
the smallest was approximately 0.3 µm.
4.2.2 EDX of the Powders
EDX point analysis (Table 4.1) showed that the 45S5 powder used for suspension
preparation was composed of 19.3 wt % Si, 17.7 wt % Ca, 16.4 wt % Na and 2.2 wt
% of P. While for the 45S5 formulation, the wt % of the glass should have 21 wt %
Si, 17.5 wt % Ca, 18.75 wt % Na, and 2.4 wt % P. The compositions were observed to
vary by 1.7 wt % Si, 0.2 wt % Ca, 2.35 wt % Na and 0.2 wt % P from their intended
composition.
Table 4.1: EDX analysis of the final powder before suspension
.





4.2.3 XRD and Raman Analysis of Bioglass® Powder
XRD analysis (Figure 4.2 a) showed that the Bioglass® powder was amorphous. The
amorphous hump present between 25◦- 35◦ 2θ showed broad diffraction and the ab-
sence of any sharp peak, which is the characteristic of short-range order. The Raman
spectrum of the 45S5 powder is given in Figure 4.2 b. The peaks observed at ∼ 610
cm−1 and 1079 cm−1 were due to the stretching of Si-O-Si, whilst the peak at 860 cm−1
was assigned due to the vibration of non- bridging oxygen i.e., Si-2NBO. The peak at
945 cm−1 was assigned to the stretching of PO4
-2 [254].
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Figure 4.2: (a) XRD and (b) Raman scan of Bioglass® powder showing its phase and
structure
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4.3 As-Sprayed Coating Characterisation
4.3.1 Coating Surface Morphology and Cross-section
The surface morphology of the as-sprayed 45S5 coatings deposited at 25, 50 and 75 kW
flame power was examined using SE imaging and is shown in Figure 4.3. Changing
flame power from low (25 kW) to medium (50 kW) and then to high (75 kW) had
a significant effect on the surface of the coatings. As shown in Figure 4.3, the low
magnification image of the 45S5 coating deposited at 25 kW,this coating had a hollow
porous sphere-like structures. Also, the higher magnification image of the 25 kW
coating (Figure 4.3 d) shows that there were some smaller spheres on the surface of
this coating. These spheres might be originated from the impact of slower and partially
re-solidified Bioglass® (45S5) droplets. Also, the surface of this coating appeared to
be porous due to the presence of these spheres and hollow sphere like structures. The
surface morphology of the 45S5 coating deposited at 50 kW contained mostly well-
flattened splats, as can be seen in Figure 4.3 b. The presence of these splats indicates
that the 45S5 particles during the spray process under the conditions of 50 kW flame
power were sufficiently heated and had experienced more significant deformation. The
high magnification image of 50 kW coating (Figure 4.3 e) shows that the size of these
splats was approximately 5 µm, and also their shape was irregular. Small spheres were
also present on the coatings’ surface like those present on the surface of 25 kW coating.
Also, some large pores were observed on this surface. For the 45S5 coating deposited
at 75 kW, large humps were observed on the surface which was evenly distributed over
the surface. The size of these humps was approximately 10 µm. The origin of these
humps might be the agglomeration of droplets at a higher flame (75 kW). Small round
particles were also present on the surface of this coating similar to those present on the
surface of 25 kW and 50 kW coatings (Figure 4.3). Figure 4.4 displays the BSE cross-
section images of three 45S5 coatings deposited at 25 kW, 50 kW and 75 kW. All three
images of the 45S5 coatings (Figure 4.4 a, b, and c.) showed a typical thermal sprayed
microstructure. No delamination and cracks along the coating- substrate interface
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Figure 4.3: SE, SEM images showing the surface morphology of the coatings deposited
at different flame power: 25 kW (a and d), 50 kW (b and e), and 75 kW (c and
f). The top row shows low magnification SE images and the bottom row shows high
magnification images of the same area.
were observed in any of the coatings. The coating deposited at low flame power of 25
kW was thin (<10 µm), and its thickness was also not uniform (Figure 4.4 a). The
microstructure of this coating suggested that the 25 kW flame power did not transfer
enough energy to particles for melting and accelerating them to deposit on to the
substrate. That is why at 25 kW the deposition efficiency was impaired, and a thin
coating (10 ± 1 µm) was obtained. Also, 25 kW flame power is the lower end of this
HVOF gun’s thermal spray, and it is a sub-sonic flame.
A thicker coating of uniform thickness was obtained at medium flame power of
50 kW (Figure 4.4 b). The thickness of this coating was 25 ± 1 µm; however, this
coating revealed to be porous (16 ± 2 %). Some vertical cracks were observed in
this coating which is probably introduced due to thermal stresses; however, there was
no delamination along the interface between the coating and substrate. The coating
obtained at high flame power of 75 kW was approximately of the same thickness as
the coating deposited at 50 kW; however, this coating appeared to be less porous than
the 50 kW coating (Figure 4.4 c). The porosity of this coating was 10 ± 1 %, and
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Figure 4.4: BSE, SEM image of coating cross-section showing the microstructure of
the coatings deposited at different flame power: 25 kW (a), 50 kW (b), and 75 kW (c).
this might be due to the better melting of particles at high flame power. Also, there
were no vertical cracks and cracks along the coating- substrate interface observed in
the high flame power coating.
4.3.2 Mechanical Properties of 45S5 Coatings
Table 4.2 shows the physical and mechanical properties of 45S5 coatings. It can be seen
that with increasing flame power from 50 to 75 kW, micro-hardness was increased from
253 ± 2 HV to 270 ± 1 HV. For the thin coating deposited at 25 kW, it was impossible
to measure the micro-hardness as the indicative coating thickness was less than 10 µm.
Also, as said earlier both of the coatings deposited at 50 kW and 75 kW flame powers
were porous. However, the 75 kW coating was less porous, having a porosity of 10 ± 1
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%, than the coating deposited at a medium flame power of 50 kW which had a porosity
of 16 ± 2 % (Figure 4.4 b and c). Table 4.2 also shows that the surface roughness (Ra)
of the low flame power coating was 2.0 ± 0.1 µm, similar to the Ra of 50 kW coating.
However, Ra was 3.0 ± 0.2 µm for the coating deposited at 75 kW coating, which
is probably due to humps present on the surface of this coating, making this coating
rougher. This high roughness might be advantageous, as its surface roughness increases
the surface area available for chemical reactions increase and it favours cell attachment
as well [255].
Table 4.2: Physical and mechanical properties of 45S5 coatings (mean value ± stan-











R25 10 ± 1 - - 2.0 ± 0.1
R50 25 ± 1 16 ± 2 253 ± 2 2.1 ± 0.1
R75 25 ± 1 10 ± 1 270 ± 1 3.0 ± 0.2
4.3.3 EDX Analysis
To determine the compositional gradient (wt %) as a function of the distance from
the coating-substrate interface to the top surface of the coating, EDX analysis was
carried out. Results are shown in Figure 4.5 with the corresponding SEM images,
where points on the images show the position where the EDX analysis was carried
out. The analysis showed that the composition of the Bioglass® (45S5) was varied
along the cross-section of the coating after thermal spray while spraying at different
flame powers. However, the compositional gradients for all three of the coatings were
different. SEM image with the corresponding EDX line scan along the cross-section of
the coating deposited at 25 kW is shown in Figure 4.5 (a and b). The Si content was
expected to be 19.3 wt % (present in 45S5 powder Table 4.2); however, it was changed
to 25 wt % at the coating-substrate interface of 25 kW coating. In the coating, Si
content was decreased, and at the top surface of the coating, it reduced to 23.5 wt %,
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16.4 wt % of Na was present in 45S5 powder before the spray which was reduced to
11 wt % closer to the coating- substrate interface. It increased toward the top surface,
where Na content was 15 wt %. For Ca, the wt % was reduced from the expected 19 wt
% to 18 wt %; however, in the coating and at the top surface, variations in Ca content
were negligible. The P content was fluctuating around 2 wt % with negligible variations
from the substrate- coating interface till the top surface of the coating. Also, some Fe
was identified near the interface between coating and substrate, which originated from
the substrate surface.
For the coating obtained at the flame power of 50 kW the compositional gradients
with the corresponding SEM image are given in Figure 4.5 c and d,, and it can be
seen that these gradients were more prominent than those observed for the coating
deposited at 25 kW flame power. Si was increased to 25 wt % at the interface between
coating and substrate and then started decreasing to 22 wt % at the top surface of the
coating. At the same time, Na reduced to 8.5 wt % at the interface, and then increasing
to 17 wt % at the top surface of the coating. Variations in the Ca content were again
to be more stable as were observed for its content in the 25-kW coating. Variations
in Ca content, which were observed during the analysis showed to be increased to 22
wt % at the interface and decreasing to 20 wt % on the top of the coating. A similar
trend was observed for P content; it changed to 2 wt % at the interface to 2.5 wt % at
the top surface.
Figure 4.5 f, represents the compositional gradients profiles along the cross-section
of the coating deposited at high 75 kW flame power. These gradient profiles seem
smoother and consistent compared to the gradient profiles of 25 kW and 50 kW coat-
ings. Si variation observed was to increase to 28 wt % at the coating substrate interface
and then reduced to 27 wt % till the top surface of the coating. Na wt % was approx-
imately 2, and this 2 wt % remained constant till the top of the coating. Ca was
increased to 22 wt % at the coating substrate interface and then started decreasing
to 21 wt % at the top of the coating. For P, the wt % was remained constant in the
whole thickness of the coating at 2. Though the compositional gradients showed the
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Figure 4.5: SE, SEM images of the cross-section of coatings deposited at 25 kW (a),
50 kW (c), and 75 kW (e) and their respective EDX line scans through the coating
cross-section in b, d and f. Points in the SEM images show the location of EDX data
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least variations along the cross-section of the coating obtained at 75 kW flame power,
however the observed composition was different in comparison to the starting original
formulation of Bioglass®.
Table 4.3: EDX area scan on the top surface s of the as- sprayed coatings.
As-sprayed (wt %)
Elements R25 R50 R75
Si 23.5 25.3 27.4
Ca 19.4 20.8 22.5
Na 9.1 9.6 5.4
P 1.8 1.6 1.2
Fe 5.0 0.0 0.0
Cr 0.9 0.0 0.0
Table 4.3 shows the EDX area analysis on the top surface of all of the three coatings.
It can be seen that increasing flame power from 25 kW to 50 kW and 75 kW had
significantly changed the wt % of the contents of the Bioglass (45S5). Before spray
16.4 wt % of Na was present in the 45S5 powder which was reduced to 9.1 wt % in 25
kW coating, 9.6 wt % in 50 kW coating and 5.4 wt % in the coating obtained at 75
kW flame power. Similarly, the content of P was 2.2 wt % in 45S5 powder and which
had reduced to 1.8, 1.6, and 1.2 wt % with increasing flame power from 25 to 50 and
75 kW. However, for Si and Ca the reverse trends were observed with the increase of
flame power. Si content was 19.3 wt % in 45S5 powder which increased to 23.5 wt %
in 25 kW coating, 25.3 wt % in 50 kW coating and 27.4 wt % in 75 kW coating %
weight of Ca increased from 17.7 (present in 45S5 powder) to 19.4, 20.8 and 22.5 wt %
with the increasing flame power from 25 to 50 and 75 kW.
4.3.4 XRD and Raman Analysis of the 45S5 Coatings
Figure 4.6 a, displays XRD spectra of 45S5 coatings deposited at 25, 50 and 75 kW.
45S5 experienced no devitrification while spraying at different flame conditions. Indeed,
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the absence of any sharp peak and the broad band appearing in 25 - 35◦ 2θ range of
the XRD patterns confirmed that the coatings were composed of glassy phase. The
only recognisable peaks which can be attributed to the metal substrate (stainless steel)
were austenite (PDF card no. 00-023-0298), and ferrite (PDF card no. 00-006-0696).
Raman spectra of 45S5 coatings and 45S5 powder (for comparison) are given in
Figure 4.6 b. As can be seen the coatings’ spectra were not different from that of the
powder. Also, all of the spectra are consistent with spectra reported by D. Bellucci
at.al [256]. The spectrum of coating deposited at 25 kW was similar to that of the 45S5
powder; however, the spectrum of 50 kW and 75 kW coatings were different after 1000
cm-1 and 1100 cm-1 from that of the 25 kW coating and 45S5 powder spectra. This
is probably due to the difference of microstructure. In spectra of the three coatings
and 45S5 powder, the peaks which were present at ∼ 610 cm-1 and 1079 cm-1 were
associated to the stretching of Si-O-Si groups. These bands are commonly present for
silicate glasses belonging to Na2O-CaO-SiO2 system [257], and also if silica is reduced
in the glass composition, then this shifts to higher wave number [258]. Further, the
peak at 860 cm-1 was associated with non-bridging oxygen–silica Si-2NBO, which was
of the same intensity for all the coatings and glass powder. Also, the peak at 1030
cm−1, which appeared as a shoulder on the right-hand side of the peak at 950 cm-1 was
assigned to vibrations involving Si2O5 with 1 NBO and two-dimensional structures.
Other than silica features, the intense peak was present at 950 cm-1. It was associated
with the symmetrical stretching of the PO4
-2 group [254, 259].
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Figure 4.6: XRD spectra (a) and Raman spectra (b) developed on the surfaces of the
SHVOF deposited Bioglass coatings at different flame powers where R25 is 25kW, R50
is 50 kW and R75 is 75kW.
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4.4 SBF Tests of the 45S5 Coatings
4.4.1 SEM Analysis
Figure 4.7 shows the SEM images of the surface morphology of 45S5 coatings after
immersing in SBF for 3 and 7 days. After 1 day of immersion of the coated samples
in SBF no HA was precipitated on any sample. Also, it can be seen in Figure 4.7 a,
that no HA deposition occurred after 3 days of immersion in SBF on the surface of
the coating deposited at 25 kW. Also, no HA was precipitated on this coating even
after 7 days of immersion in SBF (Figure 4.7 d). However, the samples containing
coatings deposited at 50 kW and 75 kW were uniformly covered with a dome - like
precipitates after 3 days of immersion in SBF and which is the characteristic for HCA
grown in vitro [260] (Figure 4.7 b and e). With the increase of immersion time in SBF
the dome- like morphology of the HA film was increased, as can be seen in Figure
4.7 c and f, which corresponds to the 50 kW and 75 kW coating surfaces after 7 days
of immersion in SBF, respectively. This suggests that with the increase of immersion,
further deposition of HA occurs. After taking out samples from SBF these were washed
Figure 4.7: SE, SEM images showing the surface morphology of the coatings after 3
days soaking in SBF solution (a), (b), (c) and after 7days soaking (d), (e), (f). Images
(a) and (d) at 25kW, (b) and (e) at 50kW, and (c) and (f) at 75kW flame power.
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with deionised water and dried at room temperature; this caused shrinkage in HA film
and resulted in cracks which can be seen in Figure 4.7 b, c, e and f [241].
4.4.2 XRD and Raman Spectroscopy
Figure 4.8 shows the XRD patterns of the 45S5 coatings after immersion in SBF for 3
and 7 days, and it can be seen that the diffraction patterns are consistent with the SEM
observations (Figure 4.7), as these also showed the presence of HA. HA was identified
from a broad peak at 32◦ 2θ, which corresponded to the prominent peak of HA. Also, a
secondary peak at about 26◦ 2θ corresponded to HA. Figure 4.8 b, is the XRD patterns
of the 45S5 after immersing in SBF for 7 days, and it can be seen that the intensity of
HA peaks increased with immersion time. This is probably due to the more deposition
of HA on the surface. It should be noted that HA was identified for coatings deposited
at 50 and 75 kW; no HA peak was found in the XRD pattern of the coating deposited
at 25 kW after immersion in SBF, even for longer time of 7 days.
In Figure 4.8 a and b, peaks other than that of the HA can be seen; these peaks
corresponded to austenite and ferrite from the substrate. The substrate peaks were
still recognisable in the XRD patterns after the precipitation of HA which might be
due to the fact that HA film was cracked, as can be seen in SEM images Figure 4.7.
Figure 4.9 shows the Raman spectra obtained on the surface of 45S5 coatings deposited
at 50 and 75 kW after immersion in SBF for 7 days, and the synthetic HA powder. It
can be seen that Raman spectra followed the same evolution for both of the coatings.
The peak around 960 cm-1 is associated with the ν1 vibration mode of PO4
-3 for HA
powder and for HA precipitated on the surfaces of the coatings; this is the main peak
of HA. The peak at 1046 cm-1 in the spectrum of HA powder and the spectrum of HA
precipitated on the coatings was associated with the PO4
-3 ν3 vibration. The peak at
1078 cm-1 in the spectrum of HA powder was associated with the PO4
-3 ν3 vibration
too. Also, the peak at 432 cm-1 in all of the spectra was due to the ν2 domain of the
PO4
-3. Moreover, the peak at 1070 cm-1 for the precipitated HA on the surfaces of
the coatings was assigned to the ν1 mode of the carbonate group, which confirmed the
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carbonated nature of the precipitated HA [256, 261]. Moreover, the peaks at 579, 590,
and 608 cm-1, were due to the ν4 vibration of PO4
-3. These peaks were present in the
spectrum of synthetic HA powder and the spectra of precipitated HA on the surface
of 50 kW and 75 kW coating [261, 262].
Figure 4.8: XRD scan (a) 45S5 coatings after 3 days of soaking in SBF solution and
XRD scan 45S5 coatings after 7 days of soaking in SBF solution (b).
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Figure 4.9: Raman spectra acquired on the surfaces of the SHVOF thermal spray
deposited bioglass coatings at flame powers of 50 kW and 75 kW after 7 days of soaking
in SBF.
4.4.3 EDX Analysis of the Coatings after SBF Test
EDX line scan along the cross-section of the coatings deposited at flame power 50 kW
and 75 kW after immersion in SBF for 7 days was carried out and presented in Figure
4.10 b and d. While Figure 4.10 a and c are the corresponding BSE images of the cross-
sections. As it can be seen from Figure 4.10 a, that the precipitated HA layer thickness
on the coating, which was deposited at 50 kW and immersed in water for 7 days, was
approximately 28 µm, while the residual glass underneath this precipitated HA layer
was approximately 8 µm thick. The EDX line scan of the cross-section (Figure 4.10 b)
showed that at the coating – substrate interface, Si content had reduced to 10 wt %,
that further had reduced till the top of HA layer. Conversely, Ca content had increased
to approximately 28 wt % at the coating – substrate interface, which further increased
to 37 wt % in the top surface of the deposited HA layer. P content had increased to 17
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wt % at the interface between coating and substrate. P content further increased to
20 wt % while going from the coating–substrate interface to the top of the HA layer.
Figure 4.10: BSE SEM images of the cross-section of coatings deposited at 50 kW
(a), and 75 kW (c) after soaking for 7 days in SBF and their respective EDX line scans
in b and d. Points in the images show the location of the EDX points. (distance is
from substrate-coating interface towards coating top surface
).
For the coating deposited at 75 kW flame power and immersed in SBF 7 days, the
precipitated HA layer was approximately 10 µm thick. Also, it can be seen in Figure
4.10 c, that the residual glass coating was approximately 22 µm thick. Figure 4.10
d, shows the line scan of this cross-section, and as it can be seen that Si content was
approximately 40 wt % at the interface between coating and substrate, then increased
to approximately 43 wt % at the interface between coating and deposited HA layer.
After which a significant decrease in Si content was observed. Ca content was 5 wt %
at the coating- substrate interface and then increased to approximately 35 wt % on
top surface of HA layer. The P content showed similar profile, initially at 2 wt % at
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the interface between coating and substrate and the increased to 22 %.
Table 4.4 shows the EDX area scan conducted on the top surfaces of the 25 kW, 50
kW and 75 kW coatings immersed in SBF for 3 and 7 days. From this analysis, it can
be seen that the coating deposited at 25 kW flame power the wt % of Si reduced to 3.7,
Ca content was 12.4 wt %, Na was reduced to 1.8 wt %. While P content increased to
9 wt %. Also, this analysis suggested that Fe and Cr had been increased to 9.1 wt %
and 7.4 wt % after immersing the 25 kW coating in SBF for 7 days. For the coating
deposited at 50 kW, Si and Na had reduced approximately to 0.3 wt % and 0.9 wt %.
However, Ca increased to 39.5 wt % and also, P increased to 18.7 wt % while those
were immersed in SBF for 7 days. Similar trends were observed for 75 kW coating and
immersed in SBF for 7 days. Its Si content had reduced to 2.5 wt %, while Na was
reduced to 1.2 wt %. Ca was increased to 34.8 wt %, while P content was increased to
18.7 wt % after immersion in SBF for 7 days.
Table 4.4: EDX area scan on top surfaces of the coatings soaking in SBF for 3 and




After Soaking for 3
Days in SBF (wt %)
After Soaking for 7
Days in SBF (wt %)
— R25 R50 R75 R25 R50 R75
Si 28.6 1.2 5.4 3.7 0.3 2.5
Ca 10.1 37.0 32.9 12.4 39.5 34.8
Na 2.2 1.2 1.5 1.8 0.9 1.2
P 4.3 19.2 17.3 9.0 18.6 18.7
Fe 6.3 0.0 0.0 9.1 0.0 0.0
Cr 2.0 0.0 0.0 7.4 0.0 0.0
Table 4.5 shows the Ca/P ratio (atomic) for the three of the 45S5 coatings after
thermal spray and immersed in SBF for 3 and 7 days. The results suggested that this
ratio was 7.6, 11 and 10.4 for 25 kW, 50 and 75 kW coatings, respectively before SBF
test. For 25 kW coating this ratio was decreased to 1.8 after 3 days of immersion in
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SBF which further reduced to 1.04 with further immersion in SBF. For 50 kW coating,
Ca/P ratio was 1.48 after 3 days of immersion in SBF, and this was increased to 1.5
with further precipitation of HA after 7 days of immersion in SBF. For 75 kW coating,
after 3 days of immersion Ca/P ratio was 1.47, which increased to 1.63 with further
immersion in SBF for 7 days.
Table 4.5: Ca/P ratio (atomic %) of the as-sprayed and soaking in SBF after 3 and














R25 7.6 1.8 1.04
R50 11 1.48 1.5
R75 10.4 1.47 1.63
4.5 Discussion
4.5.1 Coating Characterisation
It was observed that increasing the flame power from 25 kW to 50 kW and 75 kW had
a significant effect on the 45S5 coatings microstructure. At lower flame power of 25
kW a thin coating of less than 10 µm thickness was obtained. While at flame powers of
50- and 75- kW thicker coatings of thickness 25 ± 1 µm were produced but of different
microstructures. Formation of thin coating at 25 kW flame power and other literature
studies based on SHVOF thermal spray proposes that the lower flame power of 25 kW
does not provide enough energy to melt and accelerate the particles to deposit onto
a substrate and produce a thick coating. When these unmelted large particles and
agglomerates collide onto the substrate with low velocity, these bounce off, impairing
the deposition of the material. The flame at 25 kW is regarded as being subsonic with
a maximum temperature of 2,727 ◦C and velocity of 1,000 m/s, according to modelling
work done in-house using a CFD software Fluent [263]. Low velocity particles result
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in the formation of porous microstructure as some of the molten or partially molten
particles (not well-flattened splats) adhere to the substrate. At 50 kW and 75 kW
flame power, well-adhered to the substrate, thick and less porous coatings with rough
surfaces were deposited. The 75 kW coating was less porous than the 50 kW, which
may be due to the enough heat transfer from flame to the particles and melting them
well, resulting in a denser microstructure [264, 265].
Increasing the flame power had a positive effect on the surface roughness (Ra) of
the coatings. Ra of the coatings increased with increasing flame power. The coating
deposited at 75 kW was 3.0 ± 0.2 µm rough, which was higher than for the coatings
obtained at 25 and 50 kW flame power with 2.00 ± 0.01 µm rough surfaces. The
high flame power of 75 kW resulted in fully molten splats with globules on the coating
surface, which could be formed due to the agglomeration of molten particles in the
flame leading to the formation of large humps on the surface resulted in a rougher
surface [264]. Formation of humps in SHVOF sprayed coatings with alumina, titania,
and zirconia has been reported in detail before [248]. Similarly, microhardness values
of the 75kW coating 270 ± 0.9 HV were higher than that of the medium-power coating
253 ± 1.9 HV, which was also due to better melting of particles and agglomerates
at this flame power—resulting in a harder coating. However, these values achieved
were less than the microhardness of the bulk glass Bioglass® which is 586 HV hard
[254], and approximately equal to that reported by Bolelli et al., who reported 296 HV
hardness for the lowest thickness of the coating, which was 41 ± 3 for Bioglass (45S5)
glass coatings deposited using SHVOF thermal spray [241].
EDX analysis of the coatings along the cross-section (Figure 4.5 b, d and f) showed
that the Na2O-CaO-SiO2-P2O5 composition of the coating concerning the initial bulk
glass formulation of 45S5 had been changed due to thermal spraying. However, these
compositional changes were less noticeable in the coatings obtained at 25 kW and
50 kW flame power than for the coating obtained at the higher flame power of 75
kW. This was probably due to the higher heat transfer to the glass at high flame
power and hence degradation of the feedstock powder [49]. Also, Table 4.3 showed a
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decreasing trend in wt % of Na and P content in coatings when deposited at 25 kW,
50 kW and 75 kW flame power. However, wt % of Si and Ca showed increasing levels
with the increase of flame power. Volatile components from the molten glass at high
temperature of high flame power evaporate, which could reduce their wt %. Such as
the direct evaporation of the volatile component, P2O5, from the glass might happen.
Moreover, glass components such as Na2O evaporates from the molten glass in the
form of NaOH after reacting with water vapours in the combustion chamber. These
vapours are present in the combustion chamber as a consequence of the combustion
reaction [266].
45S5 coatings were amorphous as revealed by the XRD analysis and can be seen in
Figure 4.6 a. The three crystalline peaks observed were related to the substrate due
to the 40.8 µm penetration depth of the x-rays—the thickness of the coating was less
than the penetration depth. This means that the glass did not undergo crystallisation
during thermal spray. This is due to the rapid heating and cooling of the molten glass
particles and insufficient time for crystallisation[9]. Moreover, the Raman spectra for
the surface of 45S5 coatings are similar to that of the starting 45S5 powder as can be
seen Figure 4.6 b. However, slight shifts were observed in the peaks of Si-O-Si from
1079 to 1075 cm-1 in the coatings obtained at 50- and 75-kW flame power; however, it
can be still assigned to the stretching of Si-O-Si bond. Similarly, a peak had shifted
from 610 cm-1 to 600 cm-1 for the coating deposited at 75 kW flame power which was
also assigned to Si-O-Si. Since these peaks are quite strong, which is a clear indication
that there is no alteration of the glass network of SHVOF deposited Bioglass® (45S5)
coatings [218, 241].
4.5.2 SBF Studies of 45S5 Coatings
The steps involve in the reaction of 45S5 (Bioglass®) with SBF as reported in the
literature [49, 267] are as follows: (i) exchange of alkali and alkaline earth ions with
H+ and H3O
+ ions from the solution take place, (ii) loss of soluble silica occurs leaving
behind -Si-OH bonds, (iii) condensation and res-polymerisation of a silica rich layer
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depleted in cations, (iv) migration of Ca2+ and PO+4 to the surface from inside the glass
and from the body fluid and formation of an amorphous CaO–P2O5 rich film on the
silica-rich layer. This amorphous layer which also incorporates other ions such as OH-,
(CO3)
2- and F- from the solution, crystallises into carbonated hydroxyapatite (HCA).
HCA first nucleates and then grows, causing a dome-like morphology of the precipitated
layer. Based on the reaction mechanism between Bioglass® (45S5) and SBF, all three
SHVOF thermal sprayed 45S5 coatings showed different behaviour towards SBF. Such
as no HA precipitated on 25 kW coating, thick HA layer (∼ 24µm) was observed on the
surface of 50 kW coating, and comparatively a thin HA layer (∼ 17 µm) precipitated
on the surface of 75 kW coating.
For the coating deposited at lower flame power of 25 kW, no HA had precipitated
even after three and seven days of immersion in SBF solution as can be seen in Figure
4.8 no peak was observed for HA, which could be due to the thickness of the coating.
From Table 4.4, it can be suggested that the microstructure of the 25 kW coating was
not stable enough in SBF for the precipitation of HA to occur on its surface [268]. As,
the increasing wt % of Fe and Cr (from the substrate) observed from this sample after
immersion in SBF for 3 and 7 days suggest that the low flame power coating may have
degraded while in SBF, resulting in a reduction in the thickness of the coating [268].
The XRD patterns for the coatings deposited at 50 and 75 kW after immersion in
SBF revealed peaks for HA as can be seen Figure 4.8. The broad diffraction peak at ∼
32◦ 2θ may be due to crystalline structural defects such as the presence of HCA. The
presence of a carbonated group is common for Bioglasses® while reacting with SBF for
longer duration, and this group can be a cause in the broadening of XRD peak [241].
The Ca/P atomic ratios of the HA deposited on the surface of the coatings were
equal to 1.5 for coating deposited at 50 kW flame power, while it was 1.63 for higher
(75 kW) flame power coating after immersion in SBF for 7 days. Tri calcium phosphate
(TCP), which is a precursor for HA has a Ca/P ratio of 1.55 [269]. However, the Ca/P
ratio equal to 1.63 (for HA precipitated on the surface of 75 kW coating) is slightly
different from the Ca/P ratio for synthetic HA which is 1.67 [99]. The different Ca/P
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ratios obtained for the deposited HA layer on the surface of the coating were probably
because the HA layer deposited after immersion in SBF was HCA rather than HA.
Similarly, the EDX line scans along the cross-section of the 50 kW and 75 kW
coatings after immersion in SBF for 7 days showed that the interaction of these two
coatings with SBF was different (Figure 4.10). The differences observed in the precip-
itated HA layers on the surfaces of these coatings were, i) the HA layer thickness on
their surfaces, ii) reduction in the coatings thickness due to dissolution in SBF and iii)
changes in the contents of coatings after immersion in SBF for 7 days. After immer-
sion in SBF for 7 days, a thick precipitated HA layer approximately 24 µm thick was
observed on the surface of the 50 kW coating, and which showed a reduction in coating
thickness from 25 µm to 6 µm (Figure 4.10 a). This reduction in thickness is suggested
to be due to the dissolution of the glass coating while in SBF. This happened most
likely due to the high porosity observed in that coating that resulted in a larger active
surface area for the ion leaching process [27]. The more porous microstructure may
have also enabled infiltration of Ca and P ions from the SBF solution into the coating,
as increasing levels of Ca and P were observed in this coating, as can be seen in Figure
4.10 b.
However, from the EDX analysis of 75 kW coating after immersion in SBF for 7
days (Figure 4.10 d), it was observed that the Si wt % was high in the residual glass
coating and was increasing till the coating-HA layer interface. Then the wt % of Si
decreased going from the coating-HA interface to the top of the HA layer. Moreover,
Ca and P contents were observed to be increased from the coating-HA interface to the
top of the HA layer. This suggests that no Ca, and P penetrated in the coating, which
is probably due to the dense microstructure of this coating. Furthermore, only a small
reduction in coating thickness from 25 µm to approximately 23 µm was observed for
the 75 kW coating after 7 days of immersion in SBF with the formation of a thinner
∼ 17 µm thick precipitated HA layer on its surface. These results suggested that
the coating deposited at higher 75 kW flame power followed the same reaction steps
suggested in the literature for the formation of HCA precipitated on top of the residual
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glass coating while immersed in SBF [27, 241, 268].
The above observations suggest that the 75 kW coating provided a comparatively
stable and durable coating in SBF, which could provide prolonged interaction with
bone tissue. Furthermore, if tailored layers of porous and dense micro-structures were
desired, then a combination of the 50 kW and 75 kW could be considered to be applied.
4.6 Summary
The Bioglass® suspension was prepared by dispersing powder into water + IPA mixed
media. This suspension was successfully deposited using SHVOF thermal spray on
stainless steel substrates. The as-sprayed coatings have been studied for microstructure
characterisation, phase identification and structural alterations. The SBF tests were
carried out to study the reactivity of these coatings. From these observations following
conclusion can be drawn:
• The results suggest that SHVOF thermal spray is a viable processing technique
to produce Bioglass® coatings. However, the process parameters require care-
ful optimisation and control to obtain a coating with the desired thickness and
porosity on the substrate and showed desired reactivity in SBF. Well-adherent to
the substrate, thick and uniform coatings were obtained at 50 and 75 kW flame
power with varying microstructures
• The coating obtained at 50 kW had a porous microstructure, while the coating
obtained at 75 kW had a higher surface roughness.
• No crystallisation of the feedstock occurred during the thermal spray as showed
by the amorphous XRD spectra.
• The Raman spectra of the Bioglass® coatings were analogous to the spectrum
of Bioglass® feedstock powder before spray, which showed no alteration of the
glass network due to the production technique.
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• The SBF results showed that HA was not deposited on the coating deposited at
25 kW.
• HA had precipitated on coatings deposited at 50 and 75 kW after 3 days of
immersion in SBF. However, the coating’s porous microstructure obtained at 50
kW led to resorption of the coating.
• The dense, thin and rougher coating deposited at high flame power of 75 kW
developed HA layer on the surface, and the coating showed comparatively little
degradation during immersion in SBF.
• These results show that by controlling spray parameters different microstructures




ICIE16 and 1393 Bioactive Glass
Coatings and In-vitro Behaviour
5.1 Introduction
This chapter presents the set of results obtained by the deposition of ICIE16 and 13-93
bioactive glasses at flame power of 50 and 75 kW. The powder before spray and the
as-sprayed coatings were characterised using SEM, XRD, Raman spectroscopy. The
apatite forming ability of the coatings was assessed using SBF, while the cytotoxicity
of the coatings was determined using MG63 cells.
5.2 ICIE16 and 13-93 Powder Characterisation
5.2.1 Particle Size Distribution and Powder Morphology of
ICIE16 and 13-93 Bioactive Glass Before Spray
Frits of ICIE16 and 13-93 were ground separately in a zirconia jar with zirconia balls
of 5 mm diameter for 30 min and 550 rpm using ball mill, which resulted in D10 = 1.8
µm, D50 = 8.3 µm and D90 = 24 µm for the ICIE16 powders and for 13-93 powders of
D10= 1 µm, D50 = 4 µm and D90 = 20 µm. After 2nd step of milling (for 30 min at
500 RPM), the ICIE16 bioactive glass had a particle size distribution of D10 = 1 µm,
107
Chapter 5 Section 5.2
D50 = 4.5 µm and D90 = 11.4 µm (Figure 5.1 a) and had a range of 0.4 µm - 28 µm.
13-93 powder had a distribution of D10 = 0.8 µm, D50 = 2.7 µm and D90 = 11 µm
(Figure 5.1 c) with a range of 0.3 µm - 23 µm.
SEM (SE) imaging of ICIE16 powder after 2nd step of ball milling (Figure 5.1 b)
showed angular shaped particles; also some larger than 10 µm particles were present.
While, for 13-93 bioactive glass (Figure 5.1 d) it showed that most of the particles were
finer; however particles larger than 10 µm were also observed.
Figure 5.1: (a) Particle size distribution and (b) SEM (SE) image of ICIE16, (c)
particle size distribution and (d) SEM (SE) image of 13-93 bioactive glass.
5.2.2 EDX of the ICIE16 and 13-93 Powder
EDX analysis (point) of ICIE16 and 13-93 powder is given in Table 5.1. For ICIE16,
the composition was slightly different from that of the regular composition (48 % SiO2,
33 % CaO, 6.6 % Na2O, 2.4 % P2O5 and 10 % K2O, in wt %) and had 3 wt % more
Si, 5 wt % less Ca than the expected values. However, wt % of Na, K, and P in the
prepared glass was approximately the same as expected values.
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Composition of 13-93 powder was approximately the same as the expected values
(Table 5.1). Negligible variations were observed for the elements, such as O.7 wt %
for Na and Si and 0.2 wt % for P, whilst, wt % of K, Ca and Mg was the same as the
intended values.
Table 5.1: EDX analysis of the final powder before the suspension preparation (number
of measurements=3
).




4.8 22.3 1.1 8.3 23 -




4.3 24.3 1.8 9.8 14 2.9
Powder 5.0 ± 0.1 25.0±0.05 1.6 ± 0.1 10.0 ± 1 14.0 ± 0.3 3.0 ± 0.3
5.2.3 XRD and Raman Analysis of the Powder
Figure 5.2 presents the XRD spectra of ICIE16 and 13-93 powder. Both glass spectra
were amorphous except the amorphous hump at 25◦ - 35◦, which is the characteristic
of glass.
Figure 5.2: XRD spectra of ICIE16 and 13-93 powder.
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The Raman spectra for both glass powder is given in Figure 5.3. For both spectra
the peak at 621 cm−1 and 1057 cm−1 were assigned to the stretching of Si-O-Si [256] [1].
The peak at 950 cm−1 was associated with the stretching of PO4
-2 [256, 270]. However,
the spectra of ICIE16 powder revealed a peak at 886 cm−1 which was associated to
the non-bridging oxygen silica [256]; this band was not present in the Raman analysis
of 13-93 powder. Moreover, a shoulder was observed in the Raman spectrum of 13-93
powder at 786 cm−1 which was related to MgO [271].
Figure 5.3: Raman spectra of ICIE16 and 13-93 powder.
5.3 As-Sprayed Coating Characterisation
5.3.1 Surface Morphology and Cross-Section of the Coatings
The surface morphology of the as-sprayed 45S5 coatings deposited at 50 kW flame
power was examined using SE imaging and is given in Figure 5.4. Figure 5.4 a shows
the surface of the ICIE16 coating deposited at 50 kW, and it can be seen that no
globules appeared on the surface of this coating. The high magnification image (Figure
5.4 a) of the surface shows that this coating surface consisted of molten splats with
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small round unmelted particles embedded in it. Moreover, well-flattened splats of size
larger than 20 µm, as can be seen in Figure 5.4 c, were also observed.
The surface of 50 kW coating of 13-93 bioactive glass is given in Figure 5.4 d, which
shows the absence of globules. The high magnification image of this coating (Figure
5.4 e) shows that the surface contained a higher amount of round unmelted splats and
flattened splats. The size of these splats was around 10 µm in diameter (Figure 5.4 f).
The surface roughness of the 50 kW ICIE16 coating was of Ra = 1.8 ± 0.1 µm, whilst
the surface 13-93 coating was slightly rougher than ICIE16 coating with Ra = 2.4 ±
0.4 µm, which could be associated with the greater presence of the partially molten
splats on the surface of 13-93 coating (Figure 5.4 c).
Figure 5.4: SE, SEM images showing the surface morphology of the coatings deposited
at 50 kW: (a), (b) and (c) ICIE16, and (d), (e) and (f) 13-93 coatings.
Figure 5.5 presents the surface morphology of ICIE16 and 13-93 coatings deposited
at 75 kW, as can be seen in Figure 5.5a that the surface of ICIE16 coating contained
globules. A high magnification image (Figure 5.5 b) of this surface shows that those
globules were spherical deposits with a porous structure, and the size of these structures
was around 20 µm. Other than these globules, the surface had flattened lamellae and
fine partially melted splats (see Figure 5.5 c).
The surface of the 75 kW coating of 13-93 bioactive glass showed similar features
to the ICIE16 75 kW coating, presenting globules on the entire surface of the coating
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(Figure 5.5 d). However, these semi-spherical structures were not as porous as those
observed on the surface of the ICIE16 coatings deposited at the same power (i.e. 75
kW), and were also greater in size with a diameter around 40 µm, with fine particles
adhered to the surface as can be seen in Figure 5.5 e. Moreover, the surface of this
coating also contained well-flattened lamellae with some spherical particles as can be
seen in Figure 5.5 f.
Figure 5.5: SE, SEM images showing the surface morphology of the coatings deposited
at 75 kW flame power: (a), (b) and (c) show ICIE- 16 coating and (d), (e), (f) show
13-93 coating.
The surface of the 75 kW coatings of ICIE16 and 13-93 glasses were rougher than
their coatings deposited at 50 kW. The 75 kW coating of ICIE16 had a roughness of
3.7 ± 0.3 µm, whereas the surface of 13-93 coating deposited at 75 kW coating had a
surface roughness of 6.5 ± 0.6 µm.
All the coatings produced did not reveal any delamination at the coating-substrate
interface, as seen from the cross-sectional images (Figure 5.6). In addition, they pre-
sented a uniform coating thickness where some remnant porosity was detected for
coatings. Moreover, the globular features in the ICIE16 and 13-93 coatings deposited
at 75 kW which were observed on the surface of the coatings, can be seen in Figure
5.6 b and d.
The physical and mechanical properties of the ICIE16 and 13-93 coatings are pre-
sented in Table 5.2. Vicker micro-hardness testing revealed very similar values for both
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bioactive glass coatings deposited at 50 kW flame power (i.e. 250 ± 8 HV for ICIE16
246 ± 4 HV for 13-93). However, both of the glass coatings deposited at 75 kW re-
vealed higher micro-hardness values (i.e. 301 ± 10 HV for CIE16 and 318 ± 12 HV for
the 13-93 coating) than 50 kW coatings.
Figure 5.6: Cross-sectional SEM images of the coatings deposited: ICIE16 coatings
(a) deposited at 50 kW, (b) deposited at 75 kW, 13-93 coatings (c) deposited at 50 kW,
and (d) at 75 kW.
Table 5.2: Physical and mechanical properties of ICIE16 and 13-93 coatings deposited















ICIE16 13-93 ICIE16 13-93 ICIE16 13-93 ICIE16 13-93
50 68 ± 1 67 ± 1 5 ±1 6 ± 0.3 250 ± 8 246 ± 4 1.8 ± 0.1 2.4 ± 0.4
75 59 ± 10 62 ± 14 4 ± 0.5 3.5 ± 0.2 301 ± 10 318 ± 12 3.7 ± 0.3 6.5 ± 0.6
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5.3.2 EDX Analysis along the Cross-Section and on the Top
of the Coatings
In order to explore if any compositional variations had occurred during the thermal
spray process, EDX line scans across the coating thicknesses were carried out. The
results are presented in Figure 5.7, where elemental wt % is presented as a function of
distance from the coating-substrate interface to the top surface of the coatings obtained
with corresponding BSE images (points on the images show where the EDX analysis
was conducted).
The composition of the ICIE16 coating deposited at 50 kW (Figure 5.7 a) was
approximately uniform (see Figure 5.7 b). No changes were observed in Si wt % from
the expected 25 ± 0.6 (present in glass powder) and remained at this value to the top
surface of the coating. Ca wt % was 24 wt % in the coating, which was an increase from
the original powder prior to spraying (18 wt % (Table 5.1). However, in the coating,
variations in Ca content were small and were in the range of 24-25 wt %. In the starting
powder P content was 1 wt % and had reduced at the coating- substrate interface to
0.7 wt %, and remained approximately the same to the top surface of the coating. K
wt % changed from 8.9 wt % to 4 wt % at the coating-substrate interface and remained
at approximately 3 wt % to the top surface of the coating. Na changed from 5 to 3 wt
% at the interface between coating and substrate and remained at approximately 1 wt
% to the top surface of the coating.
For ICIE16 coating deposited at 75 kW, composition showed slight variations when
going from the coating-substrate interface to the top of the coating (Figure 5.7 d), also
the concentration of the elements (wt %) changed from the starting powder. Variations
in Si wt % was between 25 - 31 wt % from the interface between coating and substrate
to the top of coating. Ca content changed to 23 wt % at the interface and to 18 wt % at
the top of the coating. K was approximately 5 wt % at the interface, then decreased to
0.68 wt % at the top of the coating. P was 1 wt % at the coating- substrate interface
and then decreased to 0 wt % at the top surface of the coating. Wt % of Na was
reduced from 3 wt % at the interface to 0 wt % in the coating.
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Figure 5.7: In figure a and c are BSE images while b and d are the respective EDX
line scan of ICIE16 coatings deposited at 50 and 75 kW, e and g are BSE images while
f and h are the respective EDX scans of 13-93 coatings deposited at 50 and 75 kW
(distance is from substrate-coating interface towards coating top surface
).
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Variations were also observed from the starting powder composition of 13-93 bioac-
tive glass when deposited at 50 kW; however, the across the coating composition was
uniform, as can be seen from the EDX line scan across the coating (Figure 5.7 f). 25
wt % of Si was present in 13-93 powder before spray, and the observed deviations were
in the range of 27 to 29 wt % from the coating- substrate interface to the top surface
of the coating. Ca content remained constant at approximately 14 wt % in the coating
and which was similar to the starting powder composition. Wt % of P remained con-
stant at 1 wt % in the coating and also did not vary from the original content; however,
near to and at the top surface of the coating wt % of P was decreased to 0 %. Na was
5 wt % in the starting powder, which was then decreased to approximately 2 wt %
at the interface between the substrate and coating, and remained constant to the top
surface of the coating. Before the thermal spray process, K was approximately 10 wt
% in 13-93 bioactive glass, and after deposition at 50 kW, it decreased to 4 wt % at
the coating- substrate interface. The Mg levels also approximately remained constant
after spraying at 50 kW in coating similar to the starting 3 wt % in powder.
For the 13-93 coating deposited at 75 kW, 25 wt % of Si (present in the starting
powder) was increased to 29 wt %, and no variation was observed in its content across
the coating. Ca was observed to have increased to 16 wt % and remained at this level
across the coating. The wt % of Na content had reduced to approximately 1 wt %
at the coating–substrate interface; however, it remained same in the coating. P did
not change from the original wt % present in the powder which was 1 wt % and also
remained at this level across the coating. 2 wt % K was observed (originally 10 wt
% in powder) at the substrate-coating interface and with a small variation in coating
layer till top of coating. Mg content remained constant at approximately 3 wt % at the
interface between coating and substrate and in the coating after spraying at 75 kW.
EDX surface analysis of ICIE16 coatings can be seen in Table 5.3 3, which shows
that increasing flame power affected the glass composition. The Si (wt %) was seen
to vary slightly between 25 – 26 wt % for powder to the 50 kW samples and up to
28 % was seen for the 75 kW samples. Na wt % was seen to vary from 5 to 3 and
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2 wt % when sprayed at 50 and 75 kW flame power Wt % of Ca was increased from
18 wt % to 24 and 26 wt % with the increase of flame powers from 50 to 75 kW. P
remained approximately constant and similar in wt % to the starting powder wt % for
both flame power samples. K, however, revealed a higher variability in comparison to
the starting powder from between (8.9 wt %) to 4 wt % and 3 wt % when deposited
at 50 and 75 kW.
EDX area analysis of the top surface of the 13-93 coatings is provided in Table 5.3,
which shows that after spraying Na content had reduced from 5 wt % to 2 wt % and 1
wt % after spraying at 50 and 75 kW. Mg and P remained constant at 3 wt % and 1
wt % after spraying at both the different flame powers employed; however, K showed
the same trend as Na, with reductions observed with increasing flame power from 6 wt
% at 50 kW to 4 wt % at 75 kW flame power.
Table 5.3: EDX analysis on the top of as sprayed surfaces of ICIE16 and 13-93
coatings, where R50 is the coating deposited at 50 kW and R75 at 75 kW flame power.







4.8 22.3 1.1 8.3 23 —
Powder 5.0 ± 0.1 25.0 ± 0.6 1.1 ± 0.1 8.9 ±0.2 18.0 ± 2.0 —
R50 3.0 ± 0.4 26.0 ± 0.3 1.0 ± 0.1 4.0 ± 0.1 24.0 ± 0.2 —







4.3 24.3 1.8 9.8 14 2.9
Powder 5.0 ± 0.1 25.0±0.05 1.6 ± 0.1 10.0 ± 1 14.0 ± 0.3 3.0 ± 0.3
R50 2.3 ± 0.3 28.0 ± 0.4 1.0 ± 0.1 6.0 ± 0.6 16.0 ± 1.0 3.0 ± 0.1
R75 1.0 ± 0.5 29.4 ± 0.1 1.0 ± 0.0 4.0 ± 0.1 19.0 ± 0.7 3.6 ± 0.1
5.3.3 Raman and XRD of the Coating
The ICIE16 and 13-93 bioactive glass coatings were analysed post-deposition via XRD
analysis to explore if any phase changes had occurred and the spectra are given in
Figure 5.8. No crystalline peaks were observed in any of the spectrum (except signal
from the stainless-steel substrate in the case of ICIE16 75 kW coating). This confirmed
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that the amorphous nature of the starting materials had been preserved. The large
hump observed at 25◦ - 35◦ is fairly typical of amorphous glass structures [272, 273].
Figure 5.8: XRD spectra of ICIE16 (a) and 13-93 (b) bioactive glass coatings deposited
at 50 and 75 kW flame power. Where as R50 is the coating deposited at 50 kW and
R75 coating deposited at 75 KW.
The Raman analysis of the ICIE16 and 13-93 coatings and powder (for comparison)
are given in Figure 5.9. As can be seen that the coating spectra were very similar to
the respective glass powder, which proves that structure of both glasses did not disrupt
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during thermal spray.
Figure 5.9: Raman analysis (a) of ICIE16 (b) 13-93 bioactive glass coatings deposited
at 50 kW and 75 kW.
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5.4 Apatite Formation on the Surfaces of the Coat-
ings in SBF
5.4.1 SEM Analysis
The SBF tests and following SEM analysis showed that HA had formed on both (50
and 75 kW) ICIE16 coatings after three days of immersion in SBF (Figure 5.10 a and
c, whereas Figure 5.10 b and d depict surface deposition after 7 days of immersion
in SBF). The surface morphology of the coatings resembled “cauliflower” like features
characteristic of HA deposits on the surface post immersion in SBF. The 13-93 coating
samples deposited at 50 kW followed a similar pattern (see Figure 5.10 e for deposition
after 3 days and Figure 5.10 f for deposition after 7 days of immersion in SBF). However,
the 13-93 coatings deposited at 75 kW did not reveal any HA deposition on their
surfaces after 3 days of immersion in SBF (see Figure 5.10 g). However, after immersion
in SBF for 7 days, HA was detected on this coating surface, which was not fully covered
(see Figure 5.10 h).
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Figure 5.10: Raman analysis (a) of ICIE16 (b) 13-93 bioactive glass coatings de-
posited at 50 kW and 75 kW.
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5.4.2 XRD and Raman Spectroscopy
Figure 5.11 shows the XRD analysis acquired at the surfaces of the ICIE16 and 13-
93 coatings after SBF tests. The spectra revealed the presence of HA from peaks at
26◦ and 32◦ 2θ which matched with PDF no 00-001-1008; however, it can be seen
(Figure 5.11) for ICIE16 coatings deposited at 50 and 75 kW revealed HA peaks after
3 days of immersion in SBF (Figure 5.11 a, b). The intensity of these peaks increased
with increasing immersion time to 7 days. The same trend was seen for 13-93 coating
deposited at 50 kW, and immersed in SBF for 3 and 7 days (Figure 5.11 c).
Figure 5.11: XRD spectra (a), (b) of ICIE16 coatings and (c), (d) 13-93 coatings
after SBF tests. While (a) and (c) are 50 kW coatings, (b) and (d) after 7 coatings
deposited at 75 kW coatings.
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However, XRD analysis of 13-93 coating deposited at 75 kW showed no peak after 3
days of immersion in SBF, as shown in Figure 5.11 d. Also, this coating showed peaks
that were associated with HA deposition after immersion in SBF for 7 days, though
the intensity of these peaks was not high in comparison with the HA peaks developed
on the other three coatings. The peak at 32◦ was broader (31◦ - 32◦) in all spectra due
to the carbonated nature of HA (HCA).
Figure 5.12: Raman spectra acquired on the surfaces of the S-HVOF thermal sprayed
bioactive glass coatings deposited at flame powers of 50 kW and 75 kW after 7 days of
immersion in SBF, where (a) ICIE16 coatings and (b) 13-93 coating.
Consistent with the XRD and SEM results, the Raman spectra measured at the
top surface of all coatings immersed in SBF for 7 days resembled the spectrum of
synthetic HA powder, as shown in Figure 5.12. The peak at 960 cm-1 in the spectra
was assigned to symmetric stretching v1 of PO4
-3. The broad peak at 432 cm-1 was
assigned to v1 bending of PO4
-3. In contrast, the broad peak at 585 cm-1 was due
to the anti-symmetric bending v4 of PO4
-3 [274]. The peaks at 1045 cm-1 for the HA
powder were assigned to vibration of the PO4
-3 v3. The peak at 1070 cm-1 was assigned
to the stretching v1 mode of carbonate CO3
-2 groups, which was probably due to the
precipitated HA, as it was not present in the spectrum of synthetic HA. This also
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confirmed the carbonated nature of the precipitated HA of the coating surfaces [261].
Figure 5.10 b, which was the Raman spectra of 13-93 coatings deposited at 50 and
75 kW flame power immersed in SBF for 7 days, showed a small peak in the Raman
analysis of 50 kW coating at 556 cm-1. Moreover, Raman spectra of both 13-93 coatings
after immersed in SBF for 7 days showed a band at 584-596 cm-1 and a shoulder at
614 cm-1. These peaks and shoulders were due to the v4 bending of PO4
-3 [275].
5.4.3 EDX Analysis after Immersion in SBF
EDX line scans of the cross-sections of all the coatings after immersion in SBF for
7 days are shown in Figure 5.13. Figure 5.13 a is the cross-section of ICIE16 coating
deposited at 50 kW, whilst Figure 5.13 b is its corresponding EDX analysis. The coating
thickness was initially 68 ± 1 µm before immersion in SBF, and after immersion for
7 days the thickness had reduced to approximately 57 ± 1.5 µm whilst the deposited
HA layer on this residual coating was approximately 9 ± 1 µm (Figure 5.13 a). Figure
5.13 b showed that Si content increased to 40 wt % at the coating – substrate interface
and remained approximately constant through the coating. However, Si started to
reduce at the coating- HA interface and reached 0 wt % at the top of the HA layer.
The ICIE16 coating deposited at 75 kW was 59 ± 10 µm, and also reduced to 45 ±
13 µm, while the precipitated HA layer (after 7 days of immersion in SBF) on the
surface of this coating was approximately 13 ± 3.5 µm (see Figure 5.13 c). EDX
analysis of this coating (Figure 5.13 d) showed that Si had increased to 42 wt % at
the coating- substrate interface, and then decreased by almost 5 wt % at the coating-
HA interface. Ca was 5 wt % at the interface between coating and substrate whilst
increasing to almost 32 wt % at the top surface of HA layer. P also reduced to 1 wt %
at the coating- substrate interface and increased to almost 18 wt % in the deposited
HA layer. The 13-93 coating deposited at 50 kW was initially 67 ± 1 µm, and after
soaking in SBF for 7 days reduced to 58 ± 2 µm (Figure 5.13 e) whilst the precipitated
HA layer was 8.5 ± 4.3 µm thick. Figure 5.13 f shows that the Si content was 30 wt
%, almost the same as before the SBF test.
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Figure 5.13: In figure a, c are BSE images while b, d are the respective EDX line scan
of ICIE16 coatings deposited at 50 and 75 kW after immersion in SBF 7 days, where e,g
are BSE images while f,h are the respective EDX line scan of 13-93 coatings deposited
at 50 and 75 kW after immersion in SBF 7 days (distance is from substrate-coating
interface towards coating top surface).
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However, this also decreased at the coating- HA layer to 3 wt % in the HA layer.
Ca content started at 13 wt % at the coating – substrate interface, and then increased
at the coating- HA layer interface to almost 32 wt % in the precipitated HA layer. The
75 kW 13-93 bioactive glass coating was 62 ± 14 µm prior to immersion in SBF but
was not uniformly distributed across the surface even after 7 days, as noted above. The
thickness of this residual coating was 60 ± 5 µm, and the precipitated HA thickness
was approximately 6 ± 1 µm (Figure 5.13 g). Figure 5.13 h showed that Si content
remained constant at 30 wt % throughout the coating, and then started decreasing
at the coating- HA interface to almost 15 wt % at the top of the HA layer. The Ca
content also did not change in the coating and remained at around 15 wt %, which
then started increasing at the coating- HA layer to almost 25 wt % in the deposited
HA layer. The P content showed the same trend as Ca, and remained constant at 2
wt % in the coating and started to increase at the interface between coating and HA
layer, increasing to almost 15 wt % at the top of HA layer.
Ca/P atomic ratio of the ICIE16 coatings before SBF and after immersion in SBF
for 3 and 7 days can be seen in Table 5.4. It was observed that the Ca/P ratio decreased
after the SBF tests. Before SBF tests, it was 27.0 ± 2.01 for 50 kW coating and 28.5
± 1.61 for 75 kW coating. After immersion in SBF for 3 days, this had decreased to
1.78 ± 0.03 and 2.23 ± 0.08 for 50 and 75 kW coatings. These values further decreased
to 1.71 ± 0.05 for the 50 kW coating and 1.55 ± 0.01 for the 75 kW coating after
immersion in SBF for 7 days.
Table 5.4: Ca/P ratio (atomic %) of the ICIE16 as-sprayed coatings and soaking in
SBF after 3 and 7 days, where R50 is the coating deposited at 50 kW and R75 is the






0 days in SBF
Ca/P Ratio
Soaking for
3 days in SBF
Ca/P Ratio
Soaking for
7 days in SBF
R 50 27.0 ± 2.0 1.78 ± 0 1.71 ± 0
R 75 28.5 ± 1.6 2.23 ± 0 1.55 ± 0
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5.5 In-vitro Cell Interaction
5.5.1 Cytotoxicity Tests using Alamar Blue Assay
Cell viability and proliferation tests were performed on ICIE16 and 13-93 bioactive
glass coatings at two different time points of 3 and 7 days. Results from Alamar blue
assay are summarised in Figure 5.14.
Two repeats of experiments were performed, and both of these were comparable
in terms of cell viability. Moreover, significant differences were (P < 0.05) present
between control and any of the coatings at time point of 3 days, and intensity was
higher for the control than the coatings. However, no significant differences (P > 0.05)
were present between control and any coating when 7 days were elapsed. After 7 days,
it can be seen that the intensity was elevated for all of coatings than that of after 3
days, which indicates that cells proliferated on coating surfaces. From Figure 5.14, it
should be noted that 13-93 coating, which was deposited at 75 kW showed highest
intensity (more than the control) at time point 7, which means that cell response was
better towards this coating in comparison to the other three coatings. Also, these tests
demonstrated that all these coatings were cytocompatible.
Figure 5.14: Alamar blue assays results of the coatings using MG63 cells after 3 and
7 days of incubation, where TCP (Tissue culture plastic) is the control sample.
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5.5.2 SEM Observation
Figure 5.15 shows the morphology of MG63 cells adhered on to ICIE-16 and 13-93
bioactive glass coatings.
Figure 5.15: SEM images of MG63 cells grown on ICIE16 (a-d) and 13-93 (e-h)
bioactive glass coatings, a, b, e and f after 3 days of seeding and c, d, g and h after 7
days of seeding. a, c, e, and g are the coatings deposited at 50 kW and b, d, f and h
are deposited at 75 kW of flame power.
After 3 days of incubation, it can be seen from Figure 5.15 a, b, e and f that cells
were growing on the surfaces of the coatings and demonstrated extended lamellopodia
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and filopodia; however, as can be seen from Figure 5.15 b and f (which are SEM images
of the ICIE16 and 13-93 coatings deposited at 75 kW of flame power after 3 days of
incubation) multilayer cells were present on these surfaces. By increasing incubation
time (Figure 5.15 c, d, g and f), surfaces of all of the coatings appeared to be covered
with sheets of cells. Also, the cracks in sheets were due to dehydration of the samples
for SEM observation.
5.5.3 Cytotoxiciy Tests using Alamar Blue Assay after Gold
Coating of the Bioactive Glass Coated Surfaces
ICIE16 coating deposited at 75 kW and 13-93 at 50 and 75 kW coatings were gold
coated (ICIE16 50 kW coated samples were run out, so couldn’t include in this test)
and the cell test was performed for 7 days’ time point. The purpose of this test was
to observe the effect of the surface topography on cell viability, as after gold coating,
the composition of the glass coatings wouldn’t affect cell grow. It can be seen in
Figure 5.16,that no significant differences (P > 0.05) were present among the coatings
and control after incubation for 7 days. However, 13-93 coating deposited at 75 kW
showed high intensity in comparison to other coating (but like the control), suggesting
that the rougher surface of this coating had a positive impact on the proliferation of
the cells.
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Figure 5.16: Alamar blue assay results of the ICIE16 and 13-93 bioactive coatings
using MG63 cells after 7 days of incubation.
5.6 Discussion
5.6.1 Coating Characterisation
Regardless of the glass formulations tested or the flame power applied, all the coatings
were observed to be adhered to the substrates as no crack was present along the coating-
substrate interface. The 50 kW coatings of ICIE16 and 13-93 bioactive glasses had
approximately similar microstructure; however, comparing the roughness of the as-
sprayed samples, the 50 kW ICIE16 coating surfaces were smoother (1.8 ± 0 µm) than
the 13-93 bioactive glass coating deposited at the same flame power (2.4 ± 0 µm).
This could be due to the different particle size distribution of the two glasses used for
spraying. As the particle size distribution of 13-93 (Figure 5.1 c) showed more fine
particles present in this powder than present in the ICIE-16 powder samples (Figure
5.1). For fine particles, it has been reported that due to their low inertia, they do
not deform upon hitting the substrate; instead, they retain their spherical morphology
due to surface tension [37]. The presence of more globular particles on the surface of
the 13-93 glass 50 kW coating (Figure 5.4 c, d) also contributed to its roughness, in
comparison to the ICIE16 bioactive glass coatings deposited at the same power (Figure
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5.4 a, b).
The surfaces of the ICIE16 and 13-93 bioactive glass coatings deposited at high
flame power (75 kW) had semi-spherical features (Figure 5.5). This could have been
caused by large agglomerates forming inside the combustion chamber during spray and
adhering to the chamber walls. At high flame power, these agglomerates can melt due
to more heat transfer, leading to detachment from the combustion chamber walls and
sprayed onto the substrate [37]. These globules were also mainly responsible for the
high surface roughness of the higher flame power coatings [276] compared to the lower
50 kW coatings [277]. However, the globules present on the 13-93 coating surface were
not as porous (Figure 5.5 e) as were those present on the surface of ICIE16 coating
deposited at 75 kW (Figure 5.5 b) which could be due to the particle size difference of
the suspensions of two glasses.
The cross-sectional view of ICIE16 75 kW coatings (Figure 5.6 b) showed that in
the globules, after the porous structure at the base, a dense region was present in the
middle of these formations. From studying the morphology of these globular shapes,
it can be argued that there was small surface disruption at the start. Subsequently,
the incoming melted particles interact with these deviations, which results in larger
porous regions due to localised splat disorder. With each torch pass, splat interaction
repeats, creating more porosity [78, 276]. The 75 kW coatings of ICIE16 and 13-93
were thinner, harder and less porous in comparison with the 50 kW coatings (Figure
5.6), which was due to the enhanced melting of these materials at high flame power
leading to less porous and more dense coatings than the 50 kW flame power coatings
[264, 278].
5.6.2 SBF Studies of the ICIE16 and 13-93 Coatings
Investigation of the coatings after immersion in SBF revealed the development of
cauliflower- like precipitates on their surfaces which are characteristic of HA depo-
sition and growth in SBF [217, 279]. The broad crystalline peak at ∼ 26◦ and 32◦ was
associated with the nanocrystalline nature of the precipitated HA [280]. HA formed
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just after 3 days of immersion in SBF on both glass composition coating deposited at
50 kW as confirmed via XRD (Figure 5.11 a, c). The HA precipitation continued with
longer immersion times as the intensity of the HA peaks increased at 7 days. No HA
was observed on the 13-93 coating deposited at 75 kW after 3 days of immersion in SBF
(Figure 5.11 d). This coating revealed HA deposition only after 7 days of immersion in
SBF (Figure 5.8 d). Due to more SiO2 content, 13-93 glass is comparatively resistant
to dissolution and hence apatite formation [37]. Where presence of MgO makes this
glass less vulnerable to dissolution [281]. The 13-93 coating deposited at 75 kW has
more SiO2 and MgO relative to the starting powder (Table 5.3) which could also have
contributed to delayed apatite formation [281]. MgO in glass formulations has been
reported to decrease HA formation in vitro [217]. However, in-vivo it has been shown
to support early-stage mineralisation [217, 282]. MgO acts as network intermediate,
[217] thus inhibiting the dissolution process, which is low for 13-93 compared to 45S5
and ICIE16, due to the higher silica content [276].
Both ICIE16 coatings showed more dissolution in SBF than 13-93 coatings as sug-
gested by EDX analysis along the cross-section of the coatings after immersion in SBF
for 7 days (Figure 5.13). This difference in reactivity of the ICIE16 and 13-93 coatings
deposited at 50 kW was probably due to the higher content of silica in 13-93 than
ICIE16 (Table 5.1), as previously discussed, which caused less dissolution of 13-93 in
SBF [15]. Also, ICIE16 composition is closer to Bioglass (45S5) (which is the most
bioactive material known), as can be seen in the ternary phase diagram described by
Hench et.al [49], and this could be a reason for the more dissolution of ICIE16 coating
in comparison to 13-93 coating. However, comparing the 50 kW coating and 75 kW of
ICIE16, the 75 kW coating showed more reactivity than the 50 kW coating in terms
of dissolution in SBF, which may be due to the higher surface roughness of the 75
kW coating than the 50 kW coating. It has been shown that higher surface roughness
increases the contact area with SBF [283], which increases ion leaching from bioactive
coatings [27]. On the other hand, the 75 kW coating of 13-93 showed less reactivity
than its 50 kW coating during the SBF test. The reason for the lower reactivity of
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13-93 coating deposited at 75 kW is the same as for its coating deposited at 50 kW,
i.e. high silica content and low bioactivity in comparison to ICIE16 coating, which is
the composition closer to Bioglass (45S5).
The Ca/P ratio for ICIE16 coatings deposited at 50 kW after 7 days in SBF given
in Table 5.4, was 1.71 ± 0.05, which is approximately equal to the 1.67 Ca/P ratio
of synthetic HA [99]. For the ICIE16 coating deposited at 75 kW, after immersion
for 7 days, the Ca/P ratio obtained was 1.55 ± 0.01, much closer to that of synthetic
tricalcium phosphate (TCP) for which Ca/P ratio is 1.5 and is also regarded as a
precursor for HA [269]. However, the Ca/P ratio reported for physiologic HA has also
been suggested to be around 1.5 [71].
After immersion in SBF for 7 days, the Ca/P ratio for 13-93 coating deposited at
50 kW was 1.24 ± 0.06 and for the coating deposited at 75 kW was 2.05 ± 0.74 (see
Table 5.4). The Ca/P ratio of the deposition on the surface of the 50 kW coating of
13-93 glass suggests that it could be similar to either octocalcium phosphate (OCP) or
dicalcium phosphate (DCP), with Ca/P ratios of 1.33 and 1 [284]. Ca/P ratio less than
1.67 (which was observed for the HA deposited on 75 kW coating of ICIE16 and 50
kW coating of 13-93 after 7 days of immersion in SBF) shows that the HA precipitated
at the surfaces of the coating were calcium deficient and had carbonated nature [284,
285]. For the 75 kW coating of 13-93, Ca/P ratio was 2.0 ± 0.74, which is closer to
the Ca/P ratio of tetra calcium phosphate (TTP). TTCP is a metastable compound
that converts to HA in a continuous dissolution- precipitation process [286].
5.6.3 In-vitro Cell Interaction of ICIE16 and 13-93 Coatings
Towards MG 63 Cells
In this work, through the study of MG63 cells, it was shown that ICIE16 and 13-93
coatings deposited via SHVOF thermal spray on to stainless steel substrate were cy-
tocompatible, as the coatings showed no cytotoxicity and displayed good proliferation.
From proliferation results, both coatings supported increased viability across the length
of the study. However, it should be noted that the 13-93 coating, which was deposited
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at 75 kW showed the highest intensity after 7 days of incubation in comparison to the
other coatings (Figure 5.14). This may have been due to the rougher surface of this
coating (6.5 ± 0.6 µm), and it has been shown in the literature that rough surfaces
can significantly enhance the attachment of osteoblast-like MG 63 cells [287]; however,
this effect was noted only during the first 24 hrs of incubation and did not affect their
proliferation rate. The same effect of surface roughness on cells was also reported by
Boyan et. al [288]. Also, from the proliferation results, intensity for the 75 kW coating
of 13-93 bioactive glass was more than that of the control, this may have been due to
the enhanced cell proliferation owing to the presence of MgO in the glass composition
as Mg can directly enhance osteoblast proliferation [282]. From these results, it can
be concluded that both ICIE16 and 13-93 coatings deposited at 50 and 75 kW were
nontoxic and bioactive.
5.7 Summary
Bioactive coatings of ICIE16 and 13-93 compositions with varied apatite forming abil-
ity were successfully produced by an emerging SHVOF thermal spraying technique.
Change of flame powers for the same glass resulted in different microstructure of the
coatings, and hence their reactivity in SBF. Spraying at same flame power but with
different compositions also resulted in different microstructure and apatite forming
ability when tested using SBF. In-vitro cell culture tests showed that the surfaces of
these coatings were biocompatible with human osteoblast-like (MG-63) cells. From the
microstructure, SBF and cell tests of these coatings the following conclusions can be
drawn:
• Coatings of ICIE16 and 13-93 sprayed at high flame power (75 kW) were harder,
thinner and less porous than their 50 kW coatings due to better melting of
feedstock materials at high flame power.
• ICIE16 coatings sprayed at both flame powers, and 13-93 coating sprayed at
low flame power (50 kW) revealed HA deposition after 3 days of immersion in
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SBF; however, 13-93 coating sprayed at high flame power (75 kW) showed HA
precipitation immersed in SBF for 7 days.
• In SBF, both of ICIE16 coatings showed more resorption than the 13-93 coatings,
which is due to the high Si content of 13-93 that makes this glass comparatively
stable in SBF.
• In vitro cell tests showed that all of these coatings were biocompatible; however,
the 13-93 coating deposited at high flame power (75 kW) showed the highest
proliferation, which is likely be due to the high surface roughness of the coating
(Ra = 6.5 ± 0.6 µm) and presence of MgO in the glass composition.
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P-40 Phosphate Based Glass
Coatings
6.1 Introduction
In this chapter, Phosphate based glass (PBG) P-40 (40 mol % P2O5, 16 mol % CaO, 24
mol % MgO, 20 mol % Na2O) coatings deposited via SHVOF thermal spray at flame
power of 50 and 75 kW has been characterised. Ion leaching study of the coatings
carried out in milli-Q water, whilst mass degradation study was carried out using PBS
and milli-Q water.
6.2 Powder Characterisation
6.2.1 Particle size distribution
The final powder after ball milling had a distribution shown Figure 6.1. This distribu-
tion had the particle size with D10 = 1.1 µm, D50 = 3.6 µm, D90 = 14 µm. However,
the distribution was wider (as shown in Figure 6.1) with a range of 2 µm -27 µm.
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Figure 6.1: Particle size distribution of P-40 powder used for suspension preparation.
6.2.2 SEM Image and EDX Analysis of the Powder
Figure 6.2 shows the SEM image of the P-40 powder used for suspension preparation,
and the powder contained both fine and coarse particles. The largest particle observed
was approximately 10 µm.
EDX point analysis was carried out on the powder, and the results are presented
in Table 6.1, which shows that the powder had contained 26.4 ± 0.2 wt % P, 12.5 ±
0.2 wt % Ca, 6.2 ± 0.1 wt % Na and 8.2 ± 0.2 wt % Mg, while the elemental wt %
based on the formula of P-40 glass is 28.0 wt % P, 10.3 wt % Ca, 7.3 wt % Na and
5.0 wt % Mg, so it means that in the prepared powder P was present 2 wt % less than
the theoretical wt %. Similarly, the contents of Na and Ca were present less than the
theoretical values; however, Mg amount was more in actual than the theoretical value.
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Figure 6.2: SE, SEM image of the feed stock powder showing powder morphology.





P 28.00 26.4 ± 0.2
Ca 10.36 12.5 ± 0.2
Na 7.30 6.2 ± 0.1
Mg 5.00 8.2 ± 0.2
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6.2.3 XRD and Raman of the Powder
XRD profile of the P-40 powder is presented in Figure 6.3 a. A single broad peak at
25-30 ◦ 2θ ◦ was observed for the glass. The absence of any sharp crystalline peak
confirmed the amorphous nature of the glass.
Figure 6.3 b shows the Raman spectra of the P-40 glass powder. For the Raman
spectrum of P-40 powder, the band at 351 cm-1 was related to bending vibrations
of the O–P–O bonds of Qo tetrahedral units [29,30]. The low-intensity bands in the
range of 470-620 cm-1 are due to the bending vibrations of the P-O bonds and in-chain
P-O-P stretching vibrations [113]. The Raman bands at 670-790 cm-1 are associated
with the P-O-P symmetric stretching of bridging oxygen in Q2 units [289]. The bands
at 1160 cm-1 are related to the symmetric stretching modes of P-O-P bridging oxygen
and O-P-O non-bridging oxygen in Q2 phosphate units [28]. Also, in Q1 tetrahedra,
the bending vibrations of O–P–O bonds peaked at 1046 cm-1 [113], and the shoulder
at 1267 cm-1 was associated with the symmetric stretching of terminal oxygen bonds
[113].
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Figure 6.3: (a)XRD amorphous phase and (b) Raman spectrum of P-40 powder show-
ing structure of P-40 glass.
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6.3 Coating Characterisation
6.3.1 Surface Morphology and Microstructure of the Coatings
Two coatings of P-40 glass were deposited: 50 and 75 kW flame power. The surface
morphology of these coatings can be seen in Figure 6.4, where a, b, c are the surface
images at different magnifications of the P-40 coating deposited at 50 kW, and d, e, f
are the images of coating deposited at 75 kW. Large humps were uniformly distributed
on the surface of both coatings, as can be seen in a, d. However, the globules on
the surface of 50 kW coating (Figure 6.4 seemed to be rough as finer particles were
adhering to the humps. In contrast, the humps present on the surface of the 75 kW
coating (Figure 6.4 e) looked smoother. In addition, humps present on the surface of
both coatings were approximate the the same size and seemed to be larger than 10 µm
in diameter. In the humps-free area, there were -molten splats in both cases, as seen
in Figure 6.4 c and f. In both cases, the material was well molten so that the size of
individual splats could not be estimated.
Figure 6.4: SE, SEM images of the surface of the P-40 coatings, a, b, c coating
deposited at 50 kW, while d, e, f of the 75 kW coating showing morphology of the
coatings.
Cross-section images of the SHVOF sprayed P-40 are shown in Figure 6.5. It can
be seen that both coatings were well-adhered with the substrate, and no crack or
delamination was observed at the interface between the coatings and substrate. The
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microstructure of these coatings was dense, with 50 kW coating 2.9 ± 0.2 % porous and
75 kW coating 1.5 ± 0.4 % porous, respectively. The globular features on the top of the
coatings made their thickness non-uniform (Figure 6.5 b, d). The observed thickness
for the coating deposited at 50 kW was 24.6 ± 2.3 µm, and for the coating deposited
at 75 kW, it was 16.0 ± 3.4 µm, respectively. These globules made the surface of the
coating rough too, with 50 kW coating 2.7 ± 0.1 µm and the 75 kW coating 3.6 ± 0.1
µm.
Figure 6.5: SE, SEM images of the cross-section of P-40 coatings, a, b coating de-
posited at 50 kW and c, d deposited at 75 kW. While a and c are the globules-free
regions, and b and d are with globules.
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6.3.2 EDX Analysis of Coatings
To determine any compositional changes in P-40 glass after thermal spray, EDX scans
were carried out along the cross-section of the coatings and can be seen in Figure 6.6,
where elemental wt % is presented as function of distance from the coating-substrate
with corresponding BSE images. The points on the images show the location where
the analysis was carried out.
In the P-40 coating produced at 50 kW, slight variation was observed in comparison
to the starting powder composition (Table 6.2); however, the elemental wt % was
approximately constant along the cross-section, while going from the coating-substrate
interface to the top of coating. As can be seen in Table 6.2, P content was 26.4
wt % in the starting powder, and that was reduced to 24.5 wt % at the coating-
substrate interface; however, it was observed that wt % of P was 26.4 wt % at the top
of the coating. Before spraying, 12.5 wt % Na was present in the powder; however,
Na wt % was reduced to approximately 5.5 wt % at the coating-substrate interface,
and approximately no further variations were observed in this value up to the top of
the coating. Ca of 9.2 wt % of was observed at the coating-substrate interface and
remained at this value till the top of the coating. This means that the amount of
Ca was increased from that present in the starting powder, which was 6.2 wt %. In
Mg content, the increment was observed from that present in the starting powder,
which was 8.2 wt % to approximately 10 wt % at the coating-substrate interface, and
remained at this value to the top of the coating. Fe of 5 wt % and approximately
2 wt % of Cr were observed near the coating-substrate interface originating from the
substrate.
For the coating of P-40 glass deposited at 75 kW, the same trends were observed
as for the 50 kW coating. The elements wt % was approximately the same along the
cross-section of the coating; however, relative to the starting material, the composition
was slightly changed. Content of P was observed to be 22.6 wt % at the coating-
substrate interface; however, this amount was increased to approximately 25 wt % at
the top of the coating. For this coating, reduction in Na content was slightly more
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than that observed for the 50 kW coating, as its content reduced to 3.53 wt % at the
interface from that of 12.5 wt % (in powder) and did not change from this value till the
top of the coating. Similar to the 50 kW coating, wt % of Ca and Mg were increased
in the 75 kW coating. Ca content was less in the starting powder (6.2 wt %) before
spray and increased to approximately 11.62 wt % along the cross-section of the coating.
Similarly, 11.74 wt % of Mg observed along the coating cross-section till the top of the
coating, while in the powder 8.2 wt % of Mg was present before spraying.
Figure 6.6: a and c are the BSE images of the cross-section of P-40 coatings deposited
at 50 and 75 kW, while, b and d are the respective EDX line scan across the cross-
section (distance is from substrate-coating interface towards coating top surface).
EDX area analysis carried on the top surfaces of the coatings are shown in Table
6.2. This analysis showed that changing the flame power had a significant effect on the
composition of P-40 glass. 26.4 wt % of P was present in the powder, and this amount
was reduced to 24.0 wt % while spraying at 50 kW flame power. This amount was
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further reduced to 22.8 % while depositing at 75 kW flame power. Similar reductions
were observed for the wt % of Na, as it was 12.5 wt % in the powder and reduced to
7.1 wt % at 50 kW and 5.5 wt % in the 75 kW coating. However, the inverse effect was
observed for Ca and Mg content. As Ca wt % was increased from 6.2 (present in the
powder) to 11.6 spraying at 50 kW flame power, and to 13.4 wt % while depositing at
75 kW. Similarly, Mg content was observed to be 11.4 wt % in the 50 kW coating and
12.8 in the 75 kW coating, while in the powder, it was observed to be 8.2 wt %.
Table 6.2: EDX analysis on the top surface of the P-40 coatings in terms of elemental
















































6.3.3 XRD and Raman Analysis of the Coatings
No crystallisation of the P-40 glass occurred due to thermal spraying, and the amor-
phous phase of glass was maintained while depositing at two different flame powers, as
showed by the XRD analysis given in Figure 6.7. The broad diffraction halos centred
at 2θ ≈ 30◦ were identified in the powder and both coatings. The only crystalline peaks
recognised were originated from the substrate and were identified as ferrite (PDF card
no. 00-006-0696) and austenite (PDF card no. 00-023-0298).
Raman analysis was carried out to identify any structural changes in P-40 coatings,
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which is shown in Figure 6.8. For the P-40 powder, the peak at 351 cm-1 was related
to bending vibrations of the O–P–O bonds associated with Q2 tetrahedral units (Q
specie having two BO) [115]. The low-intensity peaks in the range of 470-620 cm-1
were suggested to be due to in-chain O-P-O stretching vibrations [290]. The Raman
peaks at 670-790 cm-1 were associated with the P-O-P symmetric stretching of the
bridging oxygen in Q2 and Q1 units (Q specie with 1 BO), respectively [290]. In the
previous study, it has been shown that P-40 formulation contained 50 % Q2 and Q1
units [115]. The peak at 1040 cm-1 was related to symmetric stretching of PO2 non-
bridging oxygen in Q1 unit. The peak at 1160 cm-1 was associated with the symmetric
stretching modes O-P-O non-bridging oxygen in Q2 phosphate units [290].
Figure 6.7: XRD patterns of the P-40 coatings, where R50 is the coating deposited at
50 KW and R75 is the coating deposited at 75 kW flame power.
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Figure 6.8: Raman spectra of P-40 coatings showing peaks of P-40 coatings.
Post thermal spraying, analysis of the P-40 glass coating at flame power 50 and 75
kW revealed that the peak at 670 cm-1 (which had been assigned to P-O-P symmetric
stretching of the bridging oxygen in Q2 units) had disappeared, whilst the peak at 790
cm-1 had appeared for both coatings. A new peak was also observed at 960 cm-1 for
both the 50 and 75 kW coatings which was associated with the symmetric stretching of
orthophosphate group (PO4
-3) in Q0 unit (Q specie with no BO) [289]. The intensity
of the band at 1046 cm-1 (associated with Q1 unit) also increased for both coatings,
whilst the peak intensity at 1160 cm-1 (associated with Q2 unit) decreased for the 50
kW coating and appeared as a shoulder in the Raman spectrum of the 75 kW coating
(Figure 6.8).
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6.4 Ion Release Profiles of the P-40 Coatings
Cation release profiles Na+, Mg2+, Ca2+ and P5+ for the P-40 coatings were investigated
via ICP-MS while recording the ions release in ultra-pure water. The cumulative ion
release profiles of the glass coatings investigated appeared to follow a linear relationship
with time as shown in Figure 6.9 a and b. In addition, Table 6.3 shows the ion release
rates. The ion release rates were calculated as the slope from the linear interpolation
of the values and are given in Figure 6.9.
Figure 6.9: Mg2+, P5+, Na+, and Ca2+ ion release profile for P-40 coatings (a)
deposited at 50 kW and (b) 75 kW flame power.
148
Chapter 6 Section 6.5
For the 50 kW coating, the highest ion release was that of total P ions with the
release rate of 1.4 ± 0.1 ppm/day, whilst the other ions such as Na+, Ca2+ and Mg2+
were released in similar amounts with the release rate of 0.38 ± 0.04 ppm/day for Na+
and a rate of 0.49 ± 0.06 ppm/day for Ca2+ and Mg2+ (while R2 values for ions of
P, Ca, Na and Mg were 0.95, 0.98, 0.99 and 0.97). Similar to the 50 kW, the 75 kW
coating also revealed total P ion released at the highest rate (1.7 ± 0.1 ppm/day) in
comparison to other ions analysed (Na+, Ca2+ and Mg2+) which were released at 0.57
± 0.02 ppm/day for Mg2+ and the same rate of 0.59 ± 0.08 ppm/day and 0.59 ± 0.02
ppm/day for Na+ and Ca2+ respectively (while R2 values for ions of P, Ca, Na and
Mg were 0.982, 0.996, 0.950 and 0.995). It can also be seen that the overall ion release
rates were higher for 75 kW coating than for the 50 kW coating.
















50 kW 0.49 ± 0.06 0.38 ± 0.04 1.4 ± 0.1 0.38 ± 0.04
75 kW 0.59 ± 0.08 0.57 ± 0.02 1.7 ± 0.1 0.59 ± 0.02
6.5 Mass Degradation Studies of the P-40 Coatings
Degradation profiles of the coatings degraded in PBS and ultra-pure water at 37 ◦C for
14 days are presented in Figure 6.10. Degradation rates were calculated by assuming
linear profiles and are given in Table 6.4. As can be seen that these rates were higher in
MQ water than in PBS for the coatings. The highest rate of 1 x 10-4 mg/mm2·day was
observed for 75 kW coating in MQ water. The lowest degradation rate was observed for
50 kW coating in PBS, which was 1 x 10-5 mg/mm2·day. While 50 kW coating degraded
in MQ water at a rate of 5 x 10-5 mg/mm2·day, that is 5 times its degradation rate in
PBS.
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Figure 6.10: Mass degradation profiles of P-40 coatings (a) deposited at 50 kW and
(b) deposited at 75 kW flame power
.









50 kW 1 5
75 kW 3 10
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6.6 Discussion
6.6.1 Coating Characterisation
It was observed that increasing the flame power from 50 kW to 75 kW had no consid-
erable effect on the microstructure of the P-40 coatings. Spraying at 50 kW and at 75
kW flame power resulted in approximately similar surface topography, e.g. formation
of globules on the surface of the coatings (Figure 6.4). In chapter 5 as well as chapter
4, it was observed that spraying of Bioglass® (45S5) at high flame power of 75 kW
resulted in globules on the surface of the coating, but not with the 50 kW flame power
[291]. The reason for this could be due the formation of large agglomerates inside the
combustion chamber during spray and adhesion of these agglomerates to the combus-
tion chamber and expansion nozzle walls. The high flame power of 75 kW had enough
energy to melt these large agglomerates. Consequently, these agglomerates detached
and resulted in the deposition onto the substrate [37]. However, in the case of P-40
glass, coating deposited at 50 kW had the same globules features on the surface of
the coating. This means that the 50 kW flame power had enough heat energy for this
P-40 glass to produce a similar surface morphology to the 45S5 coating deposited at 75
kW coating. The reason for this could be that the P-40 glass transition temperature
(448 ± 1 ◦C) and melting temperature (764 ± 1 ◦C) is lower [99] in comparison to
45S5 bioactive glass for which glass transition temperature is 520 ◦C [77] and melting
temperature is 1217 ◦C [82]. In globules-free areas, individual splats cannot be seen in
both coatings s due to the better melting of the material at both flame powers of 50
kW and 75 kW.
The microstructure of both P-40 glass coatings was dense (Figure 6.5). The dense
microstructure of 50 and 75 kW is the better melting of the glass at both flame powers
due to more energy transfer, causing better melting of the P-40 particles and resulting
in less porosity [264]. However, both coatings were of different thickness, as the 75 kW
coating was approximately two-third in thickness of the 50 kW coating. This might
be due to the fact that at a high flame of 75 kW the heat transfer was too high that
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caused the material to get evaporated, resulting in thin coating [266, 291]. Another
reason for the thin coating formation at 75 kW flame power could be comparatively
more melting at 75 kW than at 50 kW, resulting in the less porous and thin coating
as reported by Ming et al. while depositing TiO2 suspension via SHVOF [264].
Thermal spraying of P-40 glass at both flame powers of 50 kW and 75 kW caused
altering the composition of the glass with respect to the initial starting powder. Figure
6.6 shows EDX analysis along the cross-section of the coatings to determine these
compositional changes while going from the coating-substrate interface to the top of
the coating. These variations in composition were observed while carrying out EDX
area scan at the top surface of the coatings too. As in Table 6.2, it can be seen that
thermal spray caused reductions in contents of P and Na while spraying at 50 and
75 kW. This might be due to the direct evaporation of P2O5 at high temperature
from the glass melt [266]. The volatile nature of Na2O could be a cause that resulted
in a reduction in its wt % [292]. Evaporation of Na2O from the glass melt is due
to the heterogeneous chemical reaction between Na2O at the surface of the melt and
water vapours present in the combustion chamber resulting in gaseous NaOH [293]. A
decrease in the content of Na2O is followed by an increase in wt % of CaO in the glass
[293].
The structure of the P-40 glass was affected due to thermal spraying and it was
found to be different in the coating than the original powder. Figure 6.8 shows the
Raman spectra of the P-40 powder and coatings, as the Raman spectra of the coatings
were different from the Raman spectrum of the powder. A new peak was found at 960
cm-1 in the Raman spectra of coatings which was not present in the starting powder
spectrum. In the literature, this band was associated with the symmetric stretching
of orthophosphate groups (PO4
-3) [289, 290, 294] which suggested that the P-40 glass
had depolymerised forming Q0 units [113]. Higher intensity of the peak at 1046 cm-1
in coatings spectra compared to P40 powder indicated a higher concentration of Q1
units [113]. Moreover, the intensity of the peak at 1160 cm-1 decreased in the spectra
of the coatings, the decreased intensity of this peak in the coating spectra could be
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due to the reduction in the concentration of Q2 units [113, 289]. Finally, the evolution
of the peak at 670-790 cm-1 as at 750 cm-1 indicated a reduction in the chain length.
It can be concluded from the Raman spectra that the P-40 glass structure changed as
a reduction in the concentration of Q2 units, increased in Q1 units and the potential
formation of Q0 units. In Raman analysis, the observation of orthophosphate (PO4
-3)
peak/ Q0 species in both coatings could be attributed to the reduction of P2O5 content
(from 36 mol % for glass powder to 27-29 mol % for coatings) post thermal spray,
which was confirmed via EDX. In literature, it has been reported that the Q0 species
was observed for the phosphate glasses, which contained P2O5 below 35 mol % [295].
This structural analysis warrants further investigation via NMR characterisation.
However, the challenge here is to ensure that sufficient powder samples can be obtained
from the coatings deposited for accurate analysis.
6.6.2 Ion Release and Degradation Profile of P-40 Coatings
From the ion release studies conducted (Table 6.3), it can be seen that, for both P-40
coatings, cations release rates ranked P > Na > Mg > Ca. P-40 coatings suffered a
structural change during spraying and presented a higher ratio of Q1 and Q0 species
than the initial glass, as observed from Raman analysis, and these changes in the
glass structure had an effect on the glass solubility. In PBGs, Q2 species are more
soluble than species with a lower degree of polymerization, so the P-40 coatings with
a higher ratio of depolymerized species (Q1 and Q0 species) will present reduced ion
release profiles than the initial glass. Ion release study of P-40 bulk glass has been
conducted by Islam et al. [266], who reported ion release rates of 0.8 ppm/day for
Mg, 0.9 ppm/day for Ca and 1.55 ppm/day Na ions, and these values are significantly
higher than the ones obtained for the thermal sprayed P-40 coatings, indicating that
the produced coatings were more resistant to hydrolytic attack, due to the structural
changes induced in the glass during spraying, as proved by Raman analysis (Figure
6.8).
The ion release rates are also influenced by the spray conditions, and the intensity of
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the bands associated with Q1 and Q0 species are very similar for both spray conditions.
However, a higher ratio of depolymerized species was present in the coatings deposited
at 75 kW, whereas a band associated with Q2 units (1160 cm-1) was absent in the 75
kW coating while it was present in the 50 kW coating (see Figure 6.6). Therefore,
according to the glass chemistry, higher dissolution rates should be expected on the
50 kW coating. However, the coating deposited at 75 kW presented higher release
rates than the coating deposited at 50 kW. This could be due to the rougher surface
of the 75 kW coating, which involves a larger surface area in contact with the liquid,
contributing to an increased ion leaching compared to the 50 kW coating. This could
indicate that small changes in the glass structure of the coating had a limited effect on
the ion release rates.
The degradation rates of the coating followed the same behaviour as the ion release
profiles. In MQ water and PBS, both coatings were more stable and presented lower
degradation rates than the PBGs thin films reported in the literature and produced via
magnetron sputtering, probably due to the presence of a higher rate of depolymerized
species. Also, the enrichment of MgO in the coating composition from the initial glass,
which is due to the volatilization of labile elements during spraying, has an important
role because PBGs with higher MgO content tend to present lower degradation rates
[266]. The P-40 coating deposited at 75 kW showed higher degradation than the
coating deposited at 50 kW (Figure 6.10 and Table 6.4),and this could be attributed
to the higher surface roughness of the 75 kW coating.
Overall, thermal sprayed coatings of PBG showed less degradation in PBS and MQ
water and released ions at lower rates in MQ water in comparison to bulk PBG and
thin films. This behaviour of the PBG thermal sprayed coatings could be due to the
change in the structure of the glass in coatings (as revealed via Raman analysis), i.e.,
thermal spray caused the structural changes in P-40, converting it into a less resorbable
glass.
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6.7 Summary
PBG P-40 was deposited onto the stainless substrate by SHVOF thermal spray, pro-
ducing two coatings at the flame power of 50 and 75 kW. The surface topography and
microstructure of both coatings were very similar, showing globules on the top surface
of the coatings with dense cross-sections. However, ion release profiles and degradation
rates of both coatings were different. This could be due to the difference in thickness
and surface roughness of the coatings. From the above results following conclusion can
be made.
1. The SHVOF thermal spray technique was used to deposit P-40 PBG on to stain-
less steel substrate at two flame powers of 50 and 75 kW. Surface topography of
both coatings was very similar, showing globules on the top surface of the coat-
ings. However, ion release profiles and degradation rates of both coatings were
different, which might be due to the difference surface roughness of the coatings.
2. Both coatings were amorphous as shown by XRD analysis; however, the structure
of the coatings was different from that of the starting powder as revealed by
Raman analysis with the reduction in the concentration of Q2 specie, increased
of Q1 specie and the formation of Q0 specie in coatings.
3. 75 kW coating showed more mass loss and ion leaching in comparison to 50
kW coating, which could be due to the rougher surface of the 75 kW coating.
However, comparing these results with those reported in the literature for thin
films of P-40 glass and bulk P-40 glass, both coatings showed lower degradation
and ions release rates. Therefore, if less vulnerable to resorption PBG coatings





Strict operative procedures are followed to minimise the bacterial contamination; how-
ever, implants associated infections significantly raise postoperative complications. Ad-
justing and controlling the antimicrobial properties of the implant surface is one of the
promising approaches to minimise these infections. Two antimicrobial coatings, con-
taining Ga2O3 as an antibacterial agent (chapter 2, section 2.2.4) are reported in this
chapter. The first coating was deposited with the Ga2O3 doped Bioglass
® suspension.
The second coating was deposited by co-spraying Ga2O3 suspension and Bioglass
®
suspension via a hybrid nozzle using axial and radial injection. Both coatings were
deposited at 50 kW flame power. The second coating which was deposited via hybrid
nozzle and named as co-sprayed coating in this chapter. Whilst the coating made
with the Ga2O3 addition to Bioglass
®, named as Ga2O3 doped Bioglass
® coating.
The characterisation results of the coatings are presented here. The SBF study of the
coatings and cells tests are discussed, and then conclusions are drawn.
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7.2 Feedstock Characterisation
7.2.1 Particle Size Distribution and Powder Morphology of
the Ga2O3 powder, 45S5 Bioglass
® and Ga2O3 doped
Bioglass® powder
Figure 7.1 a represents the particle size distribution of Ga2O3 powder used in glass
preparation and suspension preparation, and as can be seen that the powder had a
multimodal distribution with D10 = 1.9 µm, D50 = 4.5 µm and D90 = 18.9 µm. The
SEM image of the Ga2O3 powder (Figure 7.1 b) shows that the as-received powder had
fine and coarse particles. As can be seen that the observed size of the largest particle
was approximately equal to 5 µm, and the particles were angular in shape.
Figure 7.1: (a) Particle size distribution and (b) SE image of the as received Ga2O3
powder.
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Figure 7.2 a, represents the particle size distribution of Ga2O3 doped bioglass
®,
and as can be seen that this distribution had a particle size range of 0.37 to 36.24 µm.
Also, the distribution was characterised by D10 = 1 µm, D50 = 5 µm and D90 = 18
µm. The final powder of the glass was a mixture of fine and coarse particles, as can be
seen in the SEM image of the powder (Figure 7.2 b). The particle of the largest size
observed was larger than 5 µm. Also, particles were of irregular shape.
Figure 7.2: (a) particle size distribution and (b) SE image of Ga2O3 doped Bioglass
®.
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7.2.2 EDX Analysis of Ga2O3 doped Bioglass
®
EDX point analysis were performed on the Ga2O3 doped Bioglass
®, and the results
showed that the Ga2O3 doped Bioglass
® had approximately 1 % less Si and 1 % less Ca
than the Si and Ca content present in Bioglass®. Na and P content were approximately
were equal in both glasses, with 1.7 wt % Ga present in the new formulation.
Ga2O3 doped Bioglass
® powder had 18.3 ± 1.2 wt % Si, 15.3 ± 0.3 wt % Ca, 14.3
± 0.2 wt % Na, 2.1 ± 0.2 wt % P and 1.7 ± 0.1 wt % Ga (Bioglass® composition is
given in chapter 4 section 4.2.2)
7.2.3 XRD and Raman Analysis
The XRD patterns of Bioglass® powder and Ga2O3 doped Bioglass
® powder are shown
in Figure 7.3 a, as can be seen, that both powders were amorphous. The amorphous
humps present between 15 to 38 2θ ◦ showed broad diffraction with no sharp peak
which is the characteristic of short-range order for the glasses. Figure 7.3 b shows
the XRD pattern of the as-received Ga2O3 powder, where all peaks were identified as
Ga2O3 (PDF card no. 00-041-1103).
Figure 7.4 shows the Raman spectra of Ga2O3, 45S5 (Bioglass
®) and Ga2O3 doped
Bioglass® powder. In the Ga2O3 spectrum, peaks at 650, 655 and 760 cm
-1 were due
to the bending and stretching of GaO4. Peaks at 320, 343, 416 and 470 cm
-1 were
associated with the symmetric bending and stretching vibrations of GaO6 octahedra.
The intense peak at 199 and the peak at 168 cm-1 was due to O–Ga–O bending modes
[296, 297].
In the Raman spectrum of Bioglass®, the peaks observed at 610 cm-1 and 1079
cm-1 were assigned to the stretching of Si-O-Si. The peak at 860 cm-1 was assigned
due to the vibration of non-bridging oxygen, i.e. Si-4NBO and the peak at 945 cm-1
was assigned to the stretching of PO4
-2 [254].
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Figure 7.3: XRD spectra (a) of Bioglass® and Ga2O3 doped Bioglass
® powder (b)as
received Ga2O3 powder.
In the spectrum of Ga2O3 doped Bioglass
®, peaks at 199 cm-1, belonged to Ga2O3
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can still be seen (Figure 7.4) while other Ga2O3 peaks were not anymore recognised.
Peaks that belonged to Bioglass® can easily be seen in this glass spectrum. The band
in the Bioglass® spectrum at 610 cm-1 had been moved to 625 cm-1, indicative of
reduction in bond length [113]. Also, the peak at 1075 cm-1 shifted to a lower wave
number of 1066 cm-1 in Ga2O3 incorporated bioactive glass. The peak at 945 cm
-1
appeared at the same wave number for the new glass.
Figure 7.4: Raman spectra of Ga2O3, Ga2O3 doped bioactive glass
and 45S5 (Bioglass®) powder.
7.3 As-Deposited Coatings Characterisation
7.3.1 Surface Morphology and Cross-section of the Coatings
The galium oxide doped bioglass was sprayed at 50 kW and 75 kW. Coating deposited
at 50 kW flame power however no coating deposited at 75 kW. The morphology of
the Ga2O3 doped Bioglass
® deposited at 50 kW flame power is shown in Figure 7.5.
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Figure 7.5 a shows that the surface of the coating had globules, the size of which was
approximately more than 20 µm (Figure 7.5 b). In the globules-free area of the coating,
well-flatten splats with glass drops were present, as shown in Figure 7.5 c.




® glass was a thick coating of approximately 73 ± 2 µm as
shown in Figure 7.6 a; however, this did not adhere to the substrate, as a long crack
was present at the interface between substrate and coating (Figure 7.6 b). Also, from
Figure 7.7, it can be seen that in some regions, there was coating; however, from some
regions it was flaked- off.
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Figure 7.6: SE, SEM image of the cross-section of Ga2O3 doped Bioglass
® coating
deposited at 50 kW.
The co-sprayed coating was produced by depositing Ga2O3 suspension and 45S5
(Bioglass®) suspension at 50 kW flame power, and the surface morphology of the
coating is displayed in Figure 7.8. The substrate was uniformly covered with the glass
coating as can be seen in Figure 7.9. Re-solidified glass droplets were present on the
surface (Figure 7.8 b), however, no flat glass splat was seen in the coating.
Figure 7.7: Ga2O3 doped Bioglass
® coating deposited at 50 kW.
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Figure 7.8: SE, SEM surface morphology of Ga2O3 and 45S5 co-sprayed coating
deposited at 50 kW.
Figure 7.10 shows the cross-section of the coating prepared from hybrid spray, and
as can be seen that the coating adhered to the substrate as no crack was visible at the
coating-substrate interface. The coating thickness was approximately 16 ± 3 µm, as
shown in Figure 7.10 b the coating thickness was not uniform.
Figure 7.9: Ga2O3 and 45S5 co-sprayed coating deposited at 50 kW.
Figure 7.10: SE, SEM image of the cross-section of Ga2O3 and 45S5 co-sprayed
coating deposited at 50 kW.
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7.3.2 EDX analysis of the Coatings along the Cross- Section
and Area Scan on the Top Surfaces
EDX line scan was carried along the cross-section of the coatings to explore any com-
positional changes in glass composition after thermal spray. Results are displayed in
Figure 7.11, where a and c are the SEM images of the coatings and b and d are the
corresponding EDX analysis. The EDX analysis showed that the composition of the
Ga2O3 doped Bioglass
® altered after thermal spray compared with the original glass
powder (7.2.2).
The content of Si (18.3 ± 1.2 wt % present in the powder) was observed to be
23.3 wt % at the coating- substrate interface and then decreased till the top of the
coating to wt % of 21.1 wt %. However, there was slight variation in Si content in the
cross-section of the coating as it was observed to be 24 wt % at 49 µm. Ca content
was 18.6 wt % at the interface between coating and substrate, while at the top of the
coating, it was measured to be 17.7 wt %. Similar to Si content, fluctuations in Ca
content also noted along the cross-section of the coating. Na wt % was approximately
12 at the interface between coating and substrate, and at the top, it was 12 wt %
too. However, Na wt % reduced from that was present in the starting powder (14.3 ±
0.2 wt %). P wt % was observed to be 2.5 at the coating- substrate interface till the
top of the coating. Also, P wt % was not reduced from that present in the powder,
which was 2.1 ± 0.2 wt %. Ga wt % was 1.3 at the interface and approximately 1.4
wt % at the top of the coating, while in the starting powder, it was 1.7 ± 0.1 wt
%. By comparing EDX line scan along the cross-section, the compositional changes of
Ga2O3 doped Bioglass
® coating with that of the Bioglass® coating deposited at 50
kW (4.3.3), it can be seen that Si wt % was first increased at the coating-substrate
interface and then decreased at the top of the coating in both coatings. Similar to Si
wt %, wt % of Ca and P showed similar trend in coatings. Moreover, the content of Na
was decreased in both coatings than the starting powder, Bioglass® (50 kW coating
chapter 4) and Ga2O3 doped -Bioglass
® coating. It means that presence of Ga2O3 in
the composition of Bioglass® did not affect the behaviour of other elements to thermal
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spray.
Figure 7.11: SE SEM images of the cross-section of coatings (a) Ga2O3 doped
Bioglass® (c) Co-sprayed Ga2O3 and 45S5 suspensions, and their respective EDX line
scans through the coating cross-section in b, d. Points in the SEM images show the
location of EDX data points in the graph (distance is from substrate-coating interface
towards coating top surface).
For the co-sprayed depositing Ga2O3 and 45S5 suspensions at 50 kW flame power,
45S5 composition changed due to thermal spray; however, variations in the coating
composition along the cross-section were approximately similar to the chemically mixed
glass coating (except for Ga) (Figure 7.11 d). Such as wt % of Si at the interface was
23 and at the top of the coating was approximately 26. Ca was observed to be 12 wt
% at the coating- substrate interface and then started to increase to approximately 16
wt % at the top of the coating. Na wt % was 12 at the interface and 11 at the top of
the coating. P content was observed to approximately 2 wt % along the cross-section
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of the coating. Ga was not uniformly distributed along the cross-section. Its content
was observed at two points, at one point, it was observed to be 0.9 wt % and 7.8 wt
% near the top of the coating.
EDX area scan was done on the top surfaces of the coatings and displayed in Table
1. In the Ga2O3 doped Bioglass
® coating, Si (23.3 ± 0.1 wt %) and Ca (19.7 ± 0.3 wt
%) content had increased from the intended composition (7.2.2). Na content decreased
to 10.8 ± 0.6, while in the powder, it was 14.3 ± 0.2. P wt % did not change in the
coating, as 2.3 ± 0.1 wt % of P was present in the coating as well as in the powder
before spraying. Moreover, the thermal spray did not affect the content of Ga much,
as before spray, it was observed to be 1.7 ± 0.1 wt % and after thermal spray,1.5 ±
0.1 wt %.
Table 7.1: EDX area analysis on the top surfaces of the as sprayed coatings.







Ga 1.5 ± 0.1 2.0 ± 0.1
Si 23.3 ± 0.1 24.0 ± 0.0
Ca 19.7 ± 0.3 17.3 ± 0.2
Na 10.8 ± 0.6 11.2 ± 0.1
P 2.3 ± 0.1 1.9 ± 0.0
For the co-sprayed coating of Ga2O3 and 45S5 suspensions, the expected wt %
of Ga was 1 and, in the coating, it was observed to be 2.0 ±0.1 wt %. Si content
increased from 19.8 ± 1.7 wt % to 24.0 ± 0.0 wt %, whilst other elemental wt % were
approximately the same as those that were present in the powder.
7.3.3 XRD and Raman of the Coatings
The XRD patterns of Ga2O3 doped Bioglass
® coating and co-sprayed coating of Ga2O3
and Bioglass® (45S5) are plotted in Figure 7.12. As can be seen in Figure 7.12 a, no
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crystallisation was experienced in Ga2O3 doped Bioglass
® in the thermal spray process.
The co-sprayed coating, composed of Ga2O3 and Bioglass
® was amorphous too and
characterised by broad diffraction peak appearing in 25◦ - 35◦ 2θ range. The identified
phases (Figure 7.12 b) corresponded to either crystalline Ga2O3 (PDF card no. 00-
041-1103) or metal substrate (stainless steel) were as austenite with PDF card no.
00-023-0298, and ferrite (PDF card no. 00-006-06 t96). The crystalline peaks due to
the substrate in the spectrum were present as the thickness of the coating was less than
penetration depth of X-rays (40.8 µm penetration depth of the x-rays).
Figure 7.12: XRD spectra of (a) Ga2O3 doped Bioglass
® coating and (b) co-sprayed
coating of Ga2O3 and Bioglass
®.
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Figure 7.13 a represents the Raman spectrum of the Ga2O3 doped Bioglass
® coat-
ing. The shoulder identified at 860 cm-1 was assigned due to the vibration of non-
bridging oxygen (which represents 4 non-bridging oxygen/silica tetrahedra (Q0) [153])
in the Raman spectra of Ga2O3 doped Bioglass
® glass and Bioglass® powder (Figure
7.4), was no more identified in the coating spectrum (Figure 7.13). The peak that
appeared at 430 cm-1 could be attributed to the symmetric stretching mode of GaO6
octahedra [297]. Figure 7.11 b represents the Raman spectrum of the co-sprayed coat-
ing deposited by spraying Ga2O3 and Bioglass
® suspensions. Peaks for Si-O-Si, PO4
−2
were identified; however, for Ga2O3, no peak was seen in the coating spectrum.
Figure 7.13: Raman spectrum of the (a) Ga2O3 doped Bioglass
® coating and (b)
co-sprayed Ga2O3 and Bioglass
® coating deposited at 50 kW flame power.
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7.4 SBF Tests
7.4.1 SEM Observations
Figure 7.14 represents the surface morphology of the coatings after SBF tests. After
3 days of immersion in SBF HA was deposited on the surface of the coatings (Figure
7.14 a, c), which can be identified from the dome- like morphology of the precipitate.
However, this was not clearly visible on the surface of the Ga2O3 doped Bioglass
®
coating (Figure 7.14 a), but was visible on the surface after 7 days of immersion in
SBF (Figure 7.14 b).
Figure 7.14: SE, SEM images of the surface of the coatings (a) and (c) after 3 days
and (b), (d) after 7 days of immersion in SBF. While, a,b are the images of the Ga2O3
doped Bioglass® and c, d are images of co-sprayed Ga2O3 and Bioglass
® coating.
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7.4.2 XRD and Raman Analysis
Figure 7.15 represents XRD spectra acquired at the surface of the coatings after im-
mersing in SBF for 3 and 7 days. HA was identified from the peaks at 32◦ and 26◦
2θ (PDF no 00-001-1008). In Figure 7.15 a, Ga2O3 peaks were identified at 35
◦ and
38◦ 2θ (PDF card no. 00-041-1103). However, no peak was identified in 7.15a for the
XRD spectra of Ga2O3 doped Bioglass
® coating after SBF test (Figure 7.15 a), which
could be due to the precipitation of thicker HA layer than that precipitated on the
other coating.
Figure 7.16 shows the Raman spectra obtained on the surface of Ga2O3 doped
Bioglass® coating and the co-sprayed coatings, immersed in SBF for 7 days. The
spectrum obtained for synthetic HA powder is also shown. As can be seen that Raman
spectra followed the same evolution for both of the coatings. The peak around 960 cm-1
is associated with the ν1 vibration mode of PO4
-3 for HA powder and HA precipitated
on the surfaces of the coatings; this is the main peak of HA. The peak at 1046 cm-1 in
the spectra of HA powder and HA precipitated on the coatings was associated with the
PO4
-3 ν3 vibration. Moreover the peak the peak at 1078 cm-1 in the spectrum of HA
powder was associated with the PO4
-3 ν3 vibration too. Also, peak at 432 cm-1 in all
of the spectra was due to the ν2 domain of the PO4
-3. Moreover, the peak at 1070 cm-1
for the precipitated HA on the surfaces of the coatings was assigned to the ν1 mode
of the carbonate group which confirmed the carbonated nature of the precipitated HA
[256, 261]. The three peaks at 579, 590, and 608 cm-1, and in which 590 cm-1 is the
strongest among these was due to the ν4 vibration of PO4
-3. These peaks were present
in the spectrum of synthetic HA powder as well as in the spectra of precipitated HA
on the surface of coatings [261, 262].
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Figure 7.15: XRD spectra after 3 and 7 days of soaking in SBF of (a) Ga2O3 doped
Bioglass and (b) co-sprayed Ga2O3 and 45S5 hybrid coating.
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Figure 7.16: Raman spectra of the Ga2O3 doped Bioglass
® and co-sprayed Ga2O3 and
Bioglass® coatings after 7 days of immersion in SBF; additionally Raman spectrum of
Synthetic HA powder is also presented here.
7.4.3 EDX line Scan along with the Cross-Section and Area
Analysis on the Top Surfaces
For the Ga2O3 doped Bioglass
® coating, the coating integrity was not good enough to
cut sample for the EDX line analysis along the cross-section of the coating after SBF
test. Figure 7.17 represents the EDX line scan along the cross-section of co-sprayed
Ga2O3 and 45S5 coating after 3 and 7 days of SBF test. In Figure 7.17 b, Si content
was 12.50 wt % at the interface between coating and substrate and 19 wt % at the top
of the coating.
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Figure 7.17: BSE, SEM images of the cross- section of the co-sprayed Ga2O3 and
Bioglass® coating (a) after 3 days and (b) after 7 days of immersion in SBF, (c), (d)
are the respective EDX analysis. (distance is from substrate-coating interface towards
coating top surface).
Na wt % was 0.7 at the coating- substrate interface and 0 wt % at the top of the
coating due to HA precipitation on the surface. Ca content was 18.7 wt % at the
interface and 12.0 wt % at the top of the coating. P was observed to be 10.20 wt % at
the interface and approximately 7.0 wt % at the top coating. Ga wt % was observed to
be approximately 4 at the top of the coating after 3 days of immersion in SBF, however,
no Ga was observed to be present at other point at this line. 12.10 wt % of Fe and 3.6
wt % of Cr were observed near the substrate. The EDX line scan of the coating after
immersing in SBF for 7 days is shown in Figure 7.17 d. Near the substrate, Si content
was 26 wt % and then started decreasing till the top of the coating where it decreased
approximately to 3.7 wt %. No Na was observed in the coating. P was observed to be
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1.4 wt % at the coating-substrate interface and then started increasing along the cross-
section, and at the top it was observed to be 17 wt %. Content of Ca was observed to
be 3.70 wt % at the coating-substrate interface and then started increasing till the top
of the coating where it was noticed to be 36 wt % Ga was observed only in the middle
of the EDX line scan which was 2.20 wt %. 7.50 wt % of Fe and 5.30 wt % Cr was
observed at the coating- substrate interface.
Table 7.2 shows EDX area scan carried out at the top surface of the coatings after
immersing in SBF for 3 and 7 days. In Ga2O3 doped Bioglass
® coating, Si, Na and
Ga wt % reduced to 9.0 ± 0.6, 1.8 ± 0.1 and 0.8 ± 0.2, whilst Ca and P content
was increased to 30.7 ± 0.7 and 0.8 ± 0.2 after 7 days of immersion in SBF. For the
co-sprayed Ga2O3 and 45S5 coating, Si, Na and Ga content reduced to 6.2 ± 0.8 wt
%, 0.5 ± 0.0 wt % and 0 wt %. Whilst wt % of Ca and P increased to 25.2 ± 0.6
and 12.3 ± 0.3 wt % after 7 days of SBF test. This means that less glass coating was
remained after SBF test for the co-sprayed glass coating in comparison to the Ga2O3
doped glass coating.
Table 7.3 shows the Ca/P ratio (atomic) for coatings after thermal spray and im-
mersed in SBF for 3 and 7 days. Results suggested that this ratio was high (7.2 ±
0.6) for Ga2O3 doped Bioglass
® coating than the co-sprayed Ga2O3 and 45S5 coating
before SBF test. However, after immersing in SBF for 7 days Ca/P ratio was higher
(1.6 ± 0.0 which is approximately equal to the Ca/P ratio of synthetic HA)) for the
co-sprayed Ga2O3 and 45S5 coating than Ga2O3 doped Bioglass
® coating, for which
it was 1.4 ± 0.1.
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Table 7.2: EDX area scan at the top surface of the coatings after immersion in SBF




















Si 22.7 ± 0.9 9.0 ± 0.6 10.2 ± 0.7 6.2 ± 0.8
Na 9.2 ± 4.2 1.8 ± 0.1 0.3 ± 0.1 0.5 ± 0.0
Ca 17.4 ± 1.0 30.7 ± 0.7 22.7 ± 0.6 25.2 ± 0.6
P 5.3 ± 2.5 14.2 ± 0.3 11.3 ± 0.1 12.3 ± 0.3
Ga 1.2 ± 0.2 0.8 ± 0.2 0.2 ± 0.1 0.0





0 Days in SBF
Ca/P Ratio
Soaking For
3 Days in SBF
Ca/P Ratio
Soaking For




7.2 ± 0.6 1.2 ± 0.1 1.4 ± 0.1
Ga2O3 and 45S5
Hybrid Coating
5.2 ± 0.5 1.5 ± 0.0 1.6 ± 0.0
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7.5 In-vitro Cytotoxicity Tests of the Co-Sprayed
Ga2O3 - Bioglass
® Coating
The Ga2O3 doped Bioglass
® coating integrity was not good enough to maintain adhe-
sion to the substrate to cut sample for cytotoxicity tests, so no cell test was performed
using this coating. Cytotoxicity of the co-sprayed Ga2O3 and 45S5 coating was tested
using MG63 cells, and the results are summarised in Figure 7.18. As can be seen that
the control produced relatively increased cellular response than the coated samples,
which is an indication of a relative abundance of the cells present on the surface after
incubation for 12 hours and 3 days; however, the relative intensity of the coating was
very low in comparison to that produced by the control after 3 days of incubation.
For each time points (for the repeat too, not shown here), the significant statistical
differences were present as P value was less than 0.05. According to ISO 10993-5:2009
this coating was cytotoxic [298].
Figure 7.18: Alamar blue assay results of the co-sprayed Ga2O3 and 45S5 coating
after 12 hrs and 3 days of incubation with MG63 cells.
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7.6 Discussion
7.6.1 Coating Characterisation
The surface of the Ga2O3 doped Bioglass
® coating is shown in Figure 7.5, and it can be
seen that the surface of the coating had globules, well-molten splats and glass droplets.
Similar morphology was obtained with Bioglass® while depositing at 75 kW (Fig 7.5
c, f). It means that 50 kW flame had enough heat energy for this glass to produce
a surface morphology similar to the 45S5 coating deposited at 75 kW coating. This
could be due to the addition of Ga2O3 to the glass, as it has been suggested that if
Ga enters the glass network as a network modifier, glass transition temperature (and
melting point ) of the glass should decrease [299].
Figure 7.6 shows the cross-section of the Ga2O3 doped Bioglass
® coating, and as
it can be seen that the coating was not a uniform coating as the crack can be seen
along the cross-section of the coating (Figure 7.6 b). This could be due to the residual
stresses in the coating, which are caused by property mismatch or deposition process
[300].
For the co-sprayed coating, produced by depositing Ga2O3 suspension and 45S5
suspension at 50 kW flame power, a uniform coating was obtained as the whole surface
of the substrate was fully covered with a coating (Figure 7.9). Also, no visible crack
was noticed along the cross-section of the coating (Figure 7.10). The surface of the
coating had re-solidified glass with no flat splat. It means that the glass particles did
not spent enough time in the flame to get fully molten or decelerated before reaching
the substrate, which could be the reason of the low thickness (16 ± 3 µm) of this
coating. This thickness is lower than that obtained by depositing Bioglass® at 50 kW
flame power with the obtained thickness of 25 ± 1 µm (4.3.1). this could be due to
the hybrid nozzle (shroud) attachment, as it was investigated by Suneil et al. that the
attachment of the shroud results in a lower average particle velocity with a maximum
difference of 100 m/s without and with a shroud attachment [300].
EDX analysis along the cross-section of the coatings (Figure 7.11) showed that the
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variations in the composition of both coatings are approximately similar except for
the content of Ga. As can be seen in Figure 7.11 b, the wt % of Ga is approximately
uniformly distributed along the cross-section of the Ga2O3 doped Bioglass
® coating.
While for the co-sprayed coating, Ga was observed only at two points (Figure 7.11 d),
in the middle of the coating (0.9 wt %) and near the top of the coating (7.8 wt %).
The non-uniform distribution of Ga in the co-sprayed coating could be due to the low
flowrate (25 ml/min) of Ga2O3 suspension in comparison to the Bioglass
® suspension
flow rate which was 50 ml/min. So, the coating was mainly composed of Bioglass with
non-uniform distribution of Ga2O3.
The XRD spectrum (Figure 7.13 a) of the Ga2O3 doped Bioglass
® coating was
amorphous, no crystalline peak was observed. Similarly for the co-sprayed coating
spectrum (Figure 7.13 b), crystalline peak associated with Ga2O3 was observed. This
was due to the fact that Ga2O3 was not mixed with the glass before making the glass,
but was co-sprayed with it and Ga retained its crystalline nature in thermal spraying.
In the Raman spectra of both coatings (Figure 7.13), the peak associated with 860
cm-1 was assigned due to the vibration of non-bridging oxygen (Figure 7.4) was no
more identified in coating spectra. This could be due to the increase concentration of
bridging oxygen (BO) in the glass network [153] as a result of thermal spray. The EDX
analysis of the coatings could support the high concentration of BO, as the amount of
Si in the coatings had been increased than the starting powder (Table 7.1). Moreover,
in the spectrum of co-sprayed Ga2O3 and Bioglass
® coating, no peak was identified
for Ga2O3. This could be due to the random selection of the points on the top surface
of the coating for Raman analysis. Since Ga was not uniformly distributed in coating,
so it might be missing at the analysis point.
7.6.2 Coatings SBF Tests
The present results showed that the Ga2O3 doped Bioglass
® was bioactive as apatite
formation on the surface of the coating took place after immersing in SBF after 3 days
(Figure 7.14 a, b). It has been investigated that adding 1 and 1.6 mol % Ga2O3 to
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glass composition does not affect the apatite forming ability of the bioactive glass;
moreover, this addition makes the glass durable in SBF which causes reduction in ion
release [152].
The co-sprayed coating composed of Ga2O3 and 45S5 was bioactive too, as the
coating showed apatite formation after 3 days of immersion (Figure 7.12 c, d). The
Ga2O3 suspension had only 1 wt % solid loading [152]. However, this co-sprayed
coating was chemically stable in SBF in comparison to 45S5 coating deposited at 50
kW (Chapter 4 section 4.4.3). As the 50 kW coating of 45S5 showed a reduction in
thickness form 25 µm to 6 µm after immersing in SBF for 7 days [291], however, the
present coating did not showed any noticeable reduction in thickness. This could be
due to the presence of Ga2O3 in coating [152].
Moreover, after 7 days of immersion in SBF, EDX area scan (Table 7.3) showed
that the Ga wt % was reduced to 0. However, it can be seen that there were still Ga
in the coating, as observed by the EDX line scan along the cross-section of the coating
(Figure 7.14 d). This could be due the precipitated HA layer on the surface of the
coating, which did not let EDX to detect Ga while doing area scan at the top of the
coating. Also, it could be due to the leaching out of the Ga in the solution from the
top layer of the coating surface.
7.6.3 Cytotoxicity Tests
After 3 days of incubation of MG-63 cells with the co-sprayed Ga2O3 and Bioglass
®
(Figure 7.18) the relative intensity was very low compared to the control, which showed
that this coating was cytotoxic. This could be attributed to the leaching of Ga3+
ion from the coating, which is known to possess antineoplastic and antiproliferative
properties [301]. Antineoplastic property of gallium is due its ability to bind iron-
transport protein i.e. transferrin (Tf), lactoferrin and ferritin, which enables it to
accumulate in proliferating tissue (mostly tumours) where large amounts of Tf receptors
(TfR) are released [302]. Ga3+ ion enters in Tf complexes via TfR by cells which leads
to iron deprivation and ultimately prevent cell division may leading to apoptosis. This
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could explain why cell viability was reduced when cultured with this coating.
7.7 Summary
According to the presented results and above discussion following conclusion can be
drawn
• Ga2O3 1.2 wt % incorporated bioactive glass was prepared but could not be
successfully deposited via SHVOF thermal spray at flame power of 75 kW, and
a non-homogeneous coating was produced at flame power of 50 kW.
• Ga2O3 doped Bioglass® coating was bioactive as the coating revealed HA depo-
sition after immersion in SBF.
• Co-sprayed coating of Ga2O3 and 45S5 was deposited at 50 kW flame power
using a hybrid nozzle; however, the coating was thin which could be due to the
decelerating affect of the particles in the presence of the shroud (Hybrid nozzle
attachment).
• This co-sprayed coating was bioactive as HA was precipitated on the surface of
the coating after immersion in SBF. Moreover, this coating was chemically stable
in SBF as the thickness of the coating did not changed.
• Co-sprayed Ga2O3 and 45S5 coating was cytotoxic towards MG63 osteoblast like
cells, as a pronounced (based on ISO 10993-5:2009) difference in cells viability




The body of this work was focused on (i). investigating deposition of different mate-
rials namely Bioglass®, 13-93 and ICIE16 bioactive glasses, PBG, chemically mixed
Ga2O3-Bioglass
® and Ga2O3 and 45S5 hybrid coatings deposition via SHVOF ther-
mal spraying for biomedical applications; (ii) optimisation of the process parameters
to deposit a coating suitable for physiological fluid; (iii) studying the dissolution of
bioactive coatings in SBF and cytotoxicity towards MG63 cells; (iv) investigation of
ion release and mass degradation of PBG. The general conclusions of the research work
are summarised as below.
Bioglass® (45S5) was successfully coated at flame powers of 50 and 75 kW on
to stainless steel substrate. These flame powers were optimised while depositing
45S5. Four runs were performed to deposit 45S5, i.e. 25 kW, 50 kW, 75 kW
and 90 kW. No deposition was achieved at flame power of 90 kW, thick coatings
(25 ± 1 µm) at flame powers of 50 and 75 kW and thin coating (< 10 µm) was
obtained at 25 kW flame power. Coatings deposited at 50 and 75 kW flame
powers had flattened splats, round spheres on the surface of the coatings. The
surface of the coating deposited at 75 kW flame power had globules and due
to which the surface of this coating was rougher than the 50 kW coating. This
was due to the melting of all the material because of high heat transfer from
the flame to the particles in the combustion chamber, and then depositing as
agglomerates at the surface of the coating. Heat transfer at 90 kW might be very
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high that evaporated all of the material in the suspension, and consequently, no
deposition was obtained at this flame power. The lower flame power of 25 kW
had not enough energy to melt and accelerate the particles. When the non-
molten particles and agglomerates with low velocity collide onto the substrate,
bounced back, and impaired the deposition.
SBF studies showed that 25 kW coating was not bioactive, as no HA deposition
was observed on the surface of the coating after even 7 days of immersion in SBF.
Also, this coating was not stable in SBF as increased wt % of Fe and Cr were
observed from the substrate after 3 and 7 days of immersion in SBF. 50 and 75
kW coatings of 45S5 revealed HA formation on the surface of the coatings after
3 days of immersion in SBF; however, 50 kW coating showed more dissolution in
SBF (as its thickness reduced from 25 µm to 6 µm) than 75 kW coating (before
SBF test thickness was 25 µm and after SBF test 23 µm). This could be due to
the more porous microstructure of the 50 kW coating.
ICIE16 and 13-93 bioactive glass coatings were successfully deposited at the
flame powers of 50 and 75 kW. At 50 kW, with both compositions porous (∼ 6
%), thick (∼ 68 µm), less hard (242 HV) and less rough (2 µm) coatings were
obtained. Whilst at the flame power of 75 kW, thinner, denser, and harder
(∼ 4 % porosity, 300 HV, and 60 µm thick) coatings were obtained with both
formulations. However, 13-93 coating obtained at 75 kW was rougher (Ra = 6.5
± 0.6 µm) than that of the 75 kW coating of ICIE16, which was 3.7 ± 0.6 µm
rough.
Each of the glass used in this work has a different network connectivity (NC).
For ICIE16 the NC is 2.13 and which is closer to the NC of 45S5 (2.11), while
for 13-93 it is 2.58. For ICIE16 coatings (50 and 75 kW), HA precipitated on
the surfaces of the coatings after 3 days of immersion in SBF. Following the
NC, 13-93 coatings were expected to show delayed apatite precipitation, which
was observed for 13-93 coating deposited at 75 kW flame power after 7 days of
immersion in SBF. However, its 50 kW coating showed HA precipitation after
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3 days of immersion in SBF. Ca/P atomic ratio for ICIE16 coatings was 1.71
± 0.05 for the 50 kW coating and 1.55 ± 0.01 for the 75 kW coating after 7
days of immersion in SBF, whilst for 13-93 it was 1.24 ± 0.06 for the 50 kW
coating, and for the 75 kW coating 2.05 ± 0.74. These results suggested that
HA precipitated on the surface of ICIE16 coatings had a composition closer to
synthetic HA. It means that ICIE16 coatings are more reactive towards SBF,
whilst 13-93 coatings were comparatively stable.
Cell viability and proliferation tests using MG63 cells demonstrated that ICIE16
and 13-93 coatings were cytocompatible. After 3 days of incubation, significant
differences (P < 0.05) were present between the control and any of the coating.
The relative intensity was higher for the control in comparison to the coatings.
However, after 7 days of incubation, no significant differences were present (P
> 0.05) in any of the results. The rougher coating of 13-93 deposited at 75 kW
flame power showed highest proliferation (more than the control), suggesting
that the cell response was better towards this coating in comparison to other
three coatings. This could be due to the high roughness of the surface and high
Mg wt % present in the coating composition.
Cell tests were also performed by coating the surfaces of ICIE16 and 13-93
coatings with gold. No significant differences were present among the coatings
and control after incubation for 7 days; however, 13-93 coating deposited at
75 kW showed high intensity in comparison to other coating (but similar to
the control), suggesting that the rougher surface of this coating had a positive
impact on the proliferation of the cells.
This research work then looked into PBG (P40) coatings produced at the flame
power of 50 and 75 kW. Similar to the above bioactive coatings, thin (16.0 ± 3.4
µm) and rougher (3.6 ± 0.1 µm) coating was obtained at 75 kW flame power,
whilst thicker (24.6 ± 2.3 µm) and less rough (Ra = 2.7 ± 0.1 µm) coating
was obtained at 50 kW. Due to these differences, 75 kW coating showed less
dissolution in PBS and milli-Q water and less ion release in milli-Q water.
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Raman spectra of these coatings were different from that of the P-40 before
thermal spray. Results suggested that before thermal spray P-40 had Q1, and
Q2 species. However, after the thermal spray, the Raman spectra of the coatings
proposed that the concentration of Q2 species decreased whilst the concentration
of Q1 increased and Q0 species formed. These changes in the structure of the
glass resulted in a reduced degradation and ion release profiles in comparison to
those reported for P-40 thin film and bulk glass.
Moreover, antimicrobial bioactive coatings were also explored by spraying chem-
ically mixed Ga2O3-Bioglass
® and a co-sprayed coating of Ga2O3 and Bioglass
®
suspension (via hybrid nozzle) deposited at flame power of 50 kW. With chemi-
cally mixed Ga2O3-Bioglass
®, the coating obtained was not of good quality, as
the substrate was not uniformly covered with the coatings. Also, this coating
could be easily removed in the form of flakes with a finger. This could be due to
the residual stresses in the coating that caused the poor adhesion of the coating
with the substrate. However, the coating was bioactive as the samples revealed
apatite formation after 3 days of immersion in SBF.
Co-sprayed uniform coating, deposited with Ga2O3 and 45S5 suspensions via a
hybrid nozzle was obtained at 50 kW flame power. This coating also developed
HA after 3 days of immersion in SBF, suggesting that the coating was bioac-
tive. Moreover, the cell tests demonstrated this coating to be cytotoxic, as a
pronounced (based on ISO 10993-5:2009) reduction in cells viability (relative
intensity) was observed in comparison to the control.
SHVOF is a promising technique for the deposition of adherent bioactive coat-
ings, bioactive with antimicrobial ions coatings and bioresorbable coatings which
may find applications upon bone load bearing implants for their potential to




This study has shown that coatings for biomedical applications can be produced via
SHVOF. However, further research can be carried out on these coatings to investigate
the adhesive strength of these coatings with the substrate. Also, the adhesion strength
could be done after SBF tests in case of bioactive coatings.
For Bioglass® 45S5 coatings and bioactive glasses (ICIE16 and 13-93), ion re-
lease study can be done. This could be a way to determine the amount of ions
release from the coatings related to specific compositions and their microstruc-
tures. Moreover, in-vivo study of these coatings should be a way to compare
and contrast to bone bonding and bone ingrowth simulation ability.
For P-40 coatings, since the Raman analysis showed structural changes post de-
position, this structural analysis warrants further investigation, via NMR char-
acterisation. Also, in-vitro cell tests can be done to determine cytoxicity of these
coatings.
For the chemically mixed Ga2O3-Bioglass
® glass, Optimisation of the parame-
ters such as wt % of Ga2O3 to prepare a glass that would be suitable for coating
purposes. Moreover, glass transition temperature and the reason of residual
stresses in the coating should be investigated so that the reason for the unsuc-
cessful coating could be known.
The co-sprayed Ga2O3 and Bioglass
® coating, the wt % of Ga2O3 in the sus-
186
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pension should be also optimised so that the coating would not release Ga3+
in a toxic concentration. Moreover, further study is required to do ion leaching
and antibacterial tests of the existing coating.
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